Processing 00000000.tx.1: Impaired Inhibitory G-Protein Function Contributes to Increased Calcium Currents in Rats With Diabetic Neuropathy Karen E. 

Phrase: "Impaired Inhibitory G-Protein Function"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   840   C0815043:protein function [Amino Acid, Peptide, or Protein]
   840   C1527118:Protein Function [Molecular Function]
   804   C0031843:function [Physiologic Function]
   804   C0542341:Function [Functional Concept]
   804   C0700205:FUNCTION [Classification]
   804   C1705273:Function [Intellectual Product]
   733 E C0205245:Functional [Functional Concept]
   733 E C2700217:Functional [Conceptual Entity]
   717   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415142:INHIBITORY G PROTEIN [Gene or Genome]

Phrase: "Contributes to Increased Calcium Currents"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0553702:increased calcium [Finding]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0521116:currents [Temporal Concept]
   760   C1880177:Contribute [Activity]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "in Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "With Diabetic Neuropathy Karen E."
Processing 00000000.tx.2: Hall,1,2 Jackie Liu,2 Anders A.F. 

Phrase: "Hall,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2 Jackie Liu,"

Phrase: "2 Anders A.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.3: Sima,3 and John W. 

Phrase: "Sima,"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "John W."
Processing 00000000.tx.4: Wiley1,2 1Veterans Affairs Ann Arbor Healthcare System, Geriatric Research Education Clinical Center, Ann Arbor 48105; 

Phrase: "Wiley1,"

Phrase: "2 1Veterans Affairs Ann Arbor Healthcare System,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   818   C0018696:System, Health Care [Health Care Related Organization]
   795   C0086388:Health Care [Health Care Activity]
   795   C0449913:System [Functional Concept]
   795   C1553451:System [Manufactured Object]
   795   C1704459:System [Medical Device]
   724 E C0205373:Systemic [Functional Concept]

Phrase: "Geriatric Research Education Clinical Center,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0683939:research center [Manufactured Object,Organization]
   840   C2347782:Clinical Center [Organization]
   804   C0205099:Center [Spatial Concept]

Phrase: "Ann Arbor 48105"

Phrase: ";"
Processing 00000000.tx.5: 2Department of Internal Medicine, University of Michigan Healthcare System, Ann Arbor 48109; 

Phrase: "2Department of Internal Medicine,"

Phrase: "University of Michigan Healthcare System,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0018696:System, Health Care [Health Care Related Organization]
   804   C0086388:Health Care [Health Care Activity]
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "Ann Arbor 48109"

Phrase: ";"
Processing 00000000.tx.6: and 3Department of Pathology, Wayne State University, Detroit, Michigan 48201  ABSTRACT TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Hall, Karen E., Jackie Liu, Anders A.F. 

Phrase: "and"

Phrase: "3Department of Pathology,"

Phrase: "Wayne State University,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0041740:University [Manufactured Object,Organization]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "Detroit,"

Phrase: "Michigan 48201  ABSTRACT TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Hall,"

Phrase: "Karen E.,"

Phrase: "Jackie Liu,"

Phrase: "Anders A.F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.7: Sima, and John W. 

Phrase: "Sima,"

Phrase: "and"

Phrase: "John W."
Processing 00000000.tx.8: Wiley. 

Phrase: "Wiley."
Processing 00000000.tx.9: Impaired Inhibitory G-Protein Function Contributes to Increased Calcium Currents in Rats With Diabetic Neuropathy. 

Phrase: "Impaired Inhibitory G-Protein Function"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   840   C0815043:protein function [Amino Acid, Peptide, or Protein]
   840   C1527118:Protein Function [Molecular Function]
   804   C0031843:function [Physiologic Function]
   804   C0542341:Function [Functional Concept]
   804   C0700205:FUNCTION [Classification]
   804   C1705273:Function [Intellectual Product]
   733 E C0205245:Functional [Functional Concept]
   733 E C2700217:Functional [Conceptual Entity]
   717   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415142:INHIBITORY G PROTEIN [Gene or Genome]

Phrase: "Contributes to Increased Calcium Currents"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0553702:increased calcium [Finding]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0521116:currents [Temporal Concept]
   760   C1880177:Contribute [Activity]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "in Rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "With Diabetic Neuropathy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011882:Diabetic neuropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0442874:Neuropathy [Disease or Syndrome]
Processing 00000000.tx.10: J. 

Phrase: "J."
Processing 00000000.tx.11: Neurophysiol. 

Phrase: "Neurophysiol."
Processing 00000000.tx.12: 86: 760-770, 2001. 

Phrase: "86"

Phrase: ":"

Phrase: "760-770,"

Phrase: "2001."
Processing 00000000.tx.13: There is a growing body of evidence that sensory neuropathy in diabetes is associated with abnormal calcium signaling in dorsal root ganglion (DRG) neurons. 

Phrase: "There"

Phrase: "is"

Phrase: "a growing body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "that sensory neuropathy in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0151313:Sensory neuropathy [Disease or Syndrome]
   760   C0442874:Neuropathy [Disease or Syndrome]
   760   C0445254:Sensory [Qualitative Concept]

Phrase: "is"

Phrase: "associated with abnormal calcium signaling"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C0600431:Calcium Signaling [Cell Function]
   806   C0740472:abnormal calcium [Finding]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0037083:Signaling [Cell Function]
   760   C0205161:Abnormal [Qualitative Concept]
   760   C2347472:% Abnormal [Quantitative Concept]
   760   C2699333:ABNORMAL [Intellectual Product]
   760   C2936886:Calcium [Pharmacologic Substance]
   760   C3537152:signaling [Biologic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in dorsal root ganglion (DRG) neurons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.14: Enhanced influx of calcium via multiple high-threshold calcium currents is present in sensory neurons of several models of diabetes mellitus, including the spontaneously diabetic BioBred/Worchester (BB/W) rat and the chemical streptozotocin (STZ)-induced rat. 

Phrase: "Enhanced influx of calcium"

Phrase: "via multiple high-threshold calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0521116:currents [Temporal Concept]
   771 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "is"

Phrase: "present in sensory neurons of several models of diabetes mellitus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0150312:Present [Quantitative Concept]
   739   C0449450:Present [Idea or Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the spontaneously diabetic BioBred/Worchester (BB/W) rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "the chemical streptozotocin (STZ)-induced rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
Processing 00000000.tx.15: We believe that abnormal calcium signaling in diabetes has pathologic significance as elevation of calcium influx and cytosolic calcium release has been implicated in other neurodegenerative conditions characterized by neuronal dysfunction and death. 

Phrase: "We"

Phrase: "believe"

Phrase: "that abnormal calcium signaling in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600431:Calcium Signaling [Cell Function]
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "has"

Phrase: "pathologic significance as elevation of calcium influx"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0237881:Significance [Quantitative Concept]
   748   C0750502:Significance [Idea or Concept]

Phrase: "and"

Phrase: "cytosolic calcium release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in other neurodegenerative conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "characterized by neuronal dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880022:Characterized [Activity]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "death."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]
Processing 00000000.tx.16: Using electrophysiologic and pharmacologic techniques, the present study provides evidence that significant impairment of G-protein-coupled modulation of calcium channel function may underlie the enhanced calcium entry in diabetes. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "electrophysiologic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0013865:Electrophysiology [Biomedical Occupation or Discipline]
   928   C1446476:Electrophysiology [Diagnostic Procedure]

Phrase: "and"

Phrase: "pharmacologic techniques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that significant impairment of G-protein-coupled modulation of calcium channel function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0684336:Impairment [Pathologic Function]

Phrase: "may"

Phrase: "underlie"

Phrase: "the enhanced calcium entry in diabetes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705654:Entry [Intellectual Product]
Processing 00000000.tx.17: N- and P-type voltage-activated, high-threshold calcium channels in DRGs are coupled toopiate receptors via inhibitory Go-type G proteins. 

Phrase: "N-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "P-type voltage-activated, high-threshold calcium channels in DRGs"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   797   C0752247:P-Type Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0814022:voltage activated calcium channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786 E C3541203:P-type calcium channel [Molecular Function]
   760   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0553702:high calcium [Finding]
   739   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0006726:Calcium [Inorganic Chemical]
   739   C2936886:Calcium [Pharmacologic Substance]
   706   C0439799:Channel [Spatial Concept]
   706   C1706095:Channel [Conceptual Entity]

Phrase: "are"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "toopiate receptors via inhibitory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "type G proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.18: The responsiveness of this receptor coupled model was tested in dorsal root ganglion (DRG) neurons from spontaneously-diabetic BB/W rats, and streptozotocin-induced (STZ) diabetic rats. 

Phrase: "The responsiveness of this receptor"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "was"

Phrase: "tested in dorsal root ganglion"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   862   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   862   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   806   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   806   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   760   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   760   C0040452:Root [Body Part, Organ, or Organ Component]
   760   C0205095:Dorsal [Spatial Concept]
   760   C0242726:Root [Plant]
   760   C0392366:tested [Intellectual Product]
   760   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   760   C1318154:Root [Body Part, Organ, or Organ Component]
   760   C1705917:Root [Idea or Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "(DRG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
  1000   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   901   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   901   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C0040452:Root [Body Part, Organ, or Organ Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C0242726:Root [Plant]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C1318154:Root [Body Part, Organ, or Organ Component]
   827   C1705917:Root [Idea or Concept]

Phrase: ")"

Phrase: "neurons from spontaneously-diabetic BB/W rats,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "and"

Phrase: "streptozotocin-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "(STZ) diabetic rats."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
   827   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.19: Intracellular dialysis with GTPS decreased calcium current amplitude in diabetic BB/W DRG neurons compared with those of age-matched, nondiabetic controls, suggesting that inhibitory G-protein activity was diminished in diabetes, resulting in larger calcium currents. 

Phrase: "Intracellular dialysis with GTPS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011945:Dialysis [Natural Phenomenon or Process]
   770   C0011946:dialysis [Therapeutic or Preventive Procedure]
   770   C0917873:dialysis [Therapeutic or Preventive Procedure]
   770   C1059964:Dialysis [Eukaryote]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "calcium current amplitude in diabetic BB/W DRG neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C2346753:Amplitude [Spatial Concept]

Phrase: "compared with those of age-matched, nondiabetic controls,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0001779:Age [Organism Attribute]
   744   C0150103:matched [Research Activity]
   744   C1707455:Compared [Activity]
   744   C1708943:Matched [Qualitative Concept]
   711   C0243148:control [Qualitative Concept]
   711   C1550141:Control [Substance]
   711   C1882979:Control [Conceptual Entity]
   711   C2587213:Control [Functional Concept]
   711   C3274648:Control [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that inhibitory G-protein activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1537044:protein activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415142:INHIBITORY G PROTEIN [Gene or Genome]

Phrase: "was"

Phrase: "diminished in diabetes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205216:Diminished [Quantitative Concept]

Phrase: "resulting in larger calcium currents."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0332294:Resulting in [Functional Concept]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0443228:larger [Quantitative Concept]
   760   C0521116:currents [Temporal Concept]
   760   C0549177:Larger [Quantitative Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1704243:Larger [Quantitative Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C1705970:Current [Natural Phenomenon or Process]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.20: Facilitation of calcium current density (IDCa) by large-amplitude depolarizing prepulses (proposed to transiently inactivate G proteins), was significantly less effective in neurons from BB/W and STZ-induced diabetic DRGs. 

Phrase: "Facilitation of calcium current density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "(IDCa"

Phrase: ")"

Phrase: "by large-amplitude depolarizing prepulses"

Phrase: "("

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to transiently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inactivate"

Phrase: "G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "significantly less effective in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "from BB/W"

Phrase: "and"

Phrase: "STZ-induced diabetic DRGs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0011928:DRGs [Intellectual Product]
   779 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.21: Facilitation was enhanced by intracellular dialysis with GTPS, decreased by pertussis toxin, and abolished by GDPS within 5min. 

Phrase: "Facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "enhanced by intracellular dialysis"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0011945:Dialysis [Natural Phenomenon or Process]
   770   C0011946:dialysis [Therapeutic or Preventive Procedure]
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0917873:dialysis [Therapeutic or Preventive Procedure]
   770   C1059964:Dialysis [Eukaryote]
   770   C2349975:Enhanced [Activity]

Phrase: "with GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "decreased by pertussis toxin,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   770   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   770   C0043167:Pertussis [Disease or Syndrome]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "and"

Phrase: "abolished by GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "within 5min."
Processing 00000000.tx.22: Direct measurement of GTPase activity using opiate-mediated GTP[35S] binding, confirmed that G-protein activity was significantly diminished in STZ-induced diabetic neurons compared with age-matched nondiabetic controls. 

Phrase: "Direct measurement of GTPase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0242485:Measurement [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "opiate-mediated GTP[35S"

Phrase: "] binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that G-protein activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1537044:protein activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "significantly"

Phrase: "diminished in STZ-induced diabetic neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0027882:Neurons [Cell]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0205216:Diminished [Quantitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0241863:DIABETIC [Finding]

Phrase: "compared with age-matched nondiabetic controls."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0001779:Age [Organism Attribute]
   753   C0150103:matched [Research Activity]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.23: Diabetes did not alter the level of expression ofopiate receptors and G-protein subunits. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the level of expression ofopiate receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3244092:expression level [Idea or Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "G-protein subunits."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   793   C1711351:Subunit [Quantitative Concept]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.24: These studies indicate that impaired regulation of calcium channels by G proteins is an important mechanism contributing to enhanced calcium influx in diabetes.  

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "indicate"

Phrase: "that impaired regulation of calcium channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "by G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "is"

Phrase: "an important mechanism contributing to enhanced calcium influx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contributing [Activity]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.25: INTRODUCTION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Considerable evidence suggests that impaired regulation of calcium currents in sensory neurons may contribute to neuronal dysfunction and injury in diabetes mellitus. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Considerable evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that impaired regulation of calcium currents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in sensory neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0027883:sensory neurons [Cell]
  1000   C0034837:Neurons, Sensory [Cell Component]
   861   C0027882:Neurons [Cell]
   861   C0445254:Sensory [Qualitative Concept]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "may"

Phrase: "contribute to neuronal dysfunction"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0031847:dysfunction [Functional Concept]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1880177:Contribute [Activity]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "injury in diabetes mellitus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C3263722:Injury [Injury or Poisoning]
   770   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.26: Various pathological lesions are observed in animal and human models of diabetes: segmental demyelination; 

Phrase: "Various pathological lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: "are"

Phrase: "observed in animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0003062:Animal [Animal]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "models of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: ":"

Phrase: "segmental demyelination"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333457:Segmental demyelination [Disease or Syndrome]
   861   C0011304:Demyelination [Pathologic Function]

Phrase: ";"
Processing 00000000.tx.27: atrophy; 

Phrase: "atrophy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333641:Atrophy [Pathologic Function]
   928 E C0151514:Atrophic [Disease or Syndrome]

Phrase: ";"
Processing 00000000.tx.28: loss of myelinated and unmyelinated fibers; 

Phrase: "loss of myelinated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "unmyelinated fibers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C1304649:Fibers [Tissue]
   827 E C0012173:Fiber [Food]
   827 E C0225326:Fiber [Pharmacologic Substance]
   827 E C0304068:Fiber [Plant]
   827 E C1260603:Fiber [Plant]

Phrase: ";"
Processing 00000000.tx.29: Wallerian degeneration; 

Phrase: "Wallerian degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0043020:Wallerian Degeneration [Cell or Molecular Dysfunction]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: ";"
Processing 00000000.tx.30: segmental and paranodal demyelination; 

Phrase: "segmental"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205122:Segmental [Spatial Concept]

Phrase: "and"

Phrase: "paranodal demyelination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011304:Demyelination [Pathologic Function]

Phrase: ";"
Processing 00000000.tx.31: and blunted nerve fiber regeneration (Greene et al. 1992; Ozaki et al. 1996). 

Phrase: "and"

Phrase: "blunted nerve fiber regeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C0027756:Nerve Regeneration [Cell Function]
   812   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "(Greene et al. 1992"

Phrase: "; Ozaki et al. 1996"

Phrase: ")."
Processing 00000000.tx.32: A variety of pathogenic mechanisms have been described (Greene et al. 1992), including vascular insufficiency, glycosylation of cellular components, formation of sorbitol and other polyols, mitochondrial dysfunction (Kostyuk et al. 1999), and abnormal calcium signaling in peripheral sensory pathways (Hall et al. 1995b; Voitenko et al. 2000). 

Phrase: "A variety of pathogenic mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Greene et al. 1992"

Phrase: ")"

Phrase: ","

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "vascular insufficiency,"
Meta Candidates (Total=14; Excluded=9; Pruned=0; Remaining=5)
  1000   C0232352:Vascular insufficiency [Pathologic Function]
   861   C0005847:vascular [Body Part, Organ, or Organ Component]
   861   C0231179:Insufficiency [Functional Concept]
   861   C1558950:VASCULAR [Finding]
   861   C1801960:Vascular [Qualitative Concept]
   805 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   805 E C1511228:VESSEL, BLOOD [Tissue]
   789 E C0205412:Insufficient [Qualitative Concept]
   789 E C0231180:Insufficient [Qualitative Concept]
   761 E C0005767:Blood [Tissue]
   761 E C0005768:blood [Body Substance]
   761 E C0229664:Blood [Body Substance]
   761 E C0392895:Bloods [Population Group]
   745 E C0333275:Bloody [Qualitative Concept]

Phrase: "glycosylation of cellular components,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017982:glycosylation [Natural Phenomenon or Process]
   770   C0376322:Glycosylation [Molecular Function]

Phrase: "formation of sorbitol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C1156364:sorbitol formation [Molecular Function]
   790   C0220781:formation [Biologic Function]
   790   C0439634:formation [Spatial Concept]
   790   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "other polyols,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0071629:polyols [Organic Chemical]

Phrase: "mitochondrial dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "(Kostyuk et al. 1999"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "abnormal calcium signaling in peripheral sensory pathways"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   793   C2984272:Calcium signaling pathway [Functional Concept]
   778   C0600431:Calcium Signaling [Cell Function]
   774   C0037080:pathways signaling [Molecular Function]
   757 E C0037083:signaling pathway [Cell Function]
           Signaling
   757 E C0086982:Signaling Pathway [Molecular Function]
   748   C3537152:signaling [Biologic Function]

Phrase: "(Hall et al. 1995b"

Phrase: "; Voitenko et al. 2000"

Phrase: ")."
Processing 00000000.tx.33: Impaired calcium regulation in diabetes may be of particular importance as it has been correlated with both impaired neuronal conduction and neuronal injury. 

Phrase: "Impaired calcium regulation in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "may"

Phrase: "be of particular importance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Be [Conceptual Entity]

Phrase: "as"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "correlated with both impaired neuronal conduction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0221099:Impaired [Functional Concept]
   753   C0232217:Conduction [Organ or Tissue Function]
   753   C0457405:Conduction [Natural Phenomenon or Process]
   753   C0521390:Neuronal [Immunologic Factor]
   753   C0684336:Impaired [Pathologic Function]
   753   C1707520:Correlated [Qualitative Concept]

Phrase: "and"

Phrase: "neuronal injury."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3263722:Injury [Injury or Poisoning]
   861   C3263723:Injury [Injury or Poisoning]
Processing 00000000.tx.34: Elevation of calcium currents observed in peripheral and spinal sensory neurons in rodent models of diabetes results in increased cytosolic calcium release from internal stores and impaired calcium re-sequestration (Hall et al. 1996; Voitenko et al. 1999). 

Phrase: "Elevation of calcium currents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439775:Elevation [Therapeutic or Preventive Procedure]
   770   C0702240:Elevation [Spatial Concept]

Phrase: "observed in peripheral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205100:Peripheral [Spatial Concept]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "spinal sensory neurons in rodent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0027883:sensory neurons [Cell]
   806   C0034837:Neurons, Sensory [Cell Component]
   760   C0027882:Neurons [Cell]
   760   C0445254:Sensory [Qualitative Concept]

Phrase: "models of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C3161035:Model [Intellectual Product]

Phrase: "results in increased cytosolic calcium release"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   783   C0553702:increased calcium [Finding]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0030685:Release [Health Care Activity]
   753   C0205217:Increased [Quantitative Concept]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0680255:release [Health Care Activity]
   753   C1274040:Result [Functional Concept]
   753   C1283071:Release [Functional Concept]
   753   C1383501:Cytosolic [Cell Component]
   753   C1546471:Result [Idea or Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]
   753   C2825142:Result [Finding]
   753   C2936886:Calcium [Pharmacologic Substance]

Phrase: "from internal stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]

Phrase: "and"

Phrase: "impaired calcium re-sequestration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0443301:Sequestration [Functional Concept]
   812   C2986904:RE [Idea or Concept]

Phrase: "(Hall et al. 1996"

Phrase: "; Voitenko et al. 1999"

Phrase: ")."
Processing 00000000.tx.35: The latter is of particular interest as prolonged elevation of cytosolic calcium has been implicated in the pathogenesis of neuronal injury in a variety of neurodegenerative disorders (Orrenius and Nicotera 1994). 

Phrase: "The latter"

Phrase: "is of particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "as prolonged elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "of cytosolic calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in the pathogenesis of neuronal injury"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0521390:Neuronal [Immunologic Factor]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C3263722:Injury [Injury or Poisoning]
   748   C3263723:Injury [Injury or Poisoning]

Phrase: "in a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "(Orrenius"

Phrase: "and"

Phrase: "Nicotera 1994"

Phrase: ")."
Processing 00000000.tx.36: The observation that diabetes was associated with increased current amplitude in multiple voltage-dependent calcium currents (Hall et al. 1995b; Voitenko et al. 2000) suggested that the underlying impairment might affect signal transduction pathways coupled to multiple calcium channel subtypes. 

Phrase: "The observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "associated with increased current amplitude"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C0521116:Current [Temporal Concept]
   760   C1705970:Current [Natural Phenomenon or Process]
   760   C2346753:Amplitude [Spatial Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in multiple voltage-dependent calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0521116:currents [Temporal Concept]
   771 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(Hall et al. 1995b"

Phrase: "; Voitenko et al. 2000"

Phrase: ")"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the underlying impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0684336:Impairment [Pathologic Function]

Phrase: "might"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "signal transduction pathways"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0086982:Signal Transduction Pathways [Molecular Function]
   913   C0037080:Signal Pathways [Molecular Function]
   901   C0037083:Signal Transduction [Cell Function]
   827   C1160185:transduction [Organism Function]
   827   C1704259:Pathways [Molecular Function]
   827   C1705987:Pathways [Conceptual Entity]
   827   C1710082:Signal [Phenomenon or Process]

Phrase: "coupled to multiple calcium channel subtypes."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0439799:Channel [Spatial Concept]
   753   C0449560:subtypes [Classification]
   753   C1706095:Channel [Conceptual Entity]
   753   C1948027:Coupled [Functional Concept]
   753   C2936886:Calcium [Pharmacologic Substance]
   719 E C0010222:couple [Family Group]
Processing 00000000.tx.37: Neuropathic pain and sensory paresthesias are a common complication of diabetes mellitus and are often difficult to treat with opiates. 

Phrase: "Neuropathic pain"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027796:Neuropathic Pain [Sign or Symptom]
   861   C0030193:Pain [Sign or Symptom]
   861   C1962977:Pain NOS [Finding]
   789   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "and"

Phrase: "sensory paresthesias"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030554:Paresthesias [Sign or Symptom]

Phrase: "are"

Phrase: "a common complication of diabetes mellitus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C0342257:Diabetes Mellitus Complication [Pathologic Function]
           Diabetes Complication
   753   C0009566:Complication [Pathologic Function]
   753   C2362589:Complication [Idea or Concept]

Phrase: "and"

Phrase: "are"

Phrase: "often difficult to"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332183:Often [Temporal Concept]
   827   C0332218:Difficult [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "treat with opiates."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0242401:Opiates, NOS [Laboratory Procedure]
   790   C0376196:Opiates [Hazardous or Poisonous Substance,Pharmacologic Substance]
   790   C1292734:TREAT [Functional Concept]
   790   C1522326:Treat [Functional Concept]
Processing 00000000.tx.38: In sensory dorsal root ganglion (DRG) neurons, k and m opiate receptors inhibit multiple high-threshold calcium channel subtypes via a pathway coupled primarily to the pertussis toxin (PTX)-sensitive, inhibitory guanine nucleotide binding (G) protein, Go (Moises et al. 1994; Wiley et al. 1997). 

Phrase: "In sensory dorsal root ganglion"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   923   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   923   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   902   C0206429:Ganglion, Sensory [Body Part, Organ, or Organ Component]
   875   C2333444:Sensory root [Classification]
   861   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   861   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   812   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   812   C0040452:Root [Body Part, Organ, or Organ Component]
   812   C0205095:Dorsal [Spatial Concept]
   812   C0242726:Root [Plant]
   812   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   812   C1318154:Root [Body Part, Organ, or Organ Component]
   812   C1705917:Root [Idea or Concept]

Phrase: "(DRG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
  1000   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   901   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   901   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C0040452:Root [Body Part, Organ, or Organ Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C0242726:Root [Plant]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C1318154:Root [Body Part, Organ, or Organ Component]
   827   C1705917:Root [Idea or Concept]

Phrase: ")"

Phrase: "neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "k"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "m opiate receptors"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0034801:Receptors, Opiate [Amino Acid, Peptide, or Protein,Receptor]
   827   C0376196:Opiate [Hazardous or Poisonous Substance,Pharmacologic Substance]
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "multiple high-threshold calcium channel subtypes via a pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449560:subtypes [Classification]

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "primarily to the pertussis toxin (PTX)-sensitive, inhibitory guanine nucleotide binding"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   760   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   760   C1148916:nucleotide binding [Molecular Function]
   757   C0332324:Sensitive to [Functional Concept]
           Sensitive
   757   C1817325:guanine binding [Molecular Function]
   739   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   739   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   739   C0043167:Pertussis [Disease or Syndrome]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
   739   C1550474:sensitive [Idea or Concept]
   739   C3463820:Inhibitory [Activity]

Phrase: "(G) protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "(Moises et al. 1994"

Phrase: "; Wiley et al. 1997"

Phrase: ")."
Processing 00000000.tx.39: We previously observed that opiate-mediated inhibition of calcium currents was significantly impaired in a rat model of Type I diabetes (Hall et al. 1996); 

Phrase: "We previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that opiate-mediated inhibition of calcium currents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "significantly"

Phrase: "impaired in a rat model of Type I diabetes"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0011854:Type 1 diabetes [Disease or Syndrome]
   764   C0441729:Type I [Classification]
   762   C1320657:Diabetes type [Finding]
   742   C0011847:Diabetes [Disease or Syndrome]
   742   C0011849:Diabetes [Disease or Syndrome]
   742   C0021966:I- [Inorganic Chemical]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0221099:Impaired [Functional Concept]
   742   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0332307:Type [Qualitative Concept]
   742   C0684336:Impaired [Pathologic Function]
   742   C1547052:*Type [Quantitative Concept]
   742   C3161035:Model [Intellectual Product]

Phrase: "(Hall et al. 1996"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.40: however, the underlying mechanism for this significant diminution in opiate responsiveness in diabetes was unclear. 

Phrase: "however,"

Phrase: "the underlying mechanism for this significant diminution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "in opiate responsiveness"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   789   C0205342:Responsive [Functional Concept]
   761 E C2371924:Responsivity [Mental Process]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "unclear."
Processing 00000000.tx.41: Using electrophysiologic and pharmacologic techniques, the present study was undertaken to determine whether G-protein activity and/or expression was affected by diabetes. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "electrophysiologic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0013865:Electrophysiology [Biomedical Occupation or Discipline]
   928   C1446476:Electrophysiology [Diagnostic Procedure]

Phrase: "and"

Phrase: "pharmacologic techniques,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "undertaken"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "G-protein activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1537044:protein activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and/or"

Phrase: "expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "affected by diabetes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.42: Prepulse facilitation of ionic currents by a large-amplitude depolarizing voltage step results in augmented current amplitude elicited by a subsequent test pulse. 

Phrase: "Prepulse facilitation of ionic currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "by a large-amplitude depolarizing voltage step results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   766   C1274040:Result [Functional Concept]
   766   C1546471:Result [Idea or Concept]
   766   C2825142:Result [Finding]

Phrase: "in augmented current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "elicited by a subsequent test pulse."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0449265:Elicited by [Qualitative Concept]
           elicited
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0232117:PULSE [Clinical Attribute]
   753   C0332282:Subsequent [Temporal Concept]
   753   C0391850:Pulse [Physiologic Function]
   753   C0392366:test [Intellectual Product]
   753   C1947910:Pulse [Phenomenon or Process]
Processing 00000000.tx.43: The response is both time- and voltage-dependent with rapid reversal observed within 500ms (Ikeda 1991). 

Phrase: "The response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "both time-"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "voltage-dependent with rapid reversal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0598352:Voltage [Quantitative Concept]
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "observed within 500ms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "(Ikeda 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: ")."
Processing 00000000.tx.44: The mechanism is thought to involve transient inactivation of inhibitory G proteins associated with calcium channels (De Waard et al. 1997; Ikeda 1991). 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "transient inactivation of inhibitory G proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "associated with calcium channels"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C2936886:Calcium [Pharmacologic Substance]
   737   C0439799:Channel [Spatial Concept]
   737 E C0750490:Associate [Idea or Concept]
   737   C1706095:Channel [Conceptual Entity]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(De Waard et al. 1997"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011198:DE [Geographic Area]
   804   C0017480:DE [Geographic Area]
   804   C3541240:DE [Idea or Concept]

Phrase: "; Ikeda 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: ")."
Processing 00000000.tx.45: The phenomenon of facilitation is not limited to reversal of inhibition by agonists known to act via inhibitory G proteins but can also be demonstrated to occur in the absence of exogenous inhibitory ligands (Doupnik and Pun 1994). 

Phrase: "The phenomenon of facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "limited to reversal of inhibition"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0439801:Limited [Functional Concept]
   760   C0443290:Reversal [Functional Concept]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]
   760   C3542948:Limited [Intellectual Product]
   726 E C1549649:Limit [Idea or Concept]
   726 E C2349209:Limit [Conceptual Entity]

Phrase: "by agonists"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243192:agonists [Pharmacologic Substance]
  1000   C2987634:agonists [Pharmacologic Substance]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act via inhibitory G proteins"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   828   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   828   C1415142:INHIBITORY G PROTEIN [Gene or Genome]
   806   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   781 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0439267:g% [Quantitative Concept]
   760   C3463820:Inhibitory [Activity]

Phrase: "but"

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur in the absence of exogenous inhibitory ligands"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0023688:Ligands [Chemical]
   744   C0205101:Exogenous [Spatial Concept]
   744   C0205228:Exogenous [Functional Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
   744   C3463820:Inhibitory [Activity]

Phrase: "(Doupnik"

Phrase: "and"

Phrase: "Pun 1994"

Phrase: ")."
Processing 00000000.tx.46: The latter suggests that "tonic" inhibition of calcium channels occurs. 

Phrase: "The latter"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that ""tonic"" inhibition of calcium channels"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1516145:Calcium Channel Inhibition [Cell Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "occurs."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.47: Such tonic inhibition may be due to autocrine/paracrine stimulation of receptors or may involve mechanisms independent of receptor stimulation. 

Phrase: "Such tonic inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "may"

Phrase: "be due to autocrine/paracrine stimulation of receptors"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0596138:Autocrine [Organ or Tissue Function]
   744   C0597170:paracrine [Physiologic Function]
   744   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]
   744   C2987476:Be [Conceptual Entity]
   744   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "may"

Phrase: "involve"

Phrase: "mechanisms independent of receptor stimulation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.48: Facilitation may have a physiologic role in excitable tissues receiving convergent inputs (Dolphin 1996), as neuronal excitatory postsynaptic potentials may be increased up to 50% by stimulation with repetitive or simultaneous inputs. 

Phrase: "Facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "may"

Phrase: "have"

Phrase: "a physiologic role in excitable tissues"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "receiving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514756:Receive [Qualitative Concept]

Phrase: "convergent inputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708517:Input [Conceptual Entity]

Phrase: "(Dolphin 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013005:Dolphin [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "neuronal excitatory postsynaptic potentials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0524913:Excitatory Postsynaptic Potentials [Organ or Tissue Function]
   861   C2350339:Postsynaptic Potentials [Organ or Tissue Function]
   858   C0234121:Excitatory potential [Organ or Tissue Function]
   812   C3245505:potentials [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "increased up to 50%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]

Phrase: "by stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1292856:Stimulation [Therapeutic or Preventive Procedure]
  1000   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with repetitive"

Phrase: "or"

Phrase: "simultaneous inputs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708517:Input [Conceptual Entity]
Processing 00000000.tx.49: Two animal models of Type 1diabetes were investigated: the spontaneous BioBred/Worchester (BB/W) rat and the streptozotocin (STZ)-induced diabetic rat. 

Phrase: "Two animal models of Type 1diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0599779:Models, Animal [Animal]
   753   C0003062:Animal [Animal]
   753   C3161035:Models [Intellectual Product]

Phrase: "were"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: ":"

Phrase: "the spontaneous BioBred/Worchester"

Phrase: "(BB/W"

Phrase: ")"

Phrase: "rat"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:Rat, NOS [Mammal]
  1000   C0034721:Rat [Mammal]

Phrase: "and"

Phrase: "the streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ")-"

Phrase: "induced diabetic rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0241863:DIABETIC [Finding]
Processing 00000000.tx.50: This was done to determine if the alterations in electrophysiologic and metabolic function were a ubiquitous feature of many models of diabetes or were model-specific. 

Phrase: "This"

Phrase: "was"

Phrase: "done"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "if"

Phrase: "the alterations in electrophysiologic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1515926:Alteration [Idea or Concept]

Phrase: "and"

Phrase: "metabolic function"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0031843:function [Physiologic Function]
   861   C0311400:Metabolic [Functional Concept]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1524026:Metabolic [Cell Function]
   861   C1705273:Function [Intellectual Product]
   861   C2707259:Metabolic [Clinical Attribute]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "were"

Phrase: "a ubiquitous feature of many models of diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1521970:Feature [Qualitative Concept]
   744   C1706388:Feature [Conceptual Entity]
   744   C2346469:Feature [Qualitative Concept]
   744   C2348519:Feature [Qualitative Concept]

Phrase: "or"

Phrase: "were"

Phrase: "model-specific."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205369:Specific [Qualitative Concept]
   861   C1552740:specific [Intellectual Product]
Processing 00000000.tx.51: At the ages and duration of diabetes studied in this report, autonomic and sensory neuropathy have been documented in both models. 

Phrase: "At the ages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "duration of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449238:Duration [Temporal Concept]
   790   C2926735:Duration [Pharmacologic Substance]

Phrase: "studied in this report,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0684224:Report [Intellectual Product]
   770   C0700287:Report [Health Care Activity]
   770   C3273238:Report [Intellectual Product]
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "autonomic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004388:Autonomic [Body System]

Phrase: "and"

Phrase: "sensory neuropathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0151313:Sensory neuropathy [Disease or Syndrome]
   861   C0442874:Neuropathy [Disease or Syndrome]
   861   C0445254:Sensory [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "documented in both models."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1301725:Documented [Health Care Activity]
   770   C1609436:documented [Idea or Concept]
   770   C3161035:Models [Intellectual Product]
   737 E C1301746:document [Intellectual Product]
   737 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.52: Both BB/W and STZ-induced diabetic animals demonstrate slowing of action potentials as measured by nerve-conduction studies. 

Phrase: "Both BB/W"

Phrase: "and"

Phrase: "STZ-induced diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "demonstrate"

Phrase: "slowing of action potentials"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0001272:Action Potentials [Cell Function]
   786   C0597474:slow potential [Cell Function]
   770   C0439834:slowing [Qualitative Concept]
   770   C0441472:Action [Functional Concept]
   770   C3245505:potentials [Qualitative Concept]
   770   C3266814:Action [Activity]

Phrase: "as"

Phrase: "measured by nerve-conduction studies."
Meta Candidates (Total=16; Excluded=6; Pruned=0; Remaining=10)
   862   C0200125:nerve conduction studies [Diagnostic Procedure]
   828 E C0945158:Nerve conduction study [Clinical Attribute]
   806   C0027788:Nerve Conduction [Organ or Tissue Function]
   760   C0027740:Nerve [Tissue]
   760   C0027757:NERVE [Tissue]
   760   C0232217:Conduction [Organ or Tissue Function]
   760   C0444706:Measured [Qualitative Concept]
   760   C0457405:Conduction [Natural Phenomenon or Process]
   760   C0947630:studies [Laboratory Procedure]
   760   C1280541:Nerve [Body Part, Organ, or Organ Component]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]
   704 E C0599851:Neural [Functional Concept]
Processing 00000000.tx.53: The underlying pathophysiology appears to involve both a reversible component and an irreversible component. 

Phrase: "The underlying pathophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031847:pathophysiology [Functional Concept]
   861   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "both a reversible component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "an irreversible component."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.54: The latter is likely due to neuronal loss from irreversible nodal degeneration and distal dying back of sensory neurons, while the former can be reversed by treatment with a variety of agents, including insulin, other hypoglycemic agents, aldose reductase inhibitors (Hall et al. 1995b, 1996), mitochondrial stabilizers, and antioxidants. 

Phrase: "The latter"

Phrase: "is"

Phrase: "likely due to neuronal loss"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   806   C1850496:Neuronal loss [Finding]
   770 E C0598940:neuron loss [Finding]
   760   C0332148:Likely [Qualitative Concept]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C0750492:Likely [Idea or Concept]
   760   C1517945:Loss [Quantitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "from irreversible nodal degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011164:Degeneration [Pathologic Function]
   827   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "distal dying back of sensory neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0184532:dying [Organism Function]

Phrase: "while"

Phrase: "the former"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205156:Former [Temporal Concept]
  1000   C0750523:FORMER [Idea or Concept]

Phrase: "can"

Phrase: "be"

Phrase: "reversed by treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   756   C1555029:Reverse [Idea or Concept]

Phrase: "with a variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883525:Variety [Conceptual Entity]
  1000   C2346866:Variety [Conceptual Entity]

Phrase: "of agents,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "other hypoglycemic agents,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020616:Hypoglycemic Agents [Pharmacologic Substance]
           Hypoglycaemic
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "aldose reductase inhibitors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C2348243:Aldose Reductase Inhibitor [Pharmacologic Substance]
   901   C0002003:Aldose Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1412322:ALDOSE REDUCTASE [Gene or Genome]
   827   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C0682934:Aldose [Carbohydrate]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Hall et al. 1995b,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "mitochondrial stabilizers,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0920880:stabilizers [Organ or Tissue Function]
   827 E C1550603:stabilizer [Substance]
   827 E C1705532:Stabilizer [Medical Device]

Phrase: "and"

Phrase: "antioxidants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]
Processing 00000000.tx.55: The beneficial effects of agents such as aldose reductase inhibitors on nerve conduction are independent of blood glucose and are strongly correlated with normalization of calcium signaling (Hall et al. 1995b, 1996). 

Phrase: "The beneficial effects of agents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "such as aldose reductase inhibitors"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   966   C2348243:Aldose Reductase Inhibitor [Pharmacologic Substance]
   901   C0002003:Aldose Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1412322:ALDOSE REDUCTASE [Gene or Genome]
   827   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C0682934:Aldose [Carbohydrate]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "on nerve conduction"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0027788:Nerve Conduction [Organ or Tissue Function]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C0232217:Conduction [Organ or Tissue Function]
   861   C0457405:Conduction [Natural Phenomenon or Process]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]

Phrase: "are independent of blood glucose"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0005802:Blood Glucose [Carbohydrate]
   806   C0332291:Independent of [Functional Concept]
   760   C0005767:Blood [Tissue]
   760   C0005768:blood [Body Substance]
   760   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   760   C0085862:Independent [Idea or Concept]
   760   C0229664:Blood [Body Substance]
   760   C1299583:Independent [Finding]
   760   C1551058:Are [Quantitative Concept]

Phrase: "and"

Phrase: "are"

Phrase: "strongly"

Phrase: "correlated with normalization of calcium signaling"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0600431:Calcium Signaling [Cell Function]
   753   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0006726:Calcium [Inorganic Chemical]
   753   C0037083:Signaling [Cell Function]
   753   C1707520:Correlated [Qualitative Concept]
   753   C1882115:Normalization [Research Activity]
   753   C2936886:Calcium [Pharmacologic Substance]
   753   C3537152:signaling [Biologic Function]

Phrase: "(Hall et al. 1995b,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.56: This was of particular interest as prolonged elevation of cytosolic calcium has been implicated in several models of neuronal death, thus providing a mechanism to explain the irreversible neuronal damage observed in chronic diabetes. 

Phrase: "This"

Phrase: "was of particular interest"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0543488:Interest [Mental Process]
   770   C1421478:WAS [Gene or Genome]

Phrase: "as prolonged elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "of cytosolic calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in several models of neuronal death,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0011065:Death [Organism Function]
   748   C0521390:Neuronal [Immunologic Factor]
   748   C1306577:Death, NOS [Finding]
   748   C3161035:Models [Intellectual Product]
   743   C2754100:neuron death [Cell Function]

Phrase: "thus"

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "a mechanism to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "explain"

Phrase: "the irreversible neuronal damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0010957:Damage [Injury or Poisoning]
   827   C1883709:Damage [Functional Concept]

Phrase: "observed in chronic diabetes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0205191:chronic [Temporal Concept]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.57: However, our prior studies also documented a reversible impairment in calcium channel modulation in diabetes. 

Phrase: "However,"

Phrase: "our prior studies also"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "a reversible impairment in calcium channel modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.58: G-protein-mediated modulation of calcium channels is a well-known mechanism regulating calcium influx in DRG neurons. 

Phrase: "G-protein-mediated modulation of calcium channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "is"

Phrase: "a well-known mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0441712:Mechanism [Functional Concept]
   827   C1706376:Mechanism [Manufactured Object]

Phrase: "regulating"

Phrase: "calcium influx in DRG neurons."
Processing 00000000.tx.59: In these neurons, activation of G proteins by ligands such as norepinephrine and opiates is predominantly inhibitory and mediated via Go-type G proteins (Moises et al. 1995). 

Phrase: "In these neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "activation of G proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0599177:protein activation [Genetic Function]
   770   C1879547:Activation [Activity]

Phrase: "by ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligands [Chemical]

Phrase: "such as norepinephrine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028351:Norepinephrine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "opiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242401:Opiates, NOS [Laboratory Procedure]
  1000   C0376196:Opiates [Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "predominantly inhibitory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3463820:Inhibitory [Activity]

Phrase: "and"

Phrase: "mediated via"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0086597:mediated [Social Behavior]
   833   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "type G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "(Moises et al. 1995"

Phrase: ")."
Processing 00000000.tx.60: Tonic activation of inhibitory G proteins has also been documented in DRG neurons. 

Phrase: "Tonic activation of inhibitory G proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0599177:protein activation [Genetic Function]
   753   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "documented in DRG neurons."
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   833   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   833   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   790   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   790   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   753   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0040452:Root [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0242726:Root [Plant]
   753   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   753   C1301725:Documented [Health Care Activity]
   753   C1318154:Root [Body Part, Organ, or Organ Component]
   753   C1609436:documented [Idea or Concept]
   753   C1705917:Root [Idea or Concept]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]
Processing 00000000.tx.61: This study was designed to determine whether the underlying mechanism causing elevated calcium currents in diabetic neuropathy might be diminished inhibitory G-protein activity.  

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the underlying mechanism causing elevated calcium currents in diabetic neuropathy"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0521116:currents [Temporal Concept]
   706 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "might"

Phrase: "be"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "inhibitory G-protein activity."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C1537044:protein activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
   756   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1415142:INHIBITORY G PROTEIN [Gene or Genome]
Processing 00000000.tx.62: METHODS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Animal models Prior approval for these experiments was obtained from the University of Michigan Committee on Use and Care of Animals according to National Institutes of Health guidelines. 

Phrase: "METHODS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Animal models Prior approval for these experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205540:Approval [Qualitative Concept]
   748   C2346845:Approval [Intellectual Product]

Phrase: "was"

Phrase: "obtained from the University of Michigan Committee"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0025939:Michigan [Geographic Area]
   748   C0041740:University [Manufactured Object,Organization]
   748   C1301820:Obtained [Functional Concept]
   748   C2699414:Committee [Group]
   714 E C1706701:Obtain [Activity]

Phrase: "on Use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "Care of Animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   858   C0178478:animals care [Occupation or Discipline]
   790   C1947933:Care [Activity]

Phrase: "according to National Institutes of Health guidelines."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0162791:Guidelines [Intellectual Product]
   804   C0220845:guidelines [Intellectual Product]
   804   C0282423:guidelines [Intellectual Product]
   771   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
Processing 00000000.tx.63: BB/W RAT MODEL. 

Phrase: "BB/W RAT MODEL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C3161035:Model [Intellectual Product]
Processing 00000000.tx.64: Prediabetic and nondiabetes-prone male BB/W rats were obtained from the NIH-sponsored colony at the University of Massachusetts (Worchester, MA) and maintained at the Michigan Diabetes Research and Training Center as described previously (Hall et al. 1995b). 

Phrase: "Prediabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0362046:pre-diabetic [Disease or Syndrome]

Phrase: "and"

Phrase: "nondiabetes-prone male BB/W rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0034693:rats [Mammal]
   799   C0034721:Rats [Mammal]

Phrase: "were"

Phrase: "obtained from the NIH-sponsored colony"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0027468:NIH [Health Care Related Organization]
   753   C0439158:colony [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1947989:Colony [Cell]
   719 E C1706701:Obtain [Activity]
   719   C1711305:Sponsor [Human]
   719   C2347796:SPONSOR [Organization]

Phrase: "at the University of Massachusetts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0024874:Massachusetts [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "(Worchester,"

Phrase: "MA)"

Phrase: "and"

Phrase: "maintained at the Michigan Diabetes Research"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0025939:Michigan [Geographic Area]
   753   C0035168:research [Research Activity]
   753   C0242481:Research [Research Activity]
   753   C1314677:Maintained [Functional Concept]
   719 E C0024501:Maintain [Activity]

Phrase: "and"

Phrase: "Training Center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557814:Training center [Manufactured Object]
   861   C0205099:Center [Spatial Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.65: After the onset of diabetes, ultralente insulin was administered subcutaneously daily to maintain hyperglycemic blood glucose levels between 16and 25mM/l (300-450 mg/dl) and prevent ketoacidosis. 

Phrase: "After the onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "ultralente insulin"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0041616:Ultralente Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: "subcutaneously daily to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332173:Daily [Temporal Concept]

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "hyperglycemic blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
   923   C0428554:blood glucose levels [Laboratory or Test Result]
   861   C0005802:Blood Glucose [Carbohydrate]
   861   C0428548:glucose levels [Laboratory or Test Result]
   827 E C0337438:glucose level [Laboratory Procedure]
   812   C0005767:Blood [Tissue]
   812   C0005768:blood [Body Substance]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0229664:Blood [Body Substance]
   812   C0441889:Levels [Qualitative Concept]
   779 E C0456079:Level [Classification]
   779 E C1547707:Level [Geographic Area]
   779 E C2946261:Level [Pharmacologic Substance]
   741 E C0333275:Bloody [Qualitative Concept]
   729 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   729 E C0392895:Bloods [Population Group]
   729 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   729 E C1511228:VESSEL, BLOOD [Tissue]
   712 E C1558950:VASCULAR [Finding]
   712 E C1801960:Vascular [Qualitative Concept]

Phrase: "between 16and 25mM/l (300-450 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0439269:mg% [Quantitative Concept]
   799   C1960952:mg % [Quantitative Concept]
   799   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "dl)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642216:/dL [Quantitative Concept]

Phrase: "and"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "ketoacidosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022638:Ketoacidosis [Disease or Syndrome]
  1000   C0220982:KETO ACIDOSIS [Pathologic Function]
Processing 00000000.tx.66: Blood glucose levels were monitored daily until the desired plasma glucose levels were achieved and biweekly thereafter. 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "daily until the desired plasma glucose levels"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   804   C0455280:glucose levels plasma [Laboratory or Test Result]
           plasma glucose
   778   C0202042:Plasma glucose [Laboratory Procedure]
   778   C0428548:glucose levels [Laboratory or Test Result]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0032105:Plasma [Body Substance]
   748   C0332173:Daily [Temporal Concept]
   748   C0441889:Levels [Qualitative Concept]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   745 E C0337438:glucose level [Laboratory Procedure]
   714 E C0456079:Level [Classification]
   714   C0871633:desire [Mental Process]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "were"

Phrase: "achieved"

Phrase: "and"

Phrase: "biweekly thereafter."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0585332:Biweekly [Temporal Concept]
Processing 00000000.tx.67: Age-matched animals raised in the same facility served as controls. 

Phrase: "Age-matched animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "raised in the same facility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442818:Raised [Quantitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1547538:Facility [Idea or Concept]

Phrase: "served as controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.68: Median nerve conduction velocity was measured 1-2 wk prior to death, using techniques described previously (Hall et al. 1995b). 

Phrase: "Median nerve conduction velocity"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   923   C0429381:Nerve conduction velocity [Finding]
   923   C2982003:Nerve Conduction Velocity [Diagnostic Procedure]
   861   C0025058:Median Nerve [Body Part, Organ, or Organ Component]
   861   C0027788:Nerve Conduction [Organ or Tissue Function]
   861   C0234084:Conduction velocity [Organ or Tissue Function]
   861   C1278845:Median nerve [Body Part, Organ, or Organ Component]
   812   C0027740:Nerve [Tissue]
   812   C0027757:NERVE [Tissue]
   812   C0232217:Conduction [Organ or Tissue Function]
   812   C0439830:Velocity [Quantitative Concept]
   812   C0457405:Conduction [Natural Phenomenon or Process]
   812   C0549183:Median [Spatial Concept]
   812   C0876920:Median [Quantitative Concept]
   812   C1280541:Nerve [Body Part, Organ, or Organ Component]
   812   C1547053:*Velocity [Quantitative Concept]
   812   C2347635:Median [Quantitative Concept]
   812   C2348144:Median [Quantitative Concept]
   812   C2939193:Median [Spatial Concept]
   756 E C0599851:Neural [Functional Concept]
   741 E C0027769:nervy [Sign or Symptom]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "1-2 wk prior to death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332174:/wk [Temporal Concept]
   753   C0439230:wk [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.69: STZ-INDUCED MODEL. 

Phrase: "STZ-INDUCED MODEL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]
Processing 00000000.tx.70: For studies using streptozotocin-induced diabetic animals, male Sprague-Dawley rats aged 4-5 mo were rendered diabetic by injection with 45mg/kg streptozotocin (Sigma Chemical, St. Louis, MO) as described previously (Srinivasan et al. 1997). 

Phrase: "For studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "streptozotocin-induced diabetic animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "male Sprague-Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "4-5 mo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3538743:MO [Idea or Concept]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: "were"

Phrase: "rendered"

Phrase: "diabetic by injection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0241863:DIABETIC [Finding]

Phrase: "with 45mg/kg streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(Sigma Chemical, St. Louis,"

Phrase: "MO)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Srinivasan et al. 1997"

Phrase: ")."
Processing 00000000.tx.71: Age-matched animals injected with vehicle served as controls. 

Phrase: "Age-matched animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "injected with vehicle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0042444:Vehicle [Biomedical or Dental Material]
   790   C0348005:Vehicle [Manufactured Object]
   756   C1720154:Inject [Functional Concept]
   718 E C0445373:Vehicular [Functional Concept]

Phrase: "served as controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.72: Animals injected with streptozotocin were given 10% sucrose in water for 48h after injection to prevent hypoglycemia, then maintained on an ad-lib diet. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "injected with streptozotocin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   756   C1720154:Inject [Functional Concept]

Phrase: "were"

Phrase: "given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "10% sucrose in water"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]

Phrase: "for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "after injection to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021485:injection [Therapeutic or Preventive Procedure]
   861   C1272883:Injection [Biomedical or Dental Material]
   861   C1533685:Injection [Therapeutic or Preventive Procedure]
   861   C1828121:Injection [Functional Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "hypoglycemia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0020615:Hypoglycaemia [Disease or Syndrome]
   928 E C0020616:Hypoglycaemic [Pharmacologic Substance]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "maintained on an ad-lib diet."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C1879743:Ad Lib [Qualitative Concept]
   753   C0012155:Diet [Food]
   753   C1314677:Maintained [Functional Concept]
   753   C1427148:LIB [Gene or Genome]
   753   C1442959:Diet [Organism Function]
   753   C1519433:DIET [Therapeutic or Preventive Procedure]
   753   C2983588:DIET [Food]
   719 E C0024501:Maintain [Activity]
Processing 00000000.tx.73: Blood glucose levels were monitored daily until induction of diabetes, which usually occurred within 1-3 days, then biweekly thereafter. 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "daily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332173:Daily [Temporal Concept]

Phrase: "until"

Phrase: "induction of diabetes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "which usually"

Phrase: "occurred within 1-3 days,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0439228:days [Temporal Concept]
   760   C1709305:Occurred [Activity]
   726 E C0332173:/day [Temporal Concept]
   726 E C0439505:/day [Temporal Concept]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "then biweekly thereafter."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0585332:Biweekly [Temporal Concept]
   827   C1883708:Then [Temporal Concept]
Processing 00000000.tx.74: Blood glucose ranged from 300to >550 mg/dl in STZ-injected animals. 

Phrase: "Blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "ranged from 300to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: ">550 mg/dl in STZ-injected animals."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C0439269:mg dl [Quantitative Concept]
   774 E C3463848:dl mg [Quantitative Concept]
   748   C3642216:/dL [Quantitative Concept]
Processing 00000000.tx.75: Animals were studied between 4and 8wk after induction of diabetes. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "studied between 4and 8wk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0557651:Study [Manufactured Object]
   737   C2603343:Study [Research Activity]

Phrase: "after induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.76: Weight and blood glucose were measured on the day of recording. 

Phrase: "Weight"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005910:weight [Organism Attribute]
  1000   C0043100:Weight [Quantitative Concept]
  1000   C1305866:weight [Diagnostic Procedure]
  1000   C1705104:Weight [Idea or Concept]

Phrase: "and"

Phrase: "blood glucose"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
  1000   C0005802:Blood Glucose [Carbohydrate]
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "were"

Phrase: "measured on the day of recording."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.77: DRG preparation Isolated, acutely dissociated thoracic and lumbar DRG neurons were aseptically prepared using techniques described previously (Hall et al. 1995b) but without the use of nerve growth factor or horse serum. 

Phrase: "DRG preparation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0455052:Preparation [Health Care Activity]
   812   C1521827:Preparation [Functional Concept]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]

Phrase: "Isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: ","

Phrase: "acutely"

Phrase: "dissociated"

Phrase: "thoracic"

Phrase: "and"

Phrase: "lumbar DRG neurons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   804   C0027882:Neurons [Cell]
   771   C0457468:Lumbar dorsal root ganglion [Body Part, Organ, or Organ Component]
   721 E C0521390:Neuronal [Immunologic Factor]
   717   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   717   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   708   C0229020:Lumbar ganglion [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "aseptically"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Hall et al. 1995b"

Phrase: ")"

Phrase: "but without the use of nerve growth factor"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   800   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   800   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1524063:Use of [Functional Concept]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0027740:Nerve [Tissue]
   744   C0027757:NERVE [Tissue]
   744   C0042153:use [Functional Concept]
   744   C0220844:growth [Physiologic Function]
   744   C0233535:but [Mental or Behavioral Dysfunction]
   744   C0457083:Use [Functional Concept]
   744   C1280541:Nerve [Body Part, Organ, or Organ Component]
   744   C1521761:Factor [Functional Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C1947944:Use [Intellectual Product]
   744   C2827422:Factor [Conceptual Entity]
   744   C2911660:Growth [Activity]
   743   C0814002:Neural Growth [Cell Function,Organism Function]

Phrase: "or"

Phrase: "horse serum."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1518416:Serum, Horse [Immunologic Factor]
   861   C0019944:Horse [Mammal]
   861   C0229671:Serum [Body Substance]
   861   C0242616:Horse [Mammal]
   861   C1265527:Horse [Mammal]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]
Processing 00000000.tx.78: For electrophysiology experiments, dissociated neurons were plated onto 35-mm sterile culture dishes coated with calf collagen and incubated in 95% air +5% CO2 at 37C for 30-60 min prior to performing same-day recordings. 

Phrase: "For electrophysiology experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "dissociated neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "plated onto 35-mm sterile culture dishes"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   757   C0180454:Culture plate [Medical Device]
   748   C0010453:Culture [Idea or Concept]
   748   C0220814:culture [Functional Concept]
   748   C0232920:Sterile [Qualitative Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0678108:Sterile [Pathologic Function]
   748   C2242979:Culture [Laboratory Procedure]
   714   C0005971:Plate [Medical Device]
   714   C0020498:DISH [Disease or Syndrome]
   714   C1139930:plate [Medical Device]
   714   C3537155:Plate [Manufactured Object]

Phrase: "coated with calf collagen"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0009325:Collagen [Amino Acid, Peptide, or Protein,Biologically Active Substance,Biomedical or Dental Material]
   770   C0230445:Calf [Body Location or Region]
   770   C1167364:collagen [Cell Component]
   770   C1305418:Calf [Body Part, Organ, or Organ Component]
   770   C1522408:Coated [Qualitative Concept]
   737 E C0453946:Coat [Manufactured Object]
   737 E C2987482:Coat [Body Part, Organ, or Organ Component]
   715 E C0626053:sural [Pharmacologic Substance]

Phrase: "and"

Phrase: "incubated in 95% air +5% CO2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0001861:Air [Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C2347816:Co2+ [Element, Ion, or Isotope]
   753   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]

Phrase: "at 37C"

Phrase: "for 30-60 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0456693:/30 min [Temporal Concept]
   913   C1442458:30 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "prior to performing same-day recordings."
Processing 00000000.tx.79: Electrophysiology was completed within 10h of dissociation. 

Phrase: "Electrophysiology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013865:Electrophysiology [Biomedical Occupation or Discipline]
  1000   C1446476:Electrophysiology [Diagnostic Procedure]

Phrase: "was"

Phrase: "completed within 10h of dissociation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0086168:Dissociation [Mental or Behavioral Dysfunction]
   760   C0205197:COMPLETED [Qualitative Concept]
   760   C1442445:10H [Temporal Concept]
Processing 00000000.tx.80: For GTP[35S] and opiate receptor binding assays, purified DRG membranes were prepared from acutely dissociated DRGs (Szekeres and Traynor 1997) and tested the same day. 

Phrase: "For GTP[35S"

Phrase: "]"

Phrase: "and"

Phrase: "opiate receptor binding assays,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   886   C0242401:Opiate Assay [Laboratory Procedure]
   861   C0034801:Opiate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597358:Receptor Binding [Molecular Function]
   812   C0243122:binding [Functional Concept]
   812   C0376196:Opiate [Hazardous or Poisonous Substance,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
   779   C0005507:Assay [Laboratory Procedure]
   779   C0243073:assay [Qualitative Concept]
   779   C1510438:Assay [Laboratory Procedure]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "DRG membranes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "prepared from acutely dissociated DRGs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0011928:DRGs [Intellectual Product]
   726 E C1414151:DRG [Gene or Genome]
   726   C1521827:Prepare [Functional Concept]

Phrase: "(Szekeres"

Phrase: "and"

Phrase: "Traynor 1997"

Phrase: ")"

Phrase: "and"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the same day."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]
   861   C0445247:Same [Qualitative Concept]
Processing 00000000.tx.81: Western immunoblotting for G-protein subunit expression was performed on freshly homogenized whole DRG ganglia from paired diabetic and control animals. 

Phrase: "Western immunoblotting for G-protein subunit expression"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0005863:Western Immunoblotting [Laboratory Procedure,Molecular Biology Research Technique]
   762 E C0949466:Western Immunoblot [Laboratory Procedure]
   748   C0020985:Immunoblotting [Laboratory Procedure]
   748   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "performed on freshly homogenized whole DRG ganglia"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   790   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root Ganglia
           Dorsal Root
   790   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   764   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   764   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   742   C0017067:Ganglia [Body Part, Organ, or Organ Component]
           Ganglion
   742   C0040452:Root [Body Part, Organ, or Organ Component]
   742   C0205095:Dorsal [Spatial Concept]
   742   C0242726:Root [Plant]
   742   C0444667:Whole [Quantitative Concept]
   742   C0884358:Performed [Functional Concept]
   742   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   742   C1318154:Root [Body Part, Organ, or Organ Component]
   742   C1705917:Root [Idea or Concept]
   708 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from paired diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control animals."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C1511501:Control Animal [Animal]
   861   C0003062:Animals [Animal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.82: Drug preparation for electrophysiology All reagents were obtained from Sigma. 

Phrase: "Drug preparation for electrophysiology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0013164:Drug Preparation [Health Care Activity]
   833   C0013227:Drug preparation, NOS [Pharmacologic Substance]
   770   C0455052:Preparation [Health Care Activity]
   770   C1521827:Preparation [Functional Concept]

Phrase: "All reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were"

Phrase: "obtained from Sigma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C1301820:Obtained [Functional Concept]
   790   C1719918:Sigma [Intellectual Product]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.83: GTPS and GDPS were diluted with ice-cold distilled water to 10mM. 

Phrase: "GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "diluted with ice-cold distilled water"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0456963:Ice cold [Qualitative Concept]
   790   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   783   C0020746:Water Ice [Inorganic Chemical]
           Ice
   753   C0009264:Cold [Natural Phenomenon or Process]
   753   C0009443:Cold [Disease or Syndrome]
   753   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   753   C0234192:Cold [Physiologic Function]
   753   C0599638:WATER [Substance]
   753   C0681549:distilled [Occupational Activity]
   753   C1550678:Water [Inorganic Chemical]
   719   C1720119:Dilute [Functional Concept]
   719   C1948037:Dilute [Functional Concept]

Phrase: "to 10mM."
Processing 00000000.tx.84: Twenty-microliter aliquots were lyophilized and stored at 20C. 

Phrase: "Twenty-microliter aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "lyophilized"

Phrase: "and"

Phrase: "stored at 20C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.85: On the recording day, working solutions of GTPS (500M) and GDPS (500M) were prepared using external recording solution for extracellular preincubation experiments or at 250M with pipette recording medium for experiments involving intracellular dialysis during the recording. 

Phrase: "On the recording day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "working"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Working [Occupational Activity]

Phrase: "solutions of GTPS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0037633:Solutions [Substance]
   756 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "(500M"

Phrase: ")"

Phrase: "and"

Phrase: "GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(500M"

Phrase: ")"

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "external recording solution for extracellular preincubation experiments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037633:Solution [Substance]
   748   C0525069:Solution [Biomedical or Dental Material]

Phrase: "or at 250M"

Phrase: "with pipette recording medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0009458:Medium [Intellectual Product]
   827   C0439536:Medium [Quantitative Concept]
   827   C1705217:Medium [Substance]
   827   C3244283:medium [Intellectual Product]

Phrase: "for experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "intracellular dialysis during the recording."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011945:Dialysis [Natural Phenomenon or Process]
   760   C0011946:dialysis [Therapeutic or Preventive Procedure]
   760   C0917873:dialysis [Therapeutic or Preventive Procedure]
   760   C1059964:Dialysis [Eukaryote]
Processing 00000000.tx.86: In experiments using PTX, culture dishes were either preincubated with medium containing 250or 500ng/ml PTX for 3-4 h prior to recording, or recordings were made with PTX (50ng/ml) added to the recording pipette solution. 

Phrase: "In experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "culture dishes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C2242979:Culture [Laboratory Procedure]
   827   C0020498:DISH [Disease or Syndrome]

Phrase: "were"

Phrase: "either"

Phrase: "preincubated with medium containing 250or 500ng/ml PTX"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   764   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   742   C0009458:Medium [Intellectual Product]
   742   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   742   C0043167:Pertussis [Disease or Syndrome]
   742   C0332256:Containing [Functional Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C0439536:Medium [Quantitative Concept]
   742   C1705217:Medium [Substance]
   742   C2700400:Containing [Activity]
   742   C3244283:medium [Intellectual Product]

Phrase: "for 3-4 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0041119:3 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0442757:3 4 [Finding]

Phrase: "prior to recording,"

Phrase: "or"

Phrase: "recordings"

Phrase: "were"

Phrase: "made with PTX"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   770   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   770   C0043167:Pertussis [Disease or Syndrome]
   737   C1881534:Make [Functional Concept]

Phrase: "(50ng/ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "added to the recording pipette solution."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0037633:Solution [Substance]
   753   C0182301:Pipette [Medical Device]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1524062:Added [Functional Concept]
   753   C1706407:Pipette [Medical Device]
   719   C0034869:Record [Intellectual Product]
   719 E C1883712:Add [Functional Concept]
Processing 00000000.tx.87: [D-Ala2,-Me-Phe4,Gly5-ol]-enkephalin (DAGO) was prepared as 10-L aliquots of 10mM stock solution, lyophilized, and stored at 70C. 

Phrase: "["

Phrase: "D-"

Phrase: "Ala2,-"

Phrase: "Me-Phe4,"

Phrase: "Gly5-ol]-enkephalin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014298:Enkephalin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(DAGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "was"

Phrase: "prepared as 10-L aliquots of 10mM stock solution,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0037633:Solution [Substance]
   742   C0525069:Solution [Biomedical or Dental Material]
   742   C1710198:Stock [Idea or Concept]
   708   C1510844:Aliquot [Quantitative Concept]
   708   C1521827:Prepare [Functional Concept]

Phrase: "lyophilized"

Phrase: ","

Phrase: "and"

Phrase: "stored at 70C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1698986:Store [Functional Concept]
Processing 00000000.tx.88: On the recording day, a working solution of 10M was prepared by dilution with external recording solution containing 0.4% bovine serum albumin fraction V (fatty acid-free). 

Phrase: "On the recording day,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332173:/day [Temporal Concept]
   861   C0439228:day [Temporal Concept]
   861   C0439505:/day [Temporal Concept]

Phrase: "a working solution of 10M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037633:Solution [Substance]
   760   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "prepared by dilution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0079240:Dilution [Laboratory Procedure]
   790   C1948037:Dilution [Functional Concept]
   756   C1521827:Prepare [Functional Concept]

Phrase: "with external recording solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.4% bovine serum albumin fraction V (fatty acid-free"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332296:free [Functional Concept]
   790   C1880497:Free [Qualitative Concept]
   790   C1996904:Free [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.89: Solutions were kept on ice until used. 

Phrase: "Solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "kept on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C0333118:Keep [Functional Concept]

Phrase: "until"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.90: GTP[35S] binding assay GTP[35S] binding in DRG membranes was performed using the method of Szekeres and Traynor (1997). 

Phrase: "GTP[35S"

Phrase: "] binding assay GTP[35S"

Phrase: "] binding in DRG membranes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the method of Szekeres"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Traynor"

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.91: All procedures were performed at 0-4C. 

Phrase: "All procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0025664:procedures [Intellectual Product]
  1000   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C2700391:procedures [Activity]
   966 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   966 E C3274430:PROCEDURE [Health Care Activity]
   966 E C3538935:Procedure [Idea or Concept]
   966 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "performed at 0-4C."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0450376:4c [Intellectual Product]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.92: DRG membranes were suspended in buffer A, containing 20mM HEPES, 100mM NaCl, and 4mM MgCl at pH 7.4,to give a final concentration of 10-15 g protein/ml (Lowrey et al. 1951). 

Phrase: "DRG membranes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "suspended in buffer A,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1553389:suspended [Idea or Concept]
   770   C1553403:suspended [Idea or Concept]
   770   C1705537:Suspended [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20mM HEPES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "100mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "4mM MgCl at pH 7.4,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10-15 g protein/ml (Lowrey et al. 1951"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   817   C1300565:g/mL [Quantitative Concept]
   807   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   791   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   791   C0439267:g% [Quantitative Concept]
   791   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.93: Membranes were incubated in Buffer A containing 0.05nM GTP[35S], 50M GDP, and varying concentrations of [D-Ala2, M-Me-Phe4,Gly5]enkephalin-ol; 

Phrase: "Membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "incubated in Buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "A containing 0.05nM GTP[35S"

Phrase: "],"

Phrase: "50M GDP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "varying concentrations of ["

Phrase: "D-"

Phrase: "Ala2,"

Phrase: "M-"

Phrase: "Me-Phe4,"

Phrase: "Gly5"

Phrase: "]enkephalin-ol"

Phrase: ";"
Processing 00000000.tx.94: 3-10,000 nM (DAMGO) in a total volume of 100l for 30min at 25C. 

Phrase: "3-10,000 nM (DAMGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0525773:DAMGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "in a total volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0449468:Total Volume [Quantitative Concept]
           *Volume
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]
   861   C1690016:% volume [Qualitative Concept]
   861   C1705102:Volume [Intellectual Product]
   861   C2700258:Volume [Laboratory Procedure]

Phrase: "of 100l"

Phrase: "for 30min"

Phrase: "at 25C."
Processing 00000000.tx.95: Nonspecific binding was defined using unlabeled GTPS (50M). 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "unlabeled GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(50M"

Phrase: ")."
Processing 00000000.tx.96: The mixture was rapidly vacuum-filtered through GF/B filters to separate bound from free ligand. 

Phrase: "The mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "rapidly vacuum-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042221:Vacuum [Natural Phenomenon or Process]

Phrase: "filtered through GF/B"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0016703:GF [Geographic Area]
   770   C1551081:gf [Quantitative Concept]
   737   C0180860:Filter [Manufactured Object]
   737   C0581406:Filter [Medical Device]
   737   C1522664:Filter [Intellectual Product]
   737   C1704449:Filter [Conceptual Entity]
   737   C1704684:Filter [Medical Device]
   737   C1875155:FILTER [Medical Device]

Phrase: "filters"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]
   944 E C0080194:Strain [Injury or Poisoning]
   944 E C0442694:Straining [Physiologic Function]
   944 E C0456178:strain [Intellectual Product]
   944 E C1518614:Strain [Organism]
   944 E C2987481:Strain [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "bound from free ligand."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0023688:Ligand [Chemical]
   770   C0332296:free [Functional Concept]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C1880497:Free [Qualitative Concept]
   770   C1996904:Free [Qualitative Concept]
   770   C2349209:Bound [Conceptual Entity]
Processing 00000000.tx.97: After washing three times in ice-cold buffer A, radioactivity on the filters was determined by liquid scintillation counting. 

Phrase: "After"

Phrase: "washing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "three times in ice-cold buffer A,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "radioactivity on the filters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034553:Radioactivity [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "determined by liquid scintillation counting."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0036406:Scintillation Counting [Laboratory Procedure]
   760   C0302908:Liquid [Substance]
   760   C0678573:scintillation [Natural Phenomenon or Process]
   760   C1304698:Liquid [Finding]
   760   C1546699:Liquid NOS [Intellectual Product]
   760   C1561501:Liquid NOS [Substance]
   726   C0750480:Count [Activity]
   726   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.98: Specific binding was typically 90% of total binding. 

Phrase: "Specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "typically 90% of total binding."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0243122:binding [Functional Concept]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
Processing 00000000.tx.99: Opiate receptor binding assay Mu opioid binding (Szekeres and Traynor 1997) was assessed in DRG membranes prepared as described in the preceding text. 

Phrase: "Opiate receptor binding assay Mu opioid binding"

Phrase: "(Szekeres"

Phrase: "and"

Phrase: "Traynor 1997"

Phrase: ")"

Phrase: "was"

Phrase: "assessed in DRG membranes"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   833   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   833   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   790   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   790   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   753   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   753   C0025255:Membranes [Tissue]
   753   C0040452:Root [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0242726:Root [Plant]
   753   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   753   C1318154:Root [Body Part, Organ, or Organ Component]
   753   C1516048:Assessed [Activity]
   753   C1705917:Root [Idea or Concept]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in the preceding text."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0332152:Preceding [Temporal Concept]
   760   C1527021:Text [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1554111:Text [Idea or Concept]
   760   C1705606:Text [Intellectual Product]
   760   C3541382:Text [Intellectual Product]
Processing 00000000.tx.100: DRG membranes (10-15 g/tube) were incubated in Tris-HCl buffer (pH 7.4) with [3H]naloxone at varying concentrations (1-25 nM) in a final volume of 100l for 90min at 25C. 

Phrase: "DRG membranes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "(10-15 g/tube"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C1522614:G-TUBE [Therapeutic or Preventive Procedure]
   812   C0175730:Tube [Medical Device]
   812   C0439267:g% [Quantitative Concept]
   812   C1547937:Tube NOS [Intellectual Product]
   812   C1561954:tube [Conceptual Entity]
   812   C1704730:TUBE [Medical Device]

Phrase: ")"

Phrase: "were"

Phrase: "incubated in Tris-HCl buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   760   C0814229:TRI [Intellectual Product]
   760   C1439852:Incubated [Laboratory Procedure]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "with"

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]naloxone at varying concentrations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027358:Naloxone [Organic Chemical,Pharmacologic Substance]

Phrase: "(1-25 nM) in a final volume of 100l"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0312860:NM [Cell Function]

Phrase: "for 90min"

Phrase: "at 25C."
Processing 00000000.tx.101: Naloxone acted as a preferentialagonist at these concentrations. 

Phrase: "Naloxone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027358:Naloxone [Organic Chemical,Pharmacologic Substance]

Phrase: "acted as a preferentialagonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "at these concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0086045:Concentrations [Mental Process]
   966 E C1446561:Concentration [Quantitative Concept]
   916 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.102: Bound and free naloxone were separated by vacuum filtration through GF/B filters, which were subsequently washed three times with ice-cold Tris buffer. 

Phrase: "Bound"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332297:bound [Spatial Concept]
  1000   C1145667:Bound [Activity]
  1000   C1167622:Bound [Molecular Function]
  1000   C1689898:% bound [Quantitative Concept]
  1000   C2349209:Bound [Conceptual Entity]

Phrase: "and"

Phrase: "free naloxone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027358:Naloxone [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "separated by vacuum filtration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016107:filtration [Laboratory Procedure]
   770   C0042221:Vacuum [Natural Phenomenon or Process]
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0687118:Separated [Functional Concept]

Phrase: "through GF/B filters,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0180860:Filters [Manufactured Object]
   793 E C0581406:Filter [Medical Device]
   793 E C1522664:Filter [Intellectual Product]
   793 E C1704449:Filter [Conceptual Entity]
   793 E C1704684:Filter [Medical Device]
   793 E C1875155:FILTER [Medical Device]

Phrase: "which"

Phrase: "were"

Phrase: "subsequently"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with ice-cold Tris buffer."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.103: Nonspecific binding was defined using unlabeled naloxone (10M). 

Phrase: "Nonspecific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205370:Non-specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C0750540:Nonspecific [Idea or Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "unlabeled naloxone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027358:Naloxone [Organic Chemical,Pharmacologic Substance]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.104: Specific binding was typically 80-85% of total binding at the radioligand Kd. 

Phrase: "Specific binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205369:Specific [Qualitative Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1552740:specific [Intellectual Product]

Phrase: "was"

Phrase: "typically 80-85% of total binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243122:binding [Functional Concept]
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "at the radioligand Kd."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]
Processing 00000000.tx.105: Binding assay data analysis Data for both opioid and GTP[35S] binding were analyzed using the program LIGAND (Munson and Rodbard 1980) to provide estimates for the total receptor number (Bmax), binding affinity (Kd or Ki), and slope of the binding isotherms. 

Phrase: "Binding assay data analysis Data for both opioid"

Phrase: "and"

Phrase: "GTP[35S"

Phrase: "] binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the program LIGAND"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligand [Chemical]

Phrase: "(Munson"

Phrase: "and"

Phrase: "Rodbard 1980"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "estimates for the total receptor number"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750572:estimates [Quantitative Concept]

Phrase: "(Bmax"

Phrase: ")"

Phrase: ","

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "or"

Phrase: "Ki"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "slope of the binding isotherms."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0807955:Slope [Quantitative Concept]
Processing 00000000.tx.106: The EC50 for stimulation of GTP[35S] binding obtained at various opioid concentrations was determined from nonlinear curve fitting of the data using GraphPAD Prism (GraphPAD, San Diego, CA). 

Phrase: "The EC50 for stimulation of GTP[35S"

Phrase: "]"

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "obtained at various opioid concentrations"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0242402:Opioid [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C1301820:Obtained [Functional Concept]
   726 E C1446561:Concentration [Quantitative Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "was"

Phrase: "determined from nonlinear curve fitting of the data"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0036572:Fitting [Sign or Symptom]
   744   C0205134:Curve [Spatial Concept]
   744   C0441548:Fitting [Health Care Activity]
   744   C1511726:Data [Idea or Concept]
   744   C3245479:data [Medical Device]
   711 E C0424576:Fit [Finding]
   711 E C2349186:Fit [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GraphPAD Prism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0814195:PRISM [Intellectual Product]
   805 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(GraphPAD,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.107: Statistical comparisons between diabetic and control data were performed using the Student's t-test, where P<0.05was considered significant (Mendenhall 1975). 

Phrase: "Statistical comparisons between diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707455:Comparison [Activity]

Phrase: "and"

Phrase: "control data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Student's t-test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "where P<0.05was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "(Mendenhall 1975"

Phrase: ")."
Processing 00000000.tx.108: Western immunoblot of G-protein subunits Expression of G-protein subunits was assessed in homogenized whole thoracic and lumbar dorsal root ganglia obtained from four control and four BB/W diabetic rats aged 82(SD) mo. 

Phrase: "Western immunoblot of G-protein subunits Expression of G-protein subunits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0949466:Western Immunoblot [Laboratory Procedure]
   738   C0020985:Immunoblot [Laboratory Procedure]
   738   C1705493:Western [Spatial Concept]

Phrase: "was"

Phrase: "assessed in homogenized whole thoracic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0444667:Whole [Quantitative Concept]
   760   C1516048:Assessed [Activity]

Phrase: "and"

Phrase: "lumbar dorsal root ganglia"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   983   C0457468:Lumbar dorsal root ganglion [Body Part, Organ, or Organ Component]
   923   C0017070:Dorsal Root Ganglia [Body Part, Organ, or Organ Component]
           Dorsal Root
   902   C0229020:Lumbar ganglia [Body Part, Organ, or Organ Component]
   902   C1281807:Lumbar ganglia [Body Part, Organ, or Organ Component]
   890 E C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   861   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   844   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   812   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   812   C0040452:Root [Body Part, Organ, or Organ Component]
   812   C0205095:Dorsal [Spatial Concept]
   812   C0242726:Root [Plant]
   812   C1318154:Root [Body Part, Organ, or Organ Component]
   812   C1705917:Root [Idea or Concept]
   779 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "obtained from four control"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0205450:Four [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "four BB/W diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C0241863:DIABETIC [Finding]

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "82"

Phrase: "(SD) mo."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538743:MO [Idea or Concept]
Processing 00000000.tx.109: Eight ganglia were obtained from each animal, homogenized in phosphate-buffered saline (PBS), and prepared according to the method of Mumby and Gilman (1991). 

Phrase: "Eight ganglia"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   827 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "were"

Phrase: "obtained from each animal,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003062:Animal [Animal]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "homogenized in phosphate-buffered saline (PBS),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "prepared according to the method of Mumby"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C0871511:METHOD [Intellectual Product]
   714   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "Gilman"

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.110: Protein concentrations of homogenized ganglia from each animal were measured (Lowry et al. 1951) and diluted with buffer to 100g/ml. 

Phrase: "Protein concentrations of homogenized ganglia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0427716:Protein concentration [Laboratory Procedure]
   790   C1304757:Protein concentration [Laboratory or Test Result]
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "from each animal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animal [Animal]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "(Lowry et al. 1951"

Phrase: ")"

Phrase: "and"

Phrase: "diluted with buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   756   C1720119:Dilute [Functional Concept]
   756   C1948037:Dilute [Functional Concept]

Phrase: "to 100g/ml."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.111: SDS page gel electrophoresis was performed using 25g of tissue per lane. 

Phrase: "SDS page gel electrophoresis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0596607:Gel Electrophoresis [Laboratory Procedure]
   812   C0013855:Electrophoresis [Laboratory Procedure]
   812   C0017243:Gel [Biomedical or Dental Material]
   812   C1382104:Gel [Substance]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "25g of tissue"

Phrase: "per lane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]
Processing 00000000.tx.112: Each lane consisted of tissue from one animal, and each run included tissue from a pair of diabetic and age-matched control animals. 

Phrase: "Each lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "consisted of tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040300:Tissue [Tissue]
   790   C1547928:Tissue [Intellectual Product]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "from one animal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]

Phrase: "and"

Phrase: "each"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "included tissue from a pair of diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040300:Tissue [Tissue]
   748   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "age-matched control animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511501:Control Animal [Animal]
   812   C0003062:Animals [Animal]
Processing 00000000.tx.113: Molecular weight markers (Calbiochem, San Diego, CA) and known concentrations of purified G-protein subunits (DuPont NEN Research Products, Boston, MA) were run on the same gel as controls. 

Phrase: "Molecular weight markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C0026385:Molecular Weight [Quantitative Concept]

Phrase: "(Calbiochem,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "and"

Phrase: "known concentrations of purified G-protein subunits"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0427716:Protein concentration [Laboratory Procedure]
   757   C1304757:Protein concentration [Laboratory or Test Result]
   748   C0086045:Concentrations [Mental Process]
   714 E C1446561:Concentration [Quantitative Concept]

Phrase: "(DuPont NEN Research Products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA)"

Phrase: "were"

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "the same gel as controls."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
Processing 00000000.tx.114: Immunoblot was performed using [3H]-labeled rabbit immunoglobulin directed against the subunits of Go, Gi1/2, Gi3, and Gs (Calbiochem). 

Phrase: "Immunoblot"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442460:3H [Temporal Concept]

Phrase: "]-labeled rabbit immunoglobulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0021027:Immunoglobulin [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C1621846:immunoglobulin [Molecular Function]

Phrase: "directed against the subunits of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0439851:Direct [Qualitative Concept]
   726   C1711351:Subunit [Quantitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "Gi1/2,"

Phrase: "Gi3,"

Phrase: "and"

Phrase: "Gs (Calbiochem"

Phrase: ")."
Processing 00000000.tx.115: The pixel densities of the digitized bands were imaged (Biorad Imaging System, Life Science, Hercules, CA) and analyzed using the Adobe Photoshop program (Adobe Systems, San Jose, CA). 

Phrase: "The pixel densities of the digitized bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178587:densities [Quantitative Concept]

Phrase: "were"

Phrase: "imaged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "(Biorad Imaging System,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C2697665:Imaging System [Manufactured Object]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "Life Science,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0005526:Science, Life [Occupation or Discipline]
   861   C0036397:Science [Occupation or Discipline]
   861   C0376558:Life [Idea or Concept]
   777 E C0595998:lives [Finding]

Phrase: "Hercules,"

Phrase: "CA)"

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the Adobe Photoshop program"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "(Adobe Systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "San Jose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.116: Band density measurements were corrected for background staining by dividing the band density for matched diabetic and control samples by an equivalent area of background density. 

Phrase: "Band density measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "corrected for background staining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   909   C3176809:corrected for background [Qualitative Concept]
   770   C0205202:Corrected [Qualitative Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   770   C1706907:Background [Conceptual Entity]
   737 E C2349182:Correct [Qualitative Concept]

Phrase: "by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332849:dividing [Functional Concept]

Phrase: "the band density for matched diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "and"

Phrase: "control samples by an equivalent area of background density."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0370003:Sample [Substance]
   708   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.117: To minimize inter-run variability, pixel density of bands from diabetic animals were expressed as the percentage difference compared with age-matched controls run on the same gel using the formula: [1(diabetic/control)]*100. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "inter-run variability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2827666:Variability [Conceptual Entity]
   755 E C0439828:Variable [Qualitative Concept]

Phrase: "pixel density of bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0178587:density [Quantitative Concept]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "expressed as the percentage difference"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]

Phrase: "compared with age-matched controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "run on"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0035953:run [Daily or Recreational Activity]
   861   C0600140:run [Finding]
   861   C1704688:Run [Functional Concept]
   861   C2346414:Run [Finding]

Phrase: "the same gel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the formula"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0489829:Formula [Intellectual Product]
  1000   C1705501:Formula [Intellectual Product]

Phrase: ":"

Phrase: "[1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "(diabetic/control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "]"

Phrase: "*100."
Processing 00000000.tx.118: Similar studies were performed on DRGs from four STZ-induced rats prepared as described in the preceding text, and four vehicle-injected controls. 

Phrase: "Similar studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "performed on DRGs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0011928:DRGs [Intellectual Product]
   790   C0884358:Performed [Functional Concept]
   756 E C1414151:DRG [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from four STZ-induced rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "described in the preceding text,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0332152:Preceding [Temporal Concept]
   760   C1527021:Text [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1554111:Text [Idea or Concept]
   760   C1705606:Text [Intellectual Product]
   760   C3541382:Text [Intellectual Product]

Phrase: "and"

Phrase: "four vehicle-injected controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.119: Protein loading was 100g/lane, and 1g of purified Go protein standard (Calbiochem) was run as a control. 

Phrase: "Protein loading"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "was"

Phrase: "100g/lane,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "1g of purified"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "protein standard"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "(Calbiochem"

Phrase: ")"

Phrase: "was"

Phrase: "run as a control."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0035953:run [Daily or Recreational Activity]
   770   C0243148:control [Qualitative Concept]
   770   C0600140:run [Finding]
   770   C1550141:Control [Substance]
   770   C1704688:Run [Functional Concept]
   770   C1882979:Control [Conceptual Entity]
   770   C2346414:Run [Finding]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.120: Whole cell voltage-clamp recordings Whole cell patch-clamp recordings of high-threshold calcium currents (ICa) were performed at room temperature on DRGs between 20and 40m in diameter using techniques described previously (Hall et al. 1995b). 

Phrase: "Whole cell voltage-clamp recordings Whole cell patch-clamp recordings"

Phrase: "of high-threshold calcium currents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]
   708   C0553702:high calcium [Finding]

Phrase: "(ICa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201519:ICA [Laboratory Procedure]

Phrase: "were"

Phrase: "performed at room temperature"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   770   C0005903:temperature [Organism Attribute]
   770   C0039476:*Temperature [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   770   C1547703:Room [Spatial Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011928:DRGs [Intellectual Product]
   966 E C1414151:DRG [Gene or Genome]

Phrase: "between 20and 40m"

Phrase: "in diameter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1301886:Diameter [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0025664:techniques [Intellectual Product]
  1000   C0449851:Techniques [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.121: Recording electrode resistance was 1-2 M, and seal resistance was 1G. 

Phrase: "Recording electrode resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0237834:Resistance [Mental Process]
   827   C1514892:Resistance [Physiologic Function]
   755 E C0332325:Resistant [Functional Concept]
   755 E C1550464:resistent [Idea or Concept]
   755 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "was"

Phrase: "1-2 M,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
   734   C0580272:1/2 [Intellectual Product]
   734   C1519043:1-2 [Research Activity]

Phrase: "and"

Phrase: "seal resistance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "was"

Phrase: "1G."
Processing 00000000.tx.122: Experiments were performed in a nonperfused culture dish containing the following external bath solution (in mM): 5CaCl2, 67choline Cl, 100tetraethylammonium chloride, 5.6glucose, 5.3KCl, 10HEPES, and 0.8MgCl2 (pH 7.3-7.4, 320-330 mosm/kg). 

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in a nonperfused culture dish"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0010453:Culture [Idea or Concept]
   753   C0020498:DISH [Disease or Syndrome]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C0884358:Performed [Functional Concept]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "the following external bath solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "("

Phrase: "in mM"

Phrase: ")"

Phrase: ":"

Phrase: "5CaCl2,"

Phrase: "67choline Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "100tetraethylammonium chloride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0008203:Chloride, NOS [Inorganic Chemical]
   861   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "5.6glucose,"

Phrase: "5.3KCl,"

Phrase: "10HEPES,"

Phrase: "and"

Phrase: "0.8MgCl2"

Phrase: "(pH 7.3-7.4,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   897   C2678549:PH-4 [Gene or Genome]
   853   C0601906:PH 3 [Pharmacologic Substance]
   840   C1882074:pH 7 [Qualitative Concept]
   804   C0020283:[pH] [Quantitative Concept]
   804   C0450407:ph+ [Finding]
   804   C0450408:ph++ [Finding]
   804   C0450409:ph+++ [Finding]

Phrase: "320-330 mosm/kg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439353:mOsm/kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.123: In some experiments, 5mM BaCl2 replaced CaCl2. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "5mM BaCl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0052972:BaCl2 [Hazardous or Poisonous Substance,Inorganic Chemical,Pharmacologic Substance]

Phrase: "replaced"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0559956:Replaced [Functional Concept]
  1000   C1299987:replaced [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "CaCl2."
Processing 00000000.tx.124: Recording electrodes were filled with (in mM) 140cesium Cl, 10HEPES, 10EGTA, 5MgATP, and 0.1LiGTP (Sigma). 

Phrase: "Recording electrodes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013812:Electrodes [Medical Device]
   827 E C1705652:Electrode [Medical Device]

Phrase: "were"

Phrase: "filled with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1708059:Filled [Activity]

Phrase: "("

Phrase: "in mM) 140cesium Cl,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596019:Cl - [Element, Ion, or Isotope]

Phrase: "10HEPES,"

Phrase: "10EGTA,"

Phrase: "5MgATP,"

Phrase: "and"

Phrase: "0.1LiGTP"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.125: During intracellular dialysis with GDPS or GTPS, recording solutions were prepared with GDPS or GTPS added as described in the preceding text, without additional LiGTP. 

Phrase: "During intracellular dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]

Phrase: "with GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "recording"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "prepared with GDPS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   756   C1521827:Prepare [Functional Concept]

Phrase: "or"

Phrase: "GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "as"

Phrase: "described in the preceding text,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0332152:Preceding [Temporal Concept]
   760   C1527021:Text [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1554111:Text [Idea or Concept]
   760   C1705606:Text [Intellectual Product]
   760   C3541382:Text [Intellectual Product]

Phrase: "without additional LiGTP."
Processing 00000000.tx.126: The pH was adjusted to 7.2-7.3 with 1M CsOH after addition of ATP and GTP, and the final osmolality (280-290 mosm/kg) was adjusted to 10-15% below that of the external recording solution using distilled water. 

Phrase: "The pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "adjusted to 7.2-7.3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0456081:Adjusted [Functional Concept]

Phrase: "with 1M CsOH"

Phrase: "after addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of ATP"

Phrase: "and"

Phrase: "GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "the final osmolality"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0086741:Osmolality [Clinical Attribute]
   861   C0201803:Osmolality [Laboratory Procedure]
   861   C1547034:*Osmolality [Quantitative Concept]
   761 E C0439186:osmol [Quantitative Concept]

Phrase: "(280-290 mosm/kg)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439353:mOsm/kg [Quantitative Concept]
   812   C0022718:KG [Geographic Area]
   812   C0439209:kg [Quantitative Concept]

Phrase: "was"

Phrase: "adjusted to 10-15%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0456081:Adjusted [Functional Concept]

Phrase: "below that"

Phrase: "of the external recording solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "distilled water."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0790233:Distilled water [Inorganic Chemical,Pharmacologic Substance]
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C0681549:distilled [Occupational Activity]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]
Processing 00000000.tx.127: High-threshold calcium currents were elicited by depolarizing voltage steps generated using the program CLAMPEX (pCLAMP, Axon Instruments, Foster City, CA). 

Phrase: "High-threshold calcium currents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]
   708   C0553702:high calcium [Finding]

Phrase: "were"

Phrase: "elicited by depolarizing voltage steps"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   806   C0449265:Elicited by [Qualitative Concept]
           elicited
   760   C0598352:Voltage [Quantitative Concept]
   760   C1261552:steps [Conceptual Entity]
   726 E C1704379:Step [Functional Concept]
   726 E C1705117:Step [Quantitative Concept]
   726 E C2825408:Step [Manufactured Object]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the program CLAMPEX"

Phrase: "(pCLAMP,"

Phrase: "Axon Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA)."
Processing 00000000.tx.128: Currents were recorded using an Axopatch 220A patch-clamp amplifier (Axon Instruments) with an input resistance of 1-3 M, filtered with a Bessel filter at 5kHz (3 dB), sampled at 20kHz, and stored on hard disk as binary data files. 

Phrase: "Currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an Axopatch 220A patch-clamp amplifier"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0002684:amplifier [Manufactured Object]
   804   C1706099:Amplifier [Manufactured Object]

Phrase: "(Axon Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")"

Phrase: "with an input resistance"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1708517:Input [Conceptual Entity]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "of 1-3 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "filtered with a Bessel filter"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   726   C0180860:Filter [Manufactured Object]
   726   C0581406:Filter [Medical Device]
   726   C1522664:Filter [Intellectual Product]
   726   C1704449:Filter [Conceptual Entity]
   726   C1704684:Filter [Medical Device]
   726   C1875155:FILTER [Medical Device]

Phrase: "at 5kHz"

Phrase: "(3 dB"

Phrase: ")"

Phrase: ","

Phrase: "sampled at 20kHz,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0441621:sampled [Diagnostic Procedure]
   790   C0870078:sampled [Idea or Concept]
   756 E C0370003:Sample [Substance]
   756 E C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "stored on hard disk"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2347849:Hard Disc [Manufactured Object]
   770   C0018599:Hard [Qualitative Concept]
   770   C0180459:DISC [Medical Device]
   770   C1556138:Disc [Body Part, Organ, or Organ Component]
   770   C1705229:Disc [Medical Device]
   770   C2348299:Disc [Spatial Concept]
   737   C1698986:Store [Functional Concept]

Phrase: "as binary data files."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0242193:Data Files [Intellectual Product]
   793   C0016094:File [Occupational Activity]
   793   C0180853:File [Medical Device]
   793   C1522646:File [Functional Concept]
   734   C1552664:Binary Data [Idea or Concept]
Processing 00000000.tx.129: The total duration of recording was 10-20 min from the time of patch rupture. 

Phrase: "The total duration of recording"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0489631:Recording duration [Temporal Concept]
   760   C0449238:Duration [Temporal Concept]
   760   C2926735:Duration [Pharmacologic Substance]

Phrase: "was"

Phrase: "10-20 min from the time of patch rupture."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0456692:/10 min [Temporal Concept]
   742   C0702093:/min [Temporal Concept]
Processing 00000000.tx.130: Electrophysiologic stimulation parameters Neurons were voltage-clamped at a holding potential (Vh)=80 mV. 

Phrase: "Electrophysiologic stimulation parameters Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "voltage-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0598352:Voltage [Quantitative Concept]

Phrase: "clamped at a holding potential"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C3245505:Potential [Qualitative Concept]
   726   C0175721:Clamp [Medical Device]
   726   C1553387:Hold [Idea or Concept]
   726   C1705942:Clamp [Manufactured Object]
   726   C1883710:Clamp [Functional Concept]
   726   C1948035:Hold [Activity]

Phrase: "(Vh)=80 mV."
Processing 00000000.tx.131: Immediately after patch rupture, whole cell capacitance was measured as described previously (Hall et al. 1995b). 

Phrase: "Immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "patch rupture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "whole cell capacitance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0242264:capacitance [Quantitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.132: High-threshold calcium currents (ICa) were elicited by depolarization from Vh=80 to +10 mV for 100ms. 

Phrase: "High-threshold calcium currents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]
   708   C0553702:high calcium [Finding]

Phrase: "(ICa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201519:ICA [Laboratory Procedure]

Phrase: "were"

Phrase: "elicited by depolarization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0449265:Elicited by [Qualitative Concept]
           elicited

Phrase: "from Vh=80 to +10 mV"

Phrase: "for 100ms."
Processing 00000000.tx.133: Leak currents were generated by hyperpolarizing commands of equal value to those used to depolarize the cell. 

Phrase: "Leak currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "generated by hyperpolarizing commands of equal value"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0205163:Equal [Qualitative Concept]
   748   C1522609:Value [Quantitative Concept]
   748   C1549782:Equal [Idea or Concept]
   748   C3146294:Generated [Activity]
   748   C3639196:Commands [Intellectual Product]

Phrase: "to those used to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1273517:used [Finding]

Phrase: "depolarize"

Phrase: "the cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.134: There was no significant difference in the leak current measured in control (6844pA; n=24) and diabetic neurons (8732pA; n=20). 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in the leak current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "measured in control"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0243148:control [Qualitative Concept]
   790   C0444706:Measured [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "(6844pA"

Phrase: "; n=24"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "diabetic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(8732pA"

Phrase: "; n=20"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.135: Calcium current density was calculated by dividing the leak-subtracted ICa by capacitance to yield (IDCa; pA/pF). 

Phrase: "Calcium current density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "calculated by dividing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332849:dividing [Functional Concept]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]

Phrase: "the leak-subtracted ICa by capacitance to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0201519:ICA [Laboratory Procedure]

Phrase: "yield"

Phrase: "(IDCa"

Phrase: "; pA/pF"

Phrase: ")."
Processing 00000000.tx.136: This maneuver was performed to control for the effect of diabetic macrosomia on absolute current amplitude (Hall et al. 1995b). 

Phrase: "This maneuver"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for the effect of diabetic macrosomia"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0158915:Macrosomia [Finding]
   748   C0241863:DIABETIC [Finding]
   748   C0243148:control [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2348382:Effect [Qualitative Concept]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "on absolute current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.137: Peak IDCa was calculated for neurons from diabetic and control animals and compared using the statistical software package GraphPad Prism (GraphPad Software). 

Phrase: "Peak IDCa"

Phrase: "was"

Phrase: "calculated for neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0027882:Neurons [Cell]
   790   C0444686:Calculated [Functional Concept]
   790   C1441506:Calculated [Activity]
   790   C1443182:Calculated [Laboratory Procedure]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C1511501:Control Animal [Animal]
   861   C0003062:Animals [Animal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the statistical software package GraphPad Prism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0814195:PRISM [Intellectual Product]
   748 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(GraphPad Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: ")."
Processing 00000000.tx.138: IDCa amplitude and facilitation of currents were monitored at 30-s intervals by alternating 100-ms depolarizations to +10 mV with a two-step facilitation protocol described in the following text. 

Phrase: "IDCa amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "facilitation of currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "were"

Phrase: "monitored at 30-s intervals"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C1272706:intervals [Temporal Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "by alternating 100-ms depolarizations to +10 mV"

Phrase: "with a two-step facilitation protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]

Phrase: "described in the following text."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C1527021:Text [Intellectual Product]
   760   C1552738:described [Idea or Concept]
   760   C1554111:Text [Idea or Concept]
   760   C1705606:Text [Intellectual Product]
   760   C3541382:Text [Intellectual Product]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.139: Current-voltage (I-V) curves and steady-state inactivation curves were generated using standard techniques (Hall et al. 1995a). 

Phrase: "Current-voltage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598352:Voltage [Quantitative Concept]

Phrase: "(I-V) curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0205134:Curve [Spatial Concept]

Phrase: "and"

Phrase: "steady-state inactivation curves"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0678587:steady state [Natural Phenomenon or Process]
   812   C0205361:Steady [Qualitative Concept]
   812   C0544461:Inactivation [Cell or Molecular Dysfunction]
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]
   779   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "standard techniques"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025664:techniques [Intellectual Product]
   861   C0449851:Techniques [Functional Concept]

Phrase: "(Hall et al. 1995a"

Phrase: ")."
Processing 00000000.tx.140: To determine whether diabetes affected the rate of decay of tail current deactivation, tail currents from diabetic and control recordings were normalized by dividing by the maximum tail current amplitude obtained during each recording. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "the rate of decay of tail current deactivation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "tail currents from diabetic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0521116:currents [Temporal Concept]
   737 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "control recordings"

Phrase: "were"

Phrase: "normalized by"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882115:Normalized [Research Activity]

Phrase: "dividing by the maximum tail current amplitude"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0039259:Tail [Body Part, Organ, or Organ Component]
   748   C0332849:dividing [Functional Concept]
   748   C0521116:Current [Temporal Concept]
   748   C0806909:Maximum [Quantitative Concept]
   748   C1552615:maximum [Quantitative Concept]
   748   C1705970:Current [Natural Phenomenon or Process]
   748   C2346753:Amplitude [Spatial Concept]
   748   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "obtained during each recording."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.141: To avoid transient recording artifacts immediately postdepolarization, maximum tail current amplitude was measured 50s after termination of depolarization. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "transient recording artifacts immediately postdepolarization,"

Phrase: "maximum tail current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "50s after termination of depolarization."
Processing 00000000.tx.142: After normalization, traces were averaged and the best fit for both diabetic and control recordings was obtained by a Chebyshev fit with 5,000iterations of a second-order exponential equation of the form where 1 and 2 were the time constants of the fast and slow decay components in milliseconds. 

Phrase: "After normalization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalization [Research Activity]

Phrase: "traces"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "were"

Phrase: "averaged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1510992:Average [Quantitative Concept]
   966   C2825518:AVERAGE [Quantitative Concept]

Phrase: "and"

Phrase: "the best fit for both diabetic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036572:Fit [Sign or Symptom]
   753   C0424576:Fit [Finding]
   753   C2349186:Fit [Activity]

Phrase: "and"

Phrase: "control recordings"

Phrase: "was"

Phrase: "obtained by a Chebyshev fit"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0036572:Fit [Sign or Symptom]
   760   C0424576:Fit [Finding]
   760   C1301820:Obtained [Functional Concept]
   760   C2349186:Fit [Activity]
   726 E C1706701:Obtain [Activity]

Phrase: "with 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "000iterations of a second-order exponential equation of the form where 1"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "were"

Phrase: "the time constants of the fast"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
   719   C1547014:*Constant [Quantitative Concept]
   719   C1948059:Constant [Qualitative Concept]

Phrase: "and"

Phrase: "slow decay components in milliseconds."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.143: Parameters for the control curve (n=8) were: A=1.3915; 

Phrase: "Parameters for the control curve"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0449381:Parameters [Finding]
   726 E C0549193:Parameter [Spatial Concept]
   726 E C1704769:Parameter [Conceptual Entity]
   726 E C2350001:Parameter [Quantitative Concept]

Phrase: "(n=8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: ":"

Phrase: "A=1.3915"

Phrase: ";"
Processing 00000000.tx.144: k1=0.00048; 

Phrase: "k1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "=0.00048"

Phrase: ";"
Processing 00000000.tx.145: B=1.0687; 

Phrase: "B=1.0687"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347469:/B [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.146: k2=0.05263; 

Phrase: "k2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422147:K2 [Gene or Genome]

Phrase: "=0.05263"

Phrase: ";"
Processing 00000000.tx.147: C=0.97646, diabetic curve (n=8): A=0.68774; 

Phrase: "C=0.97646,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553033:[c] [Quantitative Concept]

Phrase: "diabetic curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205134:Curve [Spatial Concept]

Phrase: "(n=8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ":"

Phrase: "A=0.68774"

Phrase: ";"
Processing 00000000.tx.148: k1=0.001733; 

Phrase: "k1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "=0.001733"

Phrase: ";"
Processing 00000000.tx.149: B=0.68064; 

Phrase: "B=0.68064"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347469:/B [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.150: k2=0.03943; 

Phrase: "k2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422147:K2 [Gene or Genome]

Phrase: "=0.03943"

Phrase: ";"
Processing 00000000.tx.151: C=0.16446. 

Phrase: "C=0.16446."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.152: Facilitation protocols Facilitation was elicited using two different protocols designed to differentiate the effect of calcium-mediated inhibition on facilitation amplitude. 

Phrase: "Facilitation protocols Facilitation"

Phrase: "was"

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two different protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0442711:Protocols [Intellectual Product]
   793 E C1507394:Protocol [Intellectual Product]
   793 E C1522729:Protocol [Intellectual Product]
   793 E C2348563:Protocol [Intellectual Product]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "the effect of calcium-mediated inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on facilitation amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.153: The first (10/90) consisted of a 50-ms prepulse to +10 mV which was followed in 15ms by a 25-ms test pulse to +10 mV (Fig. 4A). 

Phrase: "The first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "(10/90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "consisted of a 50-ms prepulse to +10 mV"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   742   C2349943:Ms. [Conceptual Entity]
   742   C3539704:MS [Gene or Genome]
   708   C0332529:CONSIST [Qualitative Concept]

Phrase: "which"

Phrase: "was"

Phrase: "followed in 15ms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0332283:followed [Temporal Concept]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "by a 25-ms test pulse to +10 mV (Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0450373:4a [Intellectual Product]
   791   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.154: After a 3-s delay to allow recovery from inactivation, a second set of paired pulses was administered, with a strongly-depolarizing prepulse amplitude of +90 mV, followed by a test pulse amplitude of +10 mV. 

Phrase: "After a 3-s"

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "recovery from inactivation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237820:Recovery [Activity]
   790   C1555688:recovery [Idea or Concept]
   790   C2004454:Recovery [Organism Function]

Phrase: "a second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "set of paired pulses"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0034107:Pulses [Health Care Activity]
   770   C0036849:Set [Mental Process]
   770   C0391850:PULSES [Physiologic Function]
   770   C1442518:Set [Functional Concept]
   770   C1705195:Set [Conceptual Entity]
   770   C1709450:Paired [Qualitative Concept]
   737 E C0232117:PULSE [Clinical Attribute]
   737 E C1947910:Pulse [Phenomenon or Process]

Phrase: "was"

Phrase: "administered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1521801:Administered [Functional Concept]
   966 E C1621583:Administer [Functional Concept]

Phrase: ","

Phrase: "with a strongly-depolarizing prepulse amplitude of +90 mV,"

Phrase: "followed by a test pulse amplitude of +10 mV."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0332283:Followed by [Temporal Concept]
           followed
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0232117:PULSE [Clinical Attribute]
   742   C0391850:Pulse [Physiologic Function]
   742   C0392366:test [Intellectual Product]
   742   C1947910:Pulse [Phenomenon or Process]
   742   C2346753:Amplitude [Spatial Concept]
   708 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.155: Facilitation was defined as the percentage increase in IDCa amplitude of the second ("facilitated") test pulse compared with the first test pulse and was calculated by the following equation A second protocol (0/90), consisting of a "null" prepulse (0depolarization/+10 mV test pulse) followed in 3s by a +90 mV/+10 mV pair, was employed to minimize the amount of calcium entering prior to facilitation (Fig. 4C). 

Phrase: "Facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "defined as the percentage increase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0439165:Percentage [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "in IDCa amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "of the second"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "("""

Phrase: "facilitated"

Phrase: """"

Phrase: ")"

Phrase: "test pulse"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0022885:Test [Laboratory Procedure]
   861   C0039593:Test [Functional Concept]
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C0392366:test [Intellectual Product]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: "compared with the first test pulse"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0205435:First [Quantitative Concept]
   753   C0232117:PULSE [Clinical Attribute]
   753   C0391850:Pulse [Physiologic Function]
   753   C0392366:test [Intellectual Product]
   753   C1279901:First [Qualitative Concept]
   753   C1707455:Compared [Activity]
   753   C1947910:Pulse [Phenomenon or Process]

Phrase: "and"

Phrase: "was"

Phrase: "calculated by the following equation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0444686:Calculated [Functional Concept]
   760   C0552449:Equation [Conceptual Entity]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]

Phrase: "A second protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "(0/90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "consisting of a ""null"" prepulse"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456148:Null [Quantitative Concept]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "(0depolarization/+10 mV test pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0232117:PULSE [Clinical Attribute]
   804   C0391850:Pulse [Physiologic Function]
   804   C1947910:Pulse [Phenomenon or Process]
   721 E C0034107:Pulses [Health Care Activity]

Phrase: ")"

Phrase: "followed in 3s"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332283:followed [Temporal Concept]
   790   C1552117:3s [Body Part, Organ, or Organ Component]
   756 E C1719822:Follow [Intellectual Product]

Phrase: "by a +90 mV/+10 mV pair,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1709450:Pair [Qualitative Concept]

Phrase: "was"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "the amount of calcium entering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "prior to facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.156: The voltage range of facilitation was determined by sequentially increasing the large-amplitude prepulse depolarization voltage from 20 to +90 mV and plotting percent facilitation of the test pulse against prepulse voltage amplitude. 

Phrase: "The voltage range of facilitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "was"

Phrase: "determined by sequentially"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the large-amplitude prepulse depolarization voltage from 20 to +90 mV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0598352:Voltage [Quantitative Concept]

Phrase: "and"

Phrase: "plotting percent facilitation of the test pulse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "against prepulse voltage amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.157: Normalized activation curves for percent facilitation in control and diabetic neurons were generated by dividing facilitation amplitude by maximum facilitation elicited by a +90-mV prepulse. 

Phrase: "Normalized activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "curves for percent facilitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205134:Curve [Spatial Concept]
   770   C0234112:Facilitation [Organ or Tissue Function]
   770   C0439165:Percent [Quantitative Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "generated by dividing facilitation amplitude"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0234112:Facilitation [Organ or Tissue Function]
   760   C0332849:dividing [Functional Concept]
   760   C2346753:Amplitude [Spatial Concept]
   760   C3146294:Generated [Activity]

Phrase: "by maximum facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "elicited by a +90-mV prepulse."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0449265:Elicited by [Qualitative Concept]
           elicited
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]
Processing 00000000.tx.158: Curves were fit using a Boltzman equation of the form where F=facilitation amplitude at prepulse voltage V, Fmax=maximum facilitation amplitude, V50=prepulse voltage at 1/2 Fmax, V=prepulse voltage, and k=slope. 

Phrase: "Curves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0205134:Curve [Spatial Concept]

Phrase: "were"

Phrase: "fit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036572:Fit [Sign or Symptom]
  1000   C0424576:Fit [Finding]
  1000   C2349186:Fit [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Boltzman equation of the form where F=facilitation amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0552449:Equation [Conceptual Entity]

Phrase: "at prepulse voltage V,"

Phrase: "Fmax=maximum facilitation amplitude,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346753:Amplitude [Spatial Concept]

Phrase: "V50"

Phrase: "=prepulse voltage at 1/2 Fmax,"

Phrase: "V=prepulse voltage,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598352:Voltage [Quantitative Concept]

Phrase: "and"

Phrase: "k=slope."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0807955:Slope [Quantitative Concept]
Processing 00000000.tx.159: The effect of varying the inter-pulse interval on facilitation amplitude was determined by sequentially increasing the inter-pulse interval from 12to 500ms, while keeping the prepulse amplitude constant at +90 mV. 

Phrase: "The effect of varying"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "the inter-pulse interval on facilitation amplitude"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1272706:Interval [Temporal Concept]
   748   C1552654:Interval [Idea or Concept]
   748   C1552713:Interval [Intellectual Product]

Phrase: "was"

Phrase: "determined by sequentially"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the inter-pulse interval from 12to 500ms,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1272706:Interval [Temporal Concept]
   748   C1552654:Interval [Idea or Concept]
   748   C1552713:Interval [Intellectual Product]

Phrase: "while"

Phrase: "keeping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "the prepulse amplitude constant at +90 mV."
Processing 00000000.tx.160: Normalized facilitation amplitude (facilitation/maximum facilitation obtained with a +90-mV prepulse; 12-ms inter-pulse interval) was plotted versus increasing inter-pulse interval. 

Phrase: "Normalized facilitation amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "(facilitation/maximum facilitation"

Phrase: "obtained with a +90-mV prepulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "; 12-ms inter-pulse interval"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1272706:Interval [Temporal Concept]
   804   C1552654:Interval [Idea or Concept]
   804   C1552713:Interval [Intellectual Product]

Phrase: ")"

Phrase: "was"

Phrase: "plotted"

Phrase: "versus"

Phrase: "increasing inter-pulse interval."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1272706:Interval [Temporal Concept]
   812   C1552654:Interval [Idea or Concept]
   812   C1552713:Interval [Intellectual Product]
Processing 00000000.tx.161: The best fit of the data was obtained with a double exponential equation of the form where F=normalized facilitation amplitude at prepulse interval T, A and B=time constants, and k1 and k2=decay rate constants. 

Phrase: "The best fit of the data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036572:Fit [Sign or Symptom]
   753   C0424576:Fit [Finding]
   753   C2349186:Fit [Activity]

Phrase: "was"

Phrase: "obtained with a double exponential equation"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0205173:Double [Functional Concept]
   753   C0552449:Equation [Conceptual Entity]
   753   C1301820:Obtained [Functional Concept]
   753   C1552645:exponential [Qualitative Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "of the form where F=normalized facilitation amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C2346753:Amplitude [Spatial Concept]

Phrase: "at prepulse interval T,"

Phrase: "A"

Phrase: "and"

Phrase: "B=time constants,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1547014:*Constant [Quantitative Concept]
   793   C1948059:Constant [Qualitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "and"

Phrase: "k1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1721009:K1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3272787:K1 [Gene or Genome]

Phrase: "and"

Phrase: "k2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1422147:K2 [Gene or Genome]

Phrase: "=decay rate constants."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   896   C2986736:Decay Constant [Quantitative Concept]
   867   C2986811:Rate Constant [Quantitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   793   C1547014:*Constant [Quantitative Concept]
   793   C1948059:Constant [Qualitative Concept]
Processing 00000000.tx.162: Statistical analysis Significance was determined by analysis with GraphPad Prism (GraphPad Software) using two way ANOVA for multiple comparisons and defined as P<0.05(Mendenhall 1975).  

Phrase: "Statistical analysis Significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0237881:Statistical Significance [Quantitative Concept]
           Significance
   913   C1709380:Statistical Significance [Quantitative Concept]
   827   C0750502:Significance [Idea or Concept]
   755 E C1546944:Significant [Qualitative Concept]
   734   C0871424:statistical analysis [Research Activity]

Phrase: "was"

Phrase: "determined by analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "with GraphPad Prism"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0814195:PRISM [Intellectual Product]
   805 E C0138404:prisma [Organic Chemical,Pharmacologic Substance]

Phrase: "(GraphPad Software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two way ANOVA for multiple comparisons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C1710497:Two-way ANOVA [Quantitative Concept]
   753   C0205448:Two [Quantitative Concept]

Phrase: "and"

Phrase: "defined as P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: "(Mendenhall 1975"

Phrase: ")."
Processing 00000000.tx.163: RESULTS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Effect of diabetes on nerve conduction velocity and high-threshold calcium currents Diabetic BB/W rats (diabetic duration, 7-10 mo) had significant decreases in body weight, elevated glycated hemoglobin (Hb), and slowing of median nerve conduction velocity (MNCV) compared with nondiabetic control animals (Table 1). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Effect of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "on nerve conduction velocity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0429381:Nerve conduction velocity [Finding]
  1000   C2982003:Nerve Conduction Velocity [Diagnostic Procedure]
   901   C0027788:Nerve Conduction [Organ or Tissue Function]
   901   C0234084:Conduction velocity [Organ or Tissue Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0232217:Conduction [Organ or Tissue Function]
   827   C0439830:Velocity [Quantitative Concept]
   827   C0457405:Conduction [Natural Phenomenon or Process]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1547053:*Velocity [Quantitative Concept]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "and"

Phrase: "high-threshold calcium currents Diabetic BB/W rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0034693:rats [Mammal]
   793   C0034721:Rats [Mammal]

Phrase: "(diabetic duration,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449238:Duration [Temporal Concept]
   861   C2926735:Duration [Pharmacologic Substance]

Phrase: "7-10 mo)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538743:MO [Idea or Concept]

Phrase: "had"

Phrase: "significant decreases in body weight,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0043096:decreases weight [Finding]
   760   C0547047:decreases [Quantitative Concept]
   726 E C0392756:Decrease [Qualitative Concept]

Phrase: "elevated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205250:Elevated [Qualitative Concept]
  1000   C3163633:Elevated [Qualitative Concept]

Phrase: "glycated hemoglobin (Hb),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017853:Glycated haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0019046:Haemoglobin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "slowing of median nerve conduction velocity (MNCV)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439834:slowing [Qualitative Concept]

Phrase: "compared with nondiabetic control animals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   773   C1511501:Control Animal [Animal]
   760   C0003062:Animals [Animal]
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1707455:Compared [Activity]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.164: Animals rendered diabetic by injection of STZ demonstrated similar changes in weight and blood sugar after 4-5 wk (Table 2). 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "rendered"

Phrase: "diabetic by injection of STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0241863:DIABETIC [Finding]

Phrase: "demonstrated"

Phrase: "similar changes in weight"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0005911:weight changes [Finding]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "blood sugar after 4-5 wk (Table 2"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0005802:Blood Sugar [Carbohydrate]
   767   C0038636:Table sugar [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   767   C0376597:Table Sugar [Carbohydrate,Food]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0007004:Sugar [Carbohydrate]
   744   C0229664:Blood [Body Substance]
   744   C0242209:Sugar [Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.165: Whole cell, voltage-clamp recordings of high-threshold calcium current density (IDCa) were performed on isolated DRG neurons prepared from BB/W and STZ-induced diabetic animals or age-matched nondiabetic controls. 

Phrase: "Whole cell, voltage-clamp recordings of high-threshold calcium current density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   772   C0242624:Whole-Cell Recordings [Research Activity]

Phrase: "(IDCa"

Phrase: ")"

Phrase: "were"

Phrase: "performed on isolated DRG neurons"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   814   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   814   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   778   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   778   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   748   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   748   C0027882:Neurons [Cell]
   748   C0040452:Root [Body Part, Organ, or Organ Component]
   748   C0205095:Dorsal [Spatial Concept]
   748   C0205409:Isolated [Functional Concept]
   748   C0242726:Root [Plant]
   748   C0884358:Performed [Functional Concept]
   748   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   748   C1318154:Root [Body Part, Organ, or Organ Component]
   748   C1548221:Isolated [Idea or Concept]
   748   C1705917:Root [Idea or Concept]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from BB/W"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "STZ-induced diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "or"

Phrase: "age-matched nondiabetic controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.166: Currents were elicited at 30-s intervals using a 100-ms depolarizing voltage step to +10 mV as described in METHODS. 

Phrase: "Currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521116:currents [Temporal Concept]
   966 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "elicited at 30-s intervals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0449265:elicited [Qualitative Concept]
   760   C1272706:intervals [Temporal Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 100-ms depolarizing voltage step to +10 mV"

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.167: IDCa increased 20-30% in amplitude during the initial 2-5 min following patch rupture ("runup") to a maximum amplitude. 

Phrase: "IDCa"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "20-30% in amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346753:Amplitude [Spatial Concept]

Phrase: "during the initial 2-5 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "patch rupture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "(""runup"""

Phrase: ")"

Phrase: "to a maximum amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.168: Maximum leak-subtracted IDCa amplitude in DRG neurons from diabetic BB/W and STZ-induced diabetic animals was significantly enhanced compared with controls (Table 3). 

Phrase: "Maximum leak-subtracted IDCa amplitude in DRG neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2346753:Amplitude [Spatial Concept]

Phrase: "from diabetic BB/W"

Phrase: "and"

Phrase: "STZ-induced diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "was"

Phrase: "significantly"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.169: Current density subsequently decreased at a steady rate ("rundown"), such that by 10min following patch rupture, the current amplitude was ~60% of the maximum amplitude recorded. 

Phrase: "Current density subsequently"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "decreased at a steady rate"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0205361:Steady [Qualitative Concept]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0442797:decreased [Qualitative Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "(""rundown"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0848283:rundown [Sign or Symptom]

Phrase: ")"

Phrase: ","

Phrase: "such"

Phrase: "that by 10min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "patch rupture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "the current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "was ~"

Phrase: "60% of the maximum amplitude"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0806909:Maximum [Quantitative Concept]
   760   C1552615:maximum [Quantitative Concept]
   760   C2346753:Amplitude [Spatial Concept]
   760   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "recorded."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]
Processing 00000000.tx.170: Rundown occurred at a similar rate in diabetic and control neurons. 

Phrase: "Rundown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0848283:rundown [Sign or Symptom]

Phrase: "occurred at a similar rate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   760   C1709305:Occurred [Activity]
   760   C2348205:Similar [Qualitative Concept]
   726 E C2745955:OCCUR [Temporal Concept]

Phrase: "in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.171: As we have reported previously (Hall et al. 1995b), the maximum amplitude of the current-voltage relationship (I-V) curve was greater in neurons from BB/W diabetic rats, and there was no shift in the voltage dependence of activation, steady-state inactivation (data not shown). 

Phrase: "As"

Phrase: "we"

Phrase: "have"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(Hall et al. 1995b"

Phrase: ")"

Phrase: ","

Phrase: "the maximum amplitude of the current-voltage relationship"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2346753:Amplitude [Spatial Concept]

Phrase: "(I-V) curve"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205134:Curve [Spatial Concept]

Phrase: "was"

Phrase: "greater in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "from BB/W diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "there"

Phrase: "was"

Phrase: "no shift in the voltage dependence of activation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0333051:Shift [Functional Concept]
   744   C2347509:Shift [Phenomenon or Process]

Phrase: "steady-state inactivation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0678587:steady state [Natural Phenomenon or Process]
   827   C0205361:Steady [Qualitative Concept]
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.172: There was also no significant difference in the deactivation time constants (; ms) of calcium currents recorded in eight control and eight diabetic BB/W neurons when fit by Boltzman equations with the following parameters: control: 1=0.30.1; 

Phrase: "There"

Phrase: "was"

Phrase: "also"

Phrase: "no significant difference in the deactivation time constants"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   767   C1442103:Time Difference [Temporal Concept]
   767   C1547049:*Time Difference [Quantitative Concept]
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "("

Phrase: "; ms) of calcium currents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   770   C2349943:Ms. [Conceptual Entity]
   770   C3539704:MS [Gene or Genome]

Phrase: "recorded in eight control"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205454:Eight [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0034869:Record [Intellectual Product]

Phrase: "and"

Phrase: "eight diabetic BB/W neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: "when"

Phrase: "fit by Boltzman equations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0036572:Fit [Sign or Symptom]
   770   C0424576:Fit [Finding]
   770   C2349186:Fit [Activity]

Phrase: "with the following parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0449381:Parameters [Finding]
   827 E C0549193:Parameter [Spatial Concept]
   827 E C1704769:Parameter [Conceptual Entity]
   827 E C2350001:Parameter [Quantitative Concept]

Phrase: ":"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "=0.30.1"

Phrase: ";"
Processing 00000000.tx.173: 2=1.90.1,diabetic: 1=0.40.1,2=1.60.1.

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "=1.90.1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439083:>90 [Quantitative Concept]
   827   C0439087:<90 [Quantitative Concept]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "=0.40.1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "=1.60.1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0442768:1/60 [Finding]
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]
Processing 00000000.tx.174: This suggests that there was no significant difference in the relative proportions of the various types of whole cell currents activated by depolarization in diabetic and control DRGs. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that there"

Phrase: "was"

Phrase: "no significant difference in the relative proportions of the various types"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1705241:*Difference [Quantitative Concept]
   738   C1705242:Difference [Qualitative Concept]

Phrase: "of whole cell currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "activated by depolarization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]

Phrase: "in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control DRGs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.175: A similar situation was observed in recordings from STZ-induced diabetic animals (results not shown).  

Phrase: "A similar situation"

Phrase: "was"

Phrase: "observed in recordings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "from STZ-induced diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.176: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.177: Body weight and nerve conduction velocity significantly decreased in diabetic BB/W rats  View this table: [in this window] [in a new window]  Table 2. 

Phrase: "Body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "nerve conduction velocity significantly"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   923   C0429381:Nerve conduction velocity [Finding]
   923   C2982003:Nerve Conduction Velocity [Diagnostic Procedure]
   861   C0027788:Nerve Conduction [Organ or Tissue Function]
   861   C0234084:Conduction velocity [Organ or Tissue Function]
   812   C0027740:Nerve [Tissue]
   812   C0027757:NERVE [Tissue]
   812   C0232217:Conduction [Organ or Tissue Function]
   812   C0439830:Velocity [Quantitative Concept]
   812   C0457405:Conduction [Natural Phenomenon or Process]
   812   C1280541:Nerve [Body Part, Organ, or Organ Component]
   812   C1547053:*Velocity [Quantitative Concept]
   756 E C0599851:Neural [Functional Concept]
   741 E C0027769:nervy [Sign or Symptom]

Phrase: "decreased in diabetic BB/W rats"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.178: Body weight and blood glucose in STZ-induced diabetic rats compared to controls  View this table: [in this window] [in a new window]  Table 3. 

Phrase: "Body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "blood glucose in STZ-induced diabetic rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0005802:Blood Glucose [Carbohydrate]
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0229664:Blood [Body Substance]

Phrase: "compared to controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.179: Enhanced calcium current density (IDCa) in DRGs from BB/W and STZ-induced diabetic rats  opiate-mediated inhibition of calcium currents was significantly decreased in STZ-induced diabetic DRGs We had previously observed that opiate-mediated inhibition of calcium currents in DRGs by dynorphin A was significantly diminished in neurons from BB/W diabetic rats, compared with age-matched controls (Hall et al. 1996). 

Phrase: "Enhanced calcium current density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0178587:density [Quantitative Concept]
   741 E C0439794:Dense [Qualitative Concept]

Phrase: "(IDCa"

Phrase: ")"

Phrase: "in DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011928:DRGs [Intellectual Product]
   966 E C1414151:DRG [Gene or Genome]

Phrase: "from BB/W"

Phrase: "and"

Phrase: "STZ-induced diabetic rats  opiate-mediated inhibition of calcium currents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased in STZ-induced diabetic DRGs"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0011928:DRGs [Intellectual Product]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   719 E C0547047:Decrease [Quantitative Concept]
   719 E C1414151:DRG [Gene or Genome]

Phrase: "We"

Phrase: "had"

Phrase: "previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that opiate-mediated inhibition of calcium currents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "in DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011928:DRGs [Intellectual Product]
   966 E C1414151:DRG [Gene or Genome]

Phrase: "by dynorphin A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086191:Dynorphin A [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0013355:Dynorphin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418447:dynorphin [Gene or Genome]

Phrase: "was"

Phrase: "significantly"

Phrase: "diminished in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0205216:Diminished [Quantitative Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from BB/W diabetic rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "compared with age-matched controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0001779:Age [Organism Attribute]
   760   C0150103:matched [Research Activity]
   760   C1707455:Compared [Activity]
   760   C1708943:Matched [Qualitative Concept]
   726   C0243148:control [Qualitative Concept]
   726   C1550141:Control [Substance]
   726   C1882979:Control [Conceptual Entity]
   726   C2587213:Control [Functional Concept]
   726   C3274648:Control [Qualitative Concept]

Phrase: "(Hall et al. 1996"

Phrase: ")."
Processing 00000000.tx.180: Using theopiate agonist DAGO, we observed a similar impairment in DAGO-mediated inhibition of calcium current density in recordings obtained from STZ-induced diabetic DRGs, compared with age-matched, nondiabetic controls (Fig. 1). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "theopiate agonist DAGO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a similar impairment in DAGO-mediated inhibition of calcium current density"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0684336:Impairment [Pathologic Function]

Phrase: "in recordings"

Phrase: "obtained from STZ-induced diabetic DRGs,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0011928:DRGs [Intellectual Product]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0205263:Induced [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C1301820:Obtained [Functional Concept]
   719 E C1414151:DRG [Gene or Genome]
   719 E C1706701:Obtain [Activity]

Phrase: "compared with age-matched, nondiabetic controls"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0001779:Age [Organism Attribute]
   753   C0150103:matched [Research Activity]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]
   719   C0243148:control [Qualitative Concept]
   719   C1550141:Control [Substance]
   719   C1882979:Control [Conceptual Entity]
   719   C2587213:Control [Functional Concept]
   719   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.181: Following patch rupture, DRG neurons were depolarized at 30-s intervals as described in METHODS. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "patch rupture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "DRG neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "depolarized at 30-s intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C1272706:intervals [Temporal Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.182: At the time of maximum IDCa amplitude (usually 2-5 min after patch rupture), 1M DAGO was applied by air-pressure ejection (Hall et al. 1995b). 

Phrase: "At the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of maximum IDCa amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "(usually 2-5 min after patch rupture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0702093:/min [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "1M DAGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "applied by air-pressure ejection"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0001876:Air Pressure [Natural Phenomenon or Process]
   760   C0001861:Air [Substance]
   760   C0033095:Pressure [Phenomenon or Process]
   760   C0185125:Applied [Health Care Activity]
   760   C0302131:Ejection [Phenomenon or Process]
   760   C0336969:Ejection [Daily or Recreational Activity]
   760   C0460139:Pressure [Finding]
   760   C0812388:Ejection [Organism Attribute]
   760   C1306345:Pressure [Functional Concept]
   760   C3536832:Air [Inorganic Chemical,Pharmacologic Substance]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.183: The effect of DAGO on calcium current amplitude was assessed within 3s of application and at 30-s intervals until the DRG current amplitude had recovered to pre-DAGO amplitude or until 10min had elapsed. 

Phrase: "The effect of DAGO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on calcium current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "assessed within 3s of application"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0185125:Application [Health Care Activity]
   760   C1516048:Assessed [Activity]
   760   C1552117:3s [Body Part, Organ, or Organ Component]
   760   C1947919:Application [Intellectual Product]
   760   C2347934:Application [Intellectual Product]
   760   C3539080:APPLICATION [Quantitative Concept]

Phrase: "and at 30-s intervals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C1272706:intervals [Temporal Concept]
   760   C1515981:And [Idea or Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]

Phrase: "until the DRG current amplitude"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2346753:Amplitude [Spatial Concept]
   717   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   717   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]

Phrase: "had"

Phrase: "recovered"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0521108:recovered [Qualitative Concept]
   966 E C2004454:recover [Organism Function]

Phrase: "to pre-DAGO amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346753:Amplitude [Spatial Concept]

Phrase: "or until 10min"

Phrase: "had"

Phrase: "elapsed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707889:Elapsed [Temporal Concept]
Processing 00000000.tx.184: The point of maximum inhibition was determined, and the current amplitude compared with the corresponding pre-DAGO amplitude using a paired t-test. 

Phrase: "The point of maximum inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1552961:Point [Quantitative Concept]
   760   C2347617:point [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: ","

Phrase: "and"

Phrase: "the current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "compared with the corresponding pre-DAGO amplitude"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0332152:Pre [Temporal Concept]
   748   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0740175:Pre [Qualitative Concept]
   748   C1707455:Compared [Activity]
   748   C2257086:PRE [Genetic Function]
   748   C2346753:Amplitude [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a paired t-test."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1709451:Paired t-Test [Intellectual Product]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
Processing 00000000.tx.185: DAGO application resulted in a significant decrease in the amplitude of IDCa in DRGs from control rats (~38%) but not in STZ-induced diabetic animals (15%). 

Phrase: "DAGO application"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0185125:Application [Health Care Activity]
   861   C1947919:Application [Intellectual Product]
   861   C2347934:Application [Intellectual Product]
   861   C3539080:APPLICATION [Quantitative Concept]

Phrase: "resulted in a significant decrease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0237881:significant [Quantitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "of IDCa"

Phrase: "in DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011928:DRGs [Intellectual Product]
   966 E C1414151:DRG [Gene or Genome]

Phrase: "from control rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(~38%"

Phrase: ")"

Phrase: "but"

Phrase: "not in STZ-induced diabetic animals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003062:Animals [Animal]
   753   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   753   C0205263:Induced [Functional Concept]
   753   C0241863:DIABETIC [Finding]
   753   C1518422:Not [Functional Concept]

Phrase: "(15%"

Phrase: ")."
Processing 00000000.tx.186: There are several possible explanations for this effect, including decreased opiate receptor expression, decreased function of the G-protein-mediated signal pathway coupling the receptor to the calcium channel, or decreased numbers/function of calcium channels. 

Phrase: "There"

Phrase: "are"

Phrase: "several possible explanations for this effect,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0681841:Explanations [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "decreased opiate receptor expression,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "decreased function of the G-protein-mediated signal pathway"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0815043:function protein [Amino Acid, Peptide, or Protein]
   762   C1527118:Protein Function [Molecular Function]
   742   C0031843:function [Physiologic Function]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1705273:Function [Intellectual Product]

Phrase: "coupling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "the receptor to the calcium channel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0249742:calcium receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "or"

Phrase: "decreased numbers/function of calcium channels."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1153433:Calcium channel, function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
Processing 00000000.tx.187: Our previous studies suggested that the latter was unlikely as neurons from both the BB/W and STZ-induced diabetic rat model had enhanced calcium currents (Hall et al. 1995b; Ristic et al. 1998) involving multiple calcium channel subtypes (Hall et al. 1995b). 

Phrase: "Our previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the latter"

Phrase: "was"

Phrase: "unlikely as neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0750558:Unlikely [Conceptual Entity]
   790   C1710571:Unlikely [Qualitative Concept]

Phrase: "from both"

Phrase: "the BB/W"

Phrase: "and"

Phrase: "STZ-induced diabetic rat model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C3161035:Model [Intellectual Product]

Phrase: "had"

Phrase: "enhanced calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(Hall et al. 1995b"

Phrase: "; Ristic et al. 1998"

Phrase: ")"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "multiple calcium channel subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0449560:subtypes [Classification]

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.188: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.189: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.190: Effect of 1m [D-Ala2,-Me-Phe4,Gly5-ol]-enkephalin (DAGO) on calcium current amplitude in control and streptozotocin (STZ)-induced diabetic dorsal root ganglion (DRG) neurons. 

Phrase: "Effect of 1m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "["

Phrase: "D-"

Phrase: "Ala2,-"

Phrase: "Me-Phe4,"

Phrase: "Gly5-ol]-enkephalin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014298:Enkephalin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(DAGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: ")"

Phrase: "on calcium current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "(STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ")-"

Phrase: "induced diabetic dorsal root ganglion"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   884   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   840   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   840   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   804   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   804   C0040452:Root [Body Part, Organ, or Organ Component]
   804   C0205095:Dorsal [Spatial Concept]
   804   C0242726:Root [Plant]
   804   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   804   C1318154:Root [Body Part, Organ, or Organ Component]
   804   C1705917:Root [Idea or Concept]

Phrase: "(DRG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
  1000   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
  1000   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   901   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   901   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   827   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   827   C0040452:Root [Body Part, Organ, or Organ Component]
   827   C0205095:Dorsal [Spatial Concept]
   827   C0242726:Root [Plant]
   827   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   827   C1318154:Root [Body Part, Organ, or Organ Component]
   827   C1705917:Root [Idea or Concept]

Phrase: ")"

Phrase: "neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.191: Left: the meansSE of 10recordings performed as described in METHODS in control and diabetic DRGs prior and subsequent to application of DAGO. 

Phrase: "Left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ":"

Phrase: "the meansSE of 10recordings"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in METHODS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "prior"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332152:Prior [Temporal Concept]
  1000   C2826257:PRIOR [Event]

Phrase: "and subsequent to application of DAGO."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0185125:Application [Health Care Activity]
   753   C0332282:Subsequent [Temporal Concept]
   753   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C1515981:And [Idea or Concept]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.192: Representative tracings from a control DRG and diabetic DRG are displayed on the right. 

Phrase: "Representative tracings from a control DRG"

Phrase: "and"

Phrase: "diabetic DRG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   923   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   923   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   861   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   861   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   812   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   812   C0040452:Root [Body Part, Organ, or Organ Component]
   812   C0205095:Dorsal [Spatial Concept]
   812   C0242726:Root [Plant]
   812   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   812   C1318154:Root [Body Part, Organ, or Organ Component]
   812   C1705917:Root [Idea or Concept]

Phrase: "are"

Phrase: "displayed on the right."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   770   C0870432:displayed [Functional Concept]
   737 E C1705417:Display [Manufactured Object]
Processing 00000000.tx.193: Prior to DAGO application, mean peak calcium current density was significantly greater in DRGs from diabetic animals (*P<0.05) compared with controls. 

Phrase: "Prior to DAGO application,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0185125:Application [Health Care Activity]
   861   C1947919:Application [Intellectual Product]
   861   C2347934:Application [Intellectual Product]
   861   C3539080:APPLICATION [Quantitative Concept]

Phrase: "mean peak calcium current density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0178587:density [Quantitative Concept]
   733 E C0439794:Dense [Qualitative Concept]

Phrase: "was"

Phrase: "significantly greater in DRGs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "("

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.194: Compared to pre-DAGO currents, control DRGs demonstrated a significant decrease in peak calcium current density amplitude (***P<0.01). 

Phrase: "Compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "to pre-DAGO currents,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "control DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "demonstrated"

Phrase: "a significant decrease in peak calcium current density amplitude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "("

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.195: Neurons from diabetic animals had a small, nonsignificant decrease in current density post-DAGO, compared with pre-DAGO levels. 

Phrase: "Neurons from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "had"

Phrase: "a small, nonsignificant decrease in current density post-DAGO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "compared with pre-DAGO levels."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0332152:Pre [Temporal Concept]
   760   C0441889:Levels [Qualitative Concept]
   760   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0740175:Pre [Qualitative Concept]
   760   C1707455:Compared [Activity]
   760   C2257086:PRE [Genetic Function]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.196: DRGopiate receptor binding was unchanged in diabetes We performedopiate receptor binding studies using naloxone (Remmers et al. 1998) to determine whether a decrease inreceptor expression might be responsible for the diminished opiate responsiveness in diabetes. 

Phrase: "DRGopiate receptor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0597358:Receptor Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "unchanged in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]

Phrase: "We performedopiate receptor binding studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "naloxone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027358:Naloxone [Organic Chemical,Pharmacologic Substance]

Phrase: "(Remmers et al. 1998"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "a decrease inreceptor expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "might"

Phrase: "be"

Phrase: "responsible for the diminished opiate responsiveness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.197: The diminished activity was not due to a decrease in expression ofopiate receptors, as there was no significant difference in binding of [3H]naloxone at -selective concentrations to DRG membrane preparations from STZ-induced diabetic and control animals (Fig. 2). 

Phrase: "The diminished activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not due to a decrease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in expression ofopiate receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "as"

Phrase: "there"

Phrase: "was"

Phrase: "no significant difference in binding of [3H"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1705241:*Difference [Quantitative Concept]
   748   C1705242:Difference [Qualitative Concept]

Phrase: "]naloxone at -selective concentrations to DRG membrane preparations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0086045:Concentrations [Mental Process]
   706 E C1446561:Concentration [Quantitative Concept]

Phrase: "from STZ-induced diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C1511501:Control Animal [Animal]
   861   C0003062:Animals [Animal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.198: Because multiple channel subtypes were affected, we hypothesized that an intermediary pathway, such as the inhibitory G proteins coupling the receptor to the channel might be impaired. 

Phrase: "Because"

Phrase: "multiple channel subtypes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449560:subtypes [Classification]

Phrase: "were"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "we"

Phrase: "hypothesized"

Phrase: "that"

Phrase: "an intermediary pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "such as the inhibitory G proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   966   C1415142:INHIBITORY G PROTEIN [Gene or Genome]
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]
   827   C3463820:Inhibitory [Activity]

Phrase: "coupling"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupling [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: "the receptor to the channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "might"

Phrase: "be"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.199: Subsequent experiments were performed to determine whether the expression and/or function of coupled G proteins was altered in diabetes. 

Phrase: "Subsequent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "function of coupled G proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   797   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   781 E C1527118:Protein Function [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1705273:Function [Intellectual Product]

Phrase: "was"

Phrase: "altered in diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0392747:Altered [Functional Concept]
Processing 00000000.tx.200: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.201: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.202: Mu receptor binding was similar in neurons from STZ-induced diabetic and control DRGs as measured by equilibrium binding of [3H] naloxone. 

Phrase: "Mu receptor binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0597358:Receptor Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C0066908:mu Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "was"

Phrase: "similar in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "from STZ-induced diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "as"

Phrase: "measured by equilibrium binding of [3H"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0014653:Equilibrium [Organism Function]
   753   C0243122:binding [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1442460:3H [Temporal Concept]
   753   C1547026:Equilibrium [Quantitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "] naloxone."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027358:Naloxone [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.203: Each experiment consisted of paired binding studies performed as described in METHODS in 1diabetic and 1control animal. 

Phrase: "Each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "consisted of paired binding studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0243122:binding [Functional Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1709450:Paired [Qualitative Concept]
   726   C0332529:CONSIST [Qualitative Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described in METHODS"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]

Phrase: "in 1diabetic"

Phrase: "and"

Phrase: "1control animal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]
Processing 00000000.tx.204: Results are the averagesSE for 4separate experiments. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the averagesSE for 4separate experiments."
Processing 00000000.tx.205: G-protein expression was not altered in diabetes Experiments were performed to assess the effect of diabetes on expression of inhibitory (Gi/o) and stimulatory (Gs) G proteins. 

Phrase: "G-protein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1171362:protein expression [Genetic Function]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered in diabetes Experiments"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0011847:Diabetes [Disease or Syndrome]
   770   C0011849:Diabetes [Disease or Syndrome]
   770   C0392747:Altered [Functional Concept]
   770   C0681814:Experiments [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the effect of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of inhibitory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463820:Inhibitory [Activity]

Phrase: "(Gi/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: "o)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "and"

Phrase: "stimulatory"

Phrase: "(Gs) G proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.206: Expression of G-protein subunits was assessed in whole ganglia obtained from four control and four BB/W diabetic rats as described in METHODS. 

Phrase: "Expression of G-protein subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "assessed in whole ganglia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017067:Ganglia [Body Part, Organ, or Organ Component]
   770   C0444667:Whole [Quantitative Concept]
   770   C1516048:Assessed [Activity]
   737 E C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]

Phrase: "obtained from four control"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0205450:Four [Quantitative Concept]
   770   C0243148:control [Qualitative Concept]
   770   C1301820:Obtained [Functional Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "four BB/W diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0034693:rats [Mammal]
   804   C0034721:Rats [Mammal]
   804   C0241863:DIABETIC [Finding]

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.207: Each lane consisted of tissue from one animal, and each run included tissue from paired diabetic and age-matched control animals. 

Phrase: "Each lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: "consisted of tissue"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040300:Tissue [Tissue]
   790   C1547928:Tissue [Intellectual Product]
   756   C0332529:CONSIST [Qualitative Concept]

Phrase: "from one animal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animal [Animal]

Phrase: "and"

Phrase: "each"

Phrase: "run"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035953:run [Daily or Recreational Activity]
  1000   C0600140:run [Finding]
  1000   C1704688:Run [Functional Concept]
  1000   C2346414:Run [Finding]

Phrase: "included tissue from paired diabetic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040300:Tissue [Tissue]
   760   C1547928:Tissue [Intellectual Product]

Phrase: "and"

Phrase: "age-matched control animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511501:Control Animal [Animal]
   812   C0003062:Animals [Animal]
Processing 00000000.tx.208: Representative immunoblots of homogenized whole dorsal root ganglion neurons from diabetic and nondiabetic BB/W rats incubated with antibodies directed against Go, Gi1/2, Gi3 are shown in Fig. 

Phrase: "Representative immunoblots of homogenized whole dorsal root ganglion neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "from diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "nondiabetic BB/W rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "incubated with antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   790   C1439852:Incubated [Laboratory Procedure]
   756 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0439851:Direct [Qualitative Concept]
   799   C1947931:Direct [Qualitative Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ","

Phrase: "Gi1/2,"

Phrase: "Gi3"

Phrase: "are"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.209: 3A. 

Phrase: "3A."
Processing 00000000.tx.210: Total pixel density of the stained bands corresponding to the G-protein subunits was determined for control and diabetic tissue by dividing the pixel density of the bands by the background staining. 

Phrase: "Total pixel density of the stained bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178587:density [Quantitative Concept]

Phrase: "corresponding to the G-protein subunits"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   783 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439267:g% [Quantitative Concept]
   719   C1711351:Subunit [Quantitative Concept]

Phrase: "was"

Phrase: "determined for control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic tissue by dividing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040300:Tissue [Tissue]
   770   C1547928:Tissue [Intellectual Product]

Phrase: "the pixel density of the bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0178587:density [Quantitative Concept]

Phrase: "by the background staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.211: Representative pixel densities for an individual run were Gi1/2: control, 2,231; 

Phrase: "Representative pixel densities for an individual run"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178587:densities [Quantitative Concept]

Phrase: "were"

Phrase: "Gi1/2"

Phrase: ":"

Phrase: "control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "2,231"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.212: diabetic, 2,216,Gi3: control, 1,232; 

Phrase: "diabetic, 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "216,"

Phrase: "Gi3"

Phrase: ":"

Phrase: "control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "1,232"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.213: diabetic 1,198,Go: control, 3,610; 

Phrase: "diabetic 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "198,"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ":"

Phrase: "control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "3,610"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ";"
Processing 00000000.tx.214: diabetic, 3,729,Gs: control, 2,367; 

Phrase: "diabetic, 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241863:DIABETIC [Finding]

Phrase: "729,"

Phrase: "Gs"

Phrase: ":"

Phrase: "control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "2,367"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.215: diabetic, 2,245.To minimize inter-run variability, total pixel density of G-protein bands from diabetic DRGs were divided by the pixel density of the matched control band and expressed as the percentage change from control. 

Phrase: "diabetic, 2,245.To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0241863:DIABETIC [Finding]

Phrase: "minimize"

Phrase: "inter-run variability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C2827666:Variability [Conceptual Entity]
   755 E C0439828:Variable [Qualitative Concept]

Phrase: "total pixel density of G-protein bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0178587:density [Quantitative Concept]

Phrase: "from diabetic DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "were"

Phrase: "divided by the pixel density of the matched control band"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   739   C0150103:matched [Research Activity]
   739   C0175723:Band [Medical Device]
   739   C0178587:density [Quantitative Concept]
   739   C0243148:control [Qualitative Concept]
   739   C0332849:Divided [Functional Concept]
   739   C0439645:Band [Spatial Concept]
   739   C1521913:band [Cell Component]
   739   C1550141:Control [Substance]
   739   C1708943:Matched [Qualitative Concept]
   739   C1709558:Pixel [Conceptual Entity]
   739   C1882979:Control [Conceptual Entity]
   739   C2587213:Control [Functional Concept]
   739   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "expressed as the percentage change"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0392747:Change [Functional Concept]
   760   C0439165:Percentage [Quantitative Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "from control."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.216: There was no significant effect of diabetes on expression of these PTX-sensitive G-protein subunits compared with control DRGs (Gi1/2: 1.5%; 

Phrase: "There"

Phrase: "was"

Phrase: "no significant effect of diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of these PTX-sensitive G-protein subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   766   C1711351:Subunit [Quantitative Concept]

Phrase: "compared with control DRGs"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0011928:DRGs [Intellectual Product]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C1414151:DRG [Gene or Genome]

Phrase: "(Gi1/2"

Phrase: ":"

Phrase: "1.5%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450316:1/5 [Quantitative Concept]
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.217: Gi3: 3.5%; 

Phrase: "Gi3"

Phrase: ":"

Phrase: "3.5%"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442758:3 5 [Quantitative Concept]
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: ";"
Processing 00000000.tx.218: Go: +2.9%; 

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ":"

Phrase: "+2.9%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: ";"
Processing 00000000.tx.219: Gs: 5%). 

Phrase: "Gs"

Phrase: ":"

Phrase: "5%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.220: Similar results were obtained for expression of Gs, which was unchanged in diabetes (not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained for expression of Gs,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "which"

Phrase: "was"

Phrase: "unchanged in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442739:Unchanged [Finding]
   790   C2346711:Unchanged [Qualitative Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.221: There was also no change in expression of Go observed between DRGs from control and STZ-induced animals (Fig. 3B). 

Phrase: "There"

Phrase: "was"

Phrase: "also"

Phrase: "no change in expression of"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0442739:No change [Finding]
   806   C1548568:No change [Intellectual Product]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "observed between DRGs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0011928:DRGs [Intellectual Product]
   790   C1441672:Observed [Functional Concept]
   756 E C1414151:DRG [Gene or Genome]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STZ-induced animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003062:Animals [Animal]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")."
Processing 00000000.tx.222: These results indicate that the diminished tonic inhibition of calcium currents observed in neurons from BB/W diabetic animals was unlikely to be due simply to decreased expression of PTX-sensitive inhibitory G proteins (Gi/o) or to increased expression of stimulatory Gs. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the diminished tonic inhibition of calcium currents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "observed in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C1441672:Observed [Functional Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from BB/W diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "was"

Phrase: "unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "be"

Phrase: "due simply to decreased expression of PTX-sensitive inhibitory G proteins"
Meta Candidates (Total=22; Excluded=2; Pruned=0; Remaining=20)
   753   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   753   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   751   C0332324:Sensitive to [Functional Concept]
           Sensitive
   751   C0678226:Due to [Functional Concept]
           due
   737   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   737   C1415142:INHIBITORY G PROTEIN [Gene or Genome]
   736   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   736   C0043167:Pertussis [Disease or Syndrome]
   736   C0185117:Expression [Therapeutic or Preventive Procedure]
   736   C0205216:Decreased [Quantitative Concept]
   736   C0392756:Decreased [Qualitative Concept]
   736   C0439267:g% [Quantitative Concept]
   736   C0442797:decreased [Qualitative Concept]
   736   C1550474:sensitive [Idea or Concept]
   736   C3146286:Due [Idea or Concept]
   736   C3463820:Inhibitory [Activity]
   734 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   734   C1171362:expression protein [Genetic Function]
   703 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Gi/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539617:GI [Idea or Concept]

Phrase: "o)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "or to increased expression of stimulatory Gs."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0205217:Increased [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
Processing 00000000.tx.223: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.224: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.225: Expression of the subunits of Gi1/2, Gi3, and Go was not affected by diabetes. 

Phrase: "Expression of the subunits of Gi1/2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "Gi3,"

Phrase: "and"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by diabetes."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]
Processing 00000000.tx.226: A: representative Western blots of BioBred/Worchester (BB/W) rat DRG homogenates stained with radiolabeled antibodies directed against the subunits of Gi1/2, Gi3, and Go. 

Phrase: "A"

Phrase: ":"

Phrase: "representative Western blots of BioBred/Worchester"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0949466:Western Blots [Laboratory Procedure]
   756 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C1705493:Western [Spatial Concept]

Phrase: "(BB/W"

Phrase: ")"

Phrase: "rat DRG homogenates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   717   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   717   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]

Phrase: "stained with radiolabeled antibodies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0243019:Radiolabeled Antibodies [Immunologic Factor,Pharmacologic Substance]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C1527121:Radiolabeled [Qualitative Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   737 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "directed against the subunits of Gi1/2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0439851:Direct [Qualitative Concept]
   714   C1711351:Subunit [Quantitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "Gi3,"

Phrase: "and"

Phrase: "Go."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]
Processing 00000000.tx.227: Left: molecular weight. 

Phrase: "Left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ":"

Phrase: "molecular weight."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0026385:Molecular Weight [Quantitative Concept]
   861   C0005910:weight [Organism Attribute]
   861   C0043100:Weight [Quantitative Concept]
   861   C1305866:weight [Diagnostic Procedure]
   861   C1521991:Molecular [Qualitative Concept]
   861   C1705104:Weight [Idea or Concept]
   789 E C0567416:Molecule [Substance]
Processing 00000000.tx.228: Each band contains 25g of homogenate. 

Phrase: "Each band"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0175723:Band [Medical Device]
  1000   C0439645:Band [Spatial Concept]
  1000   C1521913:band [Cell Component]

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "25g of homogenate."
Processing 00000000.tx.229: Bands corresponding to the appropriate G-protein subunit () were digitally scanned and pixel density measured and corrected for background staining. 

Phrase: "Bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "corresponding to the appropriate G-protein subunit"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]
   774 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439267:g% [Quantitative Concept]
   748   C1548787:Appropriate [Qualitative Concept]
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "("

Phrase: ")"

Phrase: "were"

Phrase: "digitally"

Phrase: "scanned"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0441633:scanned [Diagnostic Procedure]
   966 E C0034606:Scan [Diagnostic Procedure]
   966 E C2826292:SCAN [Finding]

Phrase: "and"

Phrase: "pixel density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0178587:density [Quantitative Concept]
   789 E C0439794:Dense [Qualitative Concept]

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "corrected for background staining."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   909   C3176809:corrected for background [Qualitative Concept]
   770   C0205202:Corrected [Qualitative Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   770   C1706907:Background [Conceptual Entity]
   737 E C2349182:Correct [Qualitative Concept]
Processing 00000000.tx.230: There was no significant difference in the band density of paired samples from BB/W and aged matched control rats. 

Phrase: "There"

Phrase: "was"

Phrase: "no significant difference in the band density of paired samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "from BB/W"

Phrase: "and"

Phrase: "aged"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0001779:Aged [Organism Attribute]
  1000   C0001792:Aged [Population Group]
  1000   C1999167:aged [Population Group]

Phrase: "matched control rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.231: B: Western blot of Go expression in paired samples from a STZ and control sham-injected animal (protein loading, 100g homogenate/lane) did not demonstrate any difference in expression. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Western blot of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   882   C0949466:Western Blot [Laboratory Procedure]
   790   C1705493:Western [Spatial Concept]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "expression in paired samples"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from a STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "and"

Phrase: "control sham-injected animal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   902   C1511501:Control Animal [Animal]
   812   C0003062:Animal [Animal]

Phrase: "(protein loading,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708715:Loading [Activity]

Phrase: "100g homogenate/lane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "any difference in expression."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.232: Bands were observed at the same location as 1g of purified Go protein standard (S). 

Phrase: "Bands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0175723:Bands [Medical Device]
   966 E C0439645:Band [Spatial Concept]
   966 E C1521913:band [Cell Component]

Phrase: "were"

Phrase: "observed at the same location"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   760   C0450429:Location [Spatial Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1515974:Location [Body Location or Region]

Phrase: "as 1g"

Phrase: "of purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "protein standard (S)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.233: Voltage-dependent calcium current facilitation was decreased in diabetes G-protein-mediated inhibition was assessed indirectly using large-amplitude prepulse facilitation of calcium currents (Ikeda 1991). 

Phrase: "Voltage-dependent calcium current facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "decreased in diabetes G-protein-mediated inhibition"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   778   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   774 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   748   C0011847:Diabetes [Disease or Syndrome]
   748   C0011849:Diabetes [Disease or Syndrome]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0086597:mediated [Social Behavior]
   748   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "assessed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assessed [Activity]

Phrase: "indirectly"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "large-amplitude prepulse facilitation of calcium currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "(Ikeda 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: ")."
Processing 00000000.tx.234: DRG neurons from BB/W diabetic rats and aged-matched nondiabetic controls were subjected to facilitation protocols alternating with 100-ms depolarizing commands performed at 30-s intervals after patch rupture as outlined in METHODS. 

Phrase: "DRG neurons from BB/W diabetic rats"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027882:Neurons [Cell]

Phrase: "and"

Phrase: "aged-matched nondiabetic controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0243148:control [Qualitative Concept]
   779   C1550141:Control [Substance]
   779   C1882979:Control [Conceptual Entity]
   779   C2587213:Control [Functional Concept]
   779   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "subjected to facilitation protocols"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0234112:Facilitation [Organ or Tissue Function]
   770   C0442711:Protocols [Intellectual Product]
   737   C0681850:Subject [Group]
   737 E C1507394:Protocol [Intellectual Product]
   737 E C1522729:Protocol [Intellectual Product]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737 E C2348563:Protocol [Intellectual Product]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "alternating with 100-ms depolarizing commands"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0039676:MS [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0332270:Alternating [Functional Concept]
   753   C2349943:Ms. [Conceptual Entity]
   753   C3539704:MS [Gene or Genome]
   753   C3639196:Commands [Intellectual Product]
   719 E C1523987:Alternate [Conceptual Entity]

Phrase: "performed at 30-s intervals"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0884358:Performed [Functional Concept]
   760   C1272706:intervals [Temporal Concept]
   726 E C1552654:Interval [Idea or Concept]
   726 E C1552713:Interval [Intellectual Product]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "after patch rupture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "as"

Phrase: "outlined in METHODS."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.235: Figure 4 shows the results of facilitation using a protocol designed to increase calcium-dependent inhibition (10/90; Fig. 4, A and B) or minimize calcium-dependent inhibition (0/90; Fig. 4, C and D) of the subsequent test pulse (TP). 

Phrase: "Figure 4"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the results of facilitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0442711:Protocol [Intellectual Product]
  1000   C1507394:Protocol [Intellectual Product]
  1000   C1522729:Protocol [Intellectual Product]
  1000   C2348563:Protocol [Intellectual Product]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "calcium-dependent inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(10/90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "; Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "minimize"

Phrase: "calcium-dependent inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "(0/90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]

Phrase: "; Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D) of the subsequent test pulse (TP)."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0232117:PULSE [Clinical Attribute]
   753   C0332282:Subsequent [Temporal Concept]
   753   C0391850:Pulse [Physiologic Function]
   753   C0392366:test [Intellectual Product]
   753   C1947910:Pulse [Phenomenon or Process]
Processing 00000000.tx.236: Using the 10/90-mV prepulses, percent facilitation of calcium currents was significantly smaller in DRG neurons from diabetic animals (164%, n=17,P<0.05) compared with controls (285%, n=18; Fig. 4B). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 10/90-mV prepulses,"

Phrase: "percent facilitation of calcium currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "significantly smaller in DRG neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0547044:Smaller [Qualitative Concept]
   748   C0700321:Smaller [Quantitative Concept]
   741   C0228075:Small neuron [Cell]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(164%,"

Phrase: "n=17,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(285%,"

Phrase: "n=18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.237: The amplitude of facilitation was relatively stable for the first 5min following patch rupture, then decreased with time during the recording, with a nonsignificant trend toward more rapid decay in control neurons. 

Phrase: "The amplitude of facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "relatively stable for the first 5min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205360:Stable [Qualitative Concept]
   753   C1547311:Stable [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "patch rupture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "decreased with time"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0040223:Time [Temporal Concept]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0547047:Decrease [Quantitative Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "during the recording,"

Phrase: "with a nonsignificant trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521798:trend [Temporal Concept]

Phrase: "toward more rapid decay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1265875:Decay [Acquired Abnormality]
   827   C2700592:Decay [Phenomenon or Process]

Phrase: "in control neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.238: Previous studies have demonstrated that facilitation amplitude is dependent on both the magnitude of the prepulse voltage and the length of the inter-pulse interval (Ikeda 1991). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that facilitation amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "is"

Phrase: "dependent on both"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0851827:Dependent [Qualitative Concept]
   790   C1701901:Dependent [Qualitative Concept]
   790   C3244310:dependent [Functional Concept]

Phrase: "the magnitude of the prepulse voltage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449286:magnitude [Quantitative Concept]
   753   C1704240:Magnitude [Quantitative Concept]

Phrase: "and"

Phrase: "the length of the inter-pulse interval"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]

Phrase: "(Ikeda 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: ")."
Processing 00000000.tx.239: We observed similar voltage- and interval-dependent changes in facilitation amplitude in our recordings. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "similar voltage-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598352:Voltage [Quantitative Concept]

Phrase: "and"

Phrase: "interval-dependent changes in facilitation amplitude"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "in our recordings."
Processing 00000000.tx.240: We observed that the test current amplitude was often decreased by the preceding +10-mV prepulse when using the 10/90 protocol (Fig. 4A). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the test current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "decreased by the preceding +10-mV prepulse"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   748   C0205216:Decreased [Quantitative Concept]
   748   C0332152:Preceding [Temporal Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "when"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 10/90 protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.241: We suspected that calcium entering during the first +10-mV depolarizing prepulse was causing calcium-dependent inhibition of the +10-mV test pulse and that the phenomenon of facilitation under these conditions might be explained by reversal of calcium-dependent inactivation. 

Phrase: "We"

Phrase: "suspected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332147:Suspected [Qualitative Concept]
  1000   C0750491:Suspected [Idea or Concept]
   966 E C1571873:Suspect [Idea or Concept]

Phrase: "that calcium entering during the first +10-mV depolarizing prepulse"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   706   C1522196:ENTER [Functional Concept]

Phrase: "was"

Phrase: "causing calcium-dependent inhibition of the +10-mV test pulse"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0201783:Inhibition test [Laboratory Procedure]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "that"

Phrase: "the phenomenon of facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "under these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "might"

Phrase: "be"

Phrase: "explained by reversal of calcium-dependent inactivation."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0443290:Reversal [Functional Concept]
   748   C0544461:Inactivation [Cell or Molecular Dysfunction]
   748   C0851827:Dependent [Qualitative Concept]
   748   C1701901:Dependent [Qualitative Concept]
   748   C2936886:Calcium [Pharmacologic Substance]
   748   C3244310:dependent [Functional Concept]
Processing 00000000.tx.242: To test this hypothesis, we performed two experiments designed to decrease Ca2+ influx prior to the large-amplitude +90-mV prepulse. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "two experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "Ca2+ influx"

Phrase: "prior to the large-amplitude +90-mV prepulse."
Processing 00000000.tx.243: First, a facilitation protocol that did not have a preliminary +10-mV prepulse was used (Fig. 4, C and D). 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "a facilitation protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442711:Protocol [Intellectual Product]
   861   C1507394:Protocol [Intellectual Product]
   861   C1522729:Protocol [Intellectual Product]
   861   C2348563:Protocol [Intellectual Product]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a preliminary +10-mV prepulse"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.244: Stimulating with facilitation protocols that did not have a preceding +10-mV prepulse demonstrated that although the amplitude of facilitation was decreased, neurons from diabetic animals continued to exhibit significantly smaller percent facilitation of test currents compared with controls (Fig. 4D). 

Phrase: "Stimulating with facilitation protocols"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1948023:Stimulating [Natural Phenomenon or Process]

Phrase: "that"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a preceding +10-mV prepulse"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "although"

Phrase: "the amplitude of facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2346753:Amplitude [Spatial Concept]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "neurons from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "significantly smaller percent facilitation of test currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   795   C0521116:currents [Temporal Concept]
   762 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.245: We also performed experiments on STZ-induced diabetic DRGs and controls in which Ca2+ in the external recording solution was replaced by 5mM Ba2+. 

Phrase: "We also performed experiments on STZ-induced diabetic DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0681814:Experiments [Research Activity]
   708 E C1706386:Experiment [Conceptual Entity]

Phrase: "and"

Phrase: "controls in which Ca2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "in the external recording solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037633:Solution [Substance]
   827   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "replaced by 5mM Ba2+."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C1299987:Replaced by [Functional Concept]
           replaced
   770   C0559956:Replaced [Functional Concept]
   770   C1413246:BA2 [Gene or Genome]
   770   C3539699:BA2 [Gene or Genome]
   737 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.246: Under these conditions, neurons from diabetic animals continued to exhibit diminished facilitation compared with controls. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "neurons from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "continued"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continued [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "diminished facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.247: This indicated that calcium-dependent inhibition, while present, could not explain the difference in facilitation between diabetic and control neurons. 

Phrase: "This"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that calcium-dependent inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "while"

Phrase: "present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "the difference in facilitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "between diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.248: View larger version (26K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(26K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.249: 4. 

Phrase: "4."
Processing 00000000.tx.250: Amplitude and time course of facilitation in control and BB/W diabetic DRGs. 

Phrase: "Amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "time course of facilitation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0449247:Time course [Temporal Concept]
   770   C0040223:Time [Temporal Concept]
   770   C0750729:Course [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "BB/W diabetic DRGs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0011928:DRGs [Intellectual Product]
   779 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.251: Left: facilitation protocols and representative current tracings; 

Phrase: "Left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ":"

Phrase: "facilitation protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "and"

Phrase: "representative current tracings"

Phrase: ";"
Processing 00000000.tx.252: right: percent facilitation vs. time from patch rupture. 

Phrase: "right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ":"

Phrase: "percent facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "vs. time from patch rupture."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.253: A: +10/90-mV prepulse depolarization protocol. 

Phrase: "A"

Phrase: ":"

Phrase: "+10/90-mV prepulse depolarization protocol."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0622660:MV protocol [Therapeutic or Preventive Procedure]
   799   C0442711:Protocol [Intellectual Product]
   799   C1507394:Protocol [Intellectual Product]
   799   C1522729:Protocol [Intellectual Product]
   799   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.254: Two superimposed current tracings are displayed below the corresponding depolarization protocols; 

Phrase: "Two superimposed current tracings"

Phrase: "are"

Phrase: "displayed below the corresponding depolarization protocols"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   753   C0442711:Protocols [Intellectual Product]
   753   C0870432:displayed [Functional Concept]
   719 E C1507394:Protocol [Intellectual Product]
   719 E C1522729:Protocol [Intellectual Product]
   719 E C1705417:Display [Manufactured Object]
   719 E C2348563:Protocol [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.255: one corresponding to a prepulse (PP) voltage of +10 mV followed by a nonfacilitated +10-mV test pulse (TP) and a second with a prepulse voltage of +90 mV and subsequent larger facilitated +10-mV test pulse (). 

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "corresponding to a prepulse (PP) voltage of +10 mV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0598352:Voltage [Quantitative Concept]

Phrase: "followed by a nonfacilitated +10-mV test pulse"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0232117:PULSE [Clinical Attribute]
   744   C0391850:Pulse [Physiologic Function]
   744   C0392366:test [Intellectual Product]
   744   C1947910:Pulse [Phenomenon or Process]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "(TP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0232117:PULSE [Clinical Attribute]
   861   C0391850:Pulse [Physiologic Function]
   861   C1947910:Pulse [Phenomenon or Process]
   777 E C0034107:Pulses [Health Care Activity]

Phrase: ")"

Phrase: "and"

Phrase: "a second with a prepulse voltage of +90 mV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0205436:Second [Quantitative Concept]
   742   C0457385:Second [Temporal Concept]
   742   C0565930:/second [Quantitative Concept]
   742   C1561503:second [Idea or Concept]
   742   C1705190:Second [Qualitative Concept]

Phrase: "and"

Phrase: "subsequent larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "facilitated"

Phrase: "+10-mV test pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0232117:PULSE [Clinical Attribute]
   812   C0391850:Pulse [Physiologic Function]
   812   C1947910:Pulse [Phenomenon or Process]
   729 E C0034107:Pulses [Health Care Activity]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.256: B: percent facilitation of the TP current was determined at 1-min intervals for control () and diabetic () DRGs and plotted vs. time from patch rupture. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "percent facilitation of the TP current"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "determined"

Phrase: "at 1-min intervals for control"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   753   C1272706:intervals [Temporal Concept]
   719 E C1552654:Interval [Idea or Concept]
   719 E C1552713:Interval [Intellectual Product]

Phrase: "("

Phrase: ")"

Phrase: "and"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "("

Phrase: ")"

Phrase: "DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011928:DRGs [Intellectual Product]
   966 E C1414151:DRG [Gene or Genome]

Phrase: "and"

Phrase: "plotted"

Phrase: "vs. time from patch rupture."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.257: Facilitation decreased with time from patch rupture. 

Phrase: "Facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "decreased with time"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0040223:Time [Temporal Concept]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C3541383:Time [Temporal Concept]
   756 E C0547047:Decrease [Quantitative Concept]
   734 E C0442043:Temporal [Spatial Concept]
   734 E C2362314:Temporal [Temporal Concept]
   706 E C1632851:Times [Quantitative Concept]

Phrase: "from patch rupture."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]
Processing 00000000.tx.258: Insets: the meansSE measured at the peak of percent facilitation, which was significantly decreased in diabetic neurons (DM; n=17; *P<0.05) compared with controls (C; n=18). 

Phrase: "Insets"

Phrase: ":"

Phrase: "the meansSE"

Phrase: "measured at the peak of percent facilitation,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0234112:Facilitation [Organ or Tissue Function]
   748   C0439165:Percent [Quantitative Concept]
   748   C0444505:Peak [Quantitative Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "which"

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased in diabetic neurons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0027882:Neurons [Cell]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "(DM"

Phrase: "; n=17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ";"

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "(C"

Phrase: "; n=18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.259: C: 0/90-mV prepulse depolarization protocol with two superimposed current tracings; 

Phrase: "C"

Phrase: ":"

Phrase: "0/90-mV prepulse depolarization protocol with two superimposed current tracings"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   754   C0622660:MV protocol [Therapeutic or Preventive Procedure]
   738   C0442711:Protocol [Intellectual Product]
   738   C1507394:Protocol [Intellectual Product]
   738   C1522729:Protocol [Intellectual Product]
   738   C2348563:Protocol [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.260: one corresponding to a prepulse voltage of 0mV followed by a nonfacilitated +10 mV test pulse, and a second with a prepulse voltage of +90 mV and subsequent larger facilitated +10-mV test pulse (). 

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "corresponding to a prepulse voltage of 0mV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0598352:Voltage [Quantitative Concept]

Phrase: "followed by a nonfacilitated +10 mV test pulse,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0332283:Followed by [Temporal Concept]
           followed
   744   C0022885:Test [Laboratory Procedure]
   744   C0039593:Test [Functional Concept]
   744   C0232117:PULSE [Clinical Attribute]
   744   C0391850:Pulse [Physiologic Function]
   744   C0392366:test [Intellectual Product]
   744   C1947910:Pulse [Phenomenon or Process]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "a second with a prepulse voltage of +90 mV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0205436:Second [Quantitative Concept]
   742   C0457385:Second [Temporal Concept]
   742   C0565930:/second [Quantitative Concept]
   742   C1561503:second [Idea or Concept]
   742   C1705190:Second [Qualitative Concept]

Phrase: "and"

Phrase: "subsequent larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "facilitated"

Phrase: "+10-mV test pulse"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0232117:PULSE [Clinical Attribute]
   812   C0391850:Pulse [Physiologic Function]
   812   C1947910:Pulse [Phenomenon or Process]
   729 E C0034107:Pulses [Health Care Activity]

Phrase: "("

Phrase: ")."
Processing 00000000.tx.261: D: percent facilitation of TP was diminished when protocols without an initial +10-mV prepulse were used. 

Phrase: "D"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ":"

Phrase: "percent facilitation of TP"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   804   C0232117:PULSE [Clinical Attribute]
   804   C0391850:Pulse [Physiologic Function]
   804   C1947910:Pulse [Phenomenon or Process]
   721 E C0034107:Pulses [Health Care Activity]

Phrase: "was"

Phrase: "diminished"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:Diminished [Quantitative Concept]

Phrase: "when"

Phrase: "protocols without an initial +10-mV prepulse"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0622660:MV protocol [Therapeutic or Preventive Procedure]
   748   C0442711:Protocols [Intellectual Product]
   714 E C1507394:Protocol [Intellectual Product]
   714 E C1522729:Protocol [Intellectual Product]
   714 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.262: Inset: mean+SE of peak percent facilitation (n=17) in the first 5min following patch rupture (inset) was significantly (*P<0.05) less in diabetic DRGs compared with controls using the 0/90 facilitation protocol. 

Phrase: "Inset"

Phrase: ":"

Phrase: "mean+SE of peak percent facilitation"

Phrase: "(n=17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in the first 5min"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "patch rupture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "(inset"

Phrase: ")"

Phrase: "was"

Phrase: "significantly"

Phrase: "("

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "less in diabetic DRGs"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0011928:DRGs [Intellectual Product]
   770   C0241863:DIABETIC [Finding]
   770   C0439092:less [Intellectual Product]
   770   C0547044:Less [Qualitative Concept]
   737 E C1414151:DRG [Gene or Genome]

Phrase: "compared with controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 0/90 facilitation protocol."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]
Processing 00000000.tx.263: Effect of PTX, GTPS, and GDPS on facilitation Experiments were performed in BB/W rats to assess whether the effect of diabetes on facilitation could be altered by opiate ligands and other pharmacologic agents that modulate G-protein function. 

Phrase: "Effect of PTX,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GDPS on facilitation Experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "performed in BB/W rats to"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "whether"

Phrase: "the effect of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "could"

Phrase: "be"

Phrase: "altered by opiate ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023688:Ligands [Chemical]
   770   C0376196:Opiate [Hazardous or Poisonous Substance,Pharmacologic Substance]
   770   C0392747:Altered [Functional Concept]

Phrase: "and"

Phrase: "other pharmacologic agents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C1254351:Pharmacologic Agent [Pharmacologic Substance]
           Agent
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "G-protein function."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   901   C0815043:protein function [Amino Acid, Peptide, or Protein]
   901   C1527118:Protein Function [Molecular Function]
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.264: The effects of PTX, GTPS, and GDPS on facilitation of IDCa were tested by two methods: preincubation and intracellular dialysis. 

Phrase: "The effects of PTX,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GDPS on facilitation of IDCa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "tested by two methods"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   802   C0871511:methods test [Intellectual Product]
       E   METHOD
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0205448:Two [Quantitative Concept]
   770   C0392366:tested [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   737 E C0022885:Test [Laboratory Procedure]
   737 E C0039593:Test [Functional Concept]

Phrase: ":"

Phrase: "preincubation"

Phrase: "and"

Phrase: "intracellular dialysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]
Processing 00000000.tx.265: Following dissociation and plating, neurons from control and diabetic animals were preincubated in culture medium containing PTX (250ng/ml) for 4h prior to recording. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "dissociation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "and"

Phrase: "plating,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0407295:Plating [Therapeutic or Preventive Procedure]

Phrase: "neurons from control"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "preincubated in culture medium containing PTX"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   778   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   748   C0009458:Medium [Intellectual Product]
   748   C0010453:Culture [Idea or Concept]
   748   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   748   C0043167:Pertussis [Disease or Syndrome]
   748   C0220814:culture [Functional Concept]
   748   C0332256:Containing [Functional Concept]
   748   C0430400:Culture [Laboratory Procedure]
   748   C0439536:Medium [Quantitative Concept]
   748   C1705217:Medium [Substance]
   748   C2242979:Culture [Laboratory Procedure]
   748   C2700400:Containing [Activity]
   748   C3244283:medium [Intellectual Product]

Phrase: "(250ng/ml) for 4h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439526:/mL [Quantitative Concept]

Phrase: "prior to recording."
Processing 00000000.tx.266: As reported previously (Hall et al. 1996), PTX preincubation caused a modest, nonsignificant increase in maximum IDCa in both control and diabetic neurons. 

Phrase: "As"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(Hall et al. 1996"

Phrase: ")"

Phrase: ","

Phrase: "PTX preincubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a modest, nonsignificant increase in maximum IDCa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.267: PTX preincubation decreased prepulse facilitation of test currents by 50% in control DRGs (154%) and 35% in diabetic DRGs (104%). 

Phrase: "PTX preincubation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "prepulse facilitation of test currents by 50%"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0521116:currents [Temporal Concept]
   714 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "in control DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "(154%"

Phrase: ")"

Phrase: "and"

Phrase: "35% in diabetic DRGs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0011928:DRGs [Intellectual Product]
   770   C0241863:DIABETIC [Finding]
   737 E C1414151:DRG [Gene or Genome]

Phrase: "(104%"

Phrase: ")."
Processing 00000000.tx.268: Preincubation of both control and diabetic neurons with GDPS (500M) in the external medium decreased facilitation by 85%. 

Phrase: "Preincubation of both control"

Phrase: "and"

Phrase: "diabetic neurons with GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "(500M"

Phrase: ")"

Phrase: "in the external medium decreased facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "by 85%."
Processing 00000000.tx.269: On the basis of earlier reports (Ikeda 1991), we had expected that GDPS would abolish facilitation completely. 

Phrase: "On the basis of earlier reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(Ikeda 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "had"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "that GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "would"

Phrase: "abolish"

Phrase: "facilitation completely."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.270: Because the effect was incomplete, we speculated that preincubation may not have allowed adequate uptake of these agents to demonstrate a maximal effect. 

Phrase: "Because"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "incomplete,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205257:Incomplete [Quantitative Concept]
  1000   C0728938:incomplete [Quantitative Concept]
  1000   C1548386:incomplete [Idea or Concept]

Phrase: "we"

Phrase: "speculated"

Phrase: "that preincubation"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "allowed adequate uptake of these agents to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243144:Uptake [Physiologic Function]
   748   C0347980:% uptake [Quantitative Concept]

Phrase: "demonstrate"

Phrase: "a maximal effect."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205289:Maximal [Qualitative Concept]
   861   C0806909:Maximal [Quantitative Concept]
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
   789 E C1552615:maximum [Quantitative Concept]
   789 E C2826546:MAXIMUM [Quantitative Concept]
Processing 00000000.tx.271: Therefore we also performed experiments in which GDPS, GTPS, and PTX were dialyzed into the cells by adding them to the recording pipette medium. 

Phrase: "Therefore"

Phrase: "we also performed experiments in which GDPS,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0681814:Experiments [Research Activity]
   714 E C1706386:Experiment [Conceptual Entity]

Phrase: "GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "were"

Phrase: "dialyzed into the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "by adding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1883712:Add [Functional Concept]

Phrase: "them to the recording pipette medium."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0182301:Pipette [Medical Device]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C1706407:Pipette [Medical Device]
   753   C3244283:medium [Intellectual Product]
   719   C0034869:Record [Intellectual Product]
Processing 00000000.tx.272: Our previous experience has shown that such intracellular dialysis reaches a maximum effect in 5-8 min following patch rupture (Hall et al. 1995a; Wiley et al. 1997). 

Phrase: "Our previous experience"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0237607:experience [Mental Process]
   861   C0596545:Experience [Mental Process]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "such intracellular dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]

Phrase: "reaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0596012:Reaches [Finding]
  1000   C2584321:Reach [Organism Function]

Phrase: "a maximum effect in 5-8 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "patch rupture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1881712:RUPTURE [Phenomenon or Process]
   861   C3203359:Rupture [Injury or Poisoning]

Phrase: "(Hall et al. 1995a"

Phrase: "; Wiley et al. 1997"

Phrase: ")."
Processing 00000000.tx.273: Compared to neurons dialyzed with recording medium containing GTP, intracellular dialysis with GTPS (250M) caused a rapid rundown in calcium current amplitude by 5min (control IDCa: 8518pA/pF; 

Phrase: "Compared to neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C1707455:Compared [Activity]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "dialyzed with recording medium containing GTP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0332256:Containing [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1705217:Medium [Substance]
   753   C2700400:Containing [Activity]
   753   C3244283:medium [Intellectual Product]

Phrase: "intracellular dialysis with GTPS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011945:Dialysis [Natural Phenomenon or Process]
   770   C0011946:dialysis [Therapeutic or Preventive Procedure]
   770   C0917873:dialysis [Therapeutic or Preventive Procedure]
   770   C1059964:Dialysis [Eukaryote]

Phrase: "(250M"

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a rapid rundown in calcium current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0848283:rundown [Sign or Symptom]

Phrase: "by 5min"

Phrase: "(control IDCa"

Phrase: ":"

Phrase: "8518pA/pF"

Phrase: ";"
Processing 00000000.tx.274: n=6,diabetic: 10014pA/pF; 

Phrase: "n=6,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: ":"

Phrase: "10014pA/pF"

Phrase: ";"
Processing 00000000.tx.275: n=5,not significantly different). 

Phrase: "n=5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "not significantly different"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705242:Different [Qualitative Concept]
   755 E C1705241:*Difference [Quantitative Concept]
   727 E C0443199:Differential [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.276: In the presence of GTPS (Fig. 5), percent facilitation was increased by a similar amount in control (4313%) and diabetic neurons (469%), whereas GDPS dialysis (250M) abolished facilitation in both control and diabetic DRGs. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "percent facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "increased by a similar amount"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C1265611:Amount [Quantitative Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(4313%"

Phrase: ")"

Phrase: "and"

Phrase: "diabetic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(469%"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "GDPS dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]

Phrase: "(250M"

Phrase: ")"

Phrase: "abolished facilitation in both control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "and"

Phrase: "diabetic DRGs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.277: Dialysis with GTPS (Fig. 6B) shifted the voltage range of facilitation to more positive voltages, as indicated by the increase in the V0.5 (50% of F/Fmax) listed in the figure legend, whereas dialysis with 250M GDPS shifted the curve to more negative voltages. 

Phrase: "Dialysis with GTPS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011945:Dialysis [Natural Phenomenon or Process]
   790   C0011946:dialysis [Therapeutic or Preventive Procedure]
   790   C0917873:dialysis [Therapeutic or Preventive Procedure]
   790   C1059964:Dialysis [Eukaryote]

Phrase: "(Fig. 6B"

Phrase: ")"

Phrase: "shifted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifted [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "the voltage range of facilitation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1514721:Range [Quantitative Concept]
   760   C2348147:Range [Quantitative Concept]
   760   C3542016:Range [Intellectual Product]

Phrase: "to more positive voltages,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0598352:Voltage [Quantitative Concept]

Phrase: "as"

Phrase: "indicated by the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C1444656:Indicated [Finding]

Phrase: "in the V0.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441906:V0 [Finding]
   861   C3540692:V0 [Quantitative Concept]

Phrase: "(50% of F/Fmax)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   770   C0439133:(f) [Intellectual Product]
   770   C1553038:[f] [Quantitative Concept]

Phrase: "listed in the figure legend,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C2729544:Legend [Pharmacologic Substance]
   726   C0745732:List [Conceptual Entity]
   726   C3272378:LIST [Intellectual Product]

Phrase: "whereas"

Phrase: "dialysis with 250M GDPS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011945:Dialysis [Natural Phenomenon or Process]
   770   C0011946:dialysis [Therapeutic or Preventive Procedure]
   770   C0917873:dialysis [Therapeutic or Preventive Procedure]
   770   C1059964:Dialysis [Eukaryote]

Phrase: "shifted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0333051:shifted [Functional Concept]
   966 E C2347509:Shift [Phenomenon or Process]

Phrase: "the curve to more negative voltages."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205134:Curve [Spatial Concept]
Processing 00000000.tx.278: The effect appeared to be analogous to the rightward voltage shift and slowing of calcium current activation observed with ligands, such as opiates, that are known to inhibit calcium currents via a PTX-sensitive G-protein pathway (Bean 1989). 

Phrase: "The effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "analogous to the rightward voltage shift"

Phrase: "and"

Phrase: "slowing of calcium current activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439834:slowing [Qualitative Concept]

Phrase: "observed with ligands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023688:Ligands [Chemical]
   790   C1441672:Observed [Functional Concept]

Phrase: "such as opiates,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242401:Opiates, NOS [Laboratory Procedure]
  1000   C0376196:Opiates [Hazardous or Poisonous Substance,Pharmacologic Substance]

Phrase: "that"

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "calcium currents via a PTX-sensitive G-protein pathway"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0521116:currents [Temporal Concept]
   706 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(Bean 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004896:Bean [Food]

Phrase: ")."
Processing 00000000.tx.279: Because larger facilitation amplitudes appear to reflect increasing preexisting G-protein-mediated inhibition, we anticipated that the direction of the shift in facilitation for agents such as GTPS would be opposite to those described by Bean for whole cell currents (which decrease in amplitude with increasing inhibition). 

Phrase: "Because"

Phrase: "larger facilitation amplitudes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2346753:Amplitude [Spatial Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "increasing preexisting G-protein-mediated inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   799   C0021467:Inhibition [Mental Process]
   799   C0021469:Inhibition [Molecular Function]
   799   C1628982:% inhibition [Quantitative Concept]
   799   C3463820:Inhibition [Activity]
   727 E C0311403:Inhibited [Qualitative Concept]

Phrase: "we"

Phrase: "anticipated"

Phrase: "that"

Phrase: "the direction of the shift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449738:Direction [Spatial Concept]

Phrase: "in facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "for agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0450442:Agent [Chemical Viewed Functionally]
   966   C1254351:Agent [Pharmacologic Substance]
   966   C1521826:Agent [Intellectual Product]

Phrase: "such as GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "would"

Phrase: "be"

Phrase: "opposite to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1521805:Opposite [Spatial Concept]

Phrase: "described by Bean"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0004896:Bean [Food]
   790   C1552738:described [Idea or Concept]

Phrase: "for whole cell currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "("

Phrase: "which"

Phrase: "decrease in amplitude"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0392756:Decrease [Qualitative Concept]
   790   C0547047:Decrease [Quantitative Concept]
   790   C2346753:Amplitude [Spatial Concept]

Phrase: "with increasing inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0021467:Inhibition [Mental Process]
   861   C0021469:Inhibition [Molecular Function]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.280: These results indicate some degree of reversibility in the effect of diabetes on G-protein-mediated current facilitation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "some degree of reversibility"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0441889:Degree [Qualitative Concept]
   770   C0449286:Degree [Quantitative Concept]
   770   C0542560:Degree [Intellectual Product]
   770   C1561545:degree [Quantitative Concept]
   770   C2348088:Degree [Quantitative Concept]

Phrase: "in the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "of diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "on G-protein-mediated current facilitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.281: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.282: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.283: Effect of intracellular dialysis with GTPS, GDPS, and PTX on facilitated calcium current density. 

Phrase: "Effect of intracellular dialysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "with GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "GDPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PTX on facilitated calcium current density."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   748   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   748   C0043167:Pertussis [Disease or Syndrome]
Processing 00000000.tx.284: The graph shows the meansSE facilitation recorded in neurons from control and BB/W diabetic animals after 5min intracellular dialysis with GTP, GTPS, GTP+PTX, and GDPS. 

Phrase: "The graph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681493:Graph [Intellectual Product]
  1000   C2698021:Graph [Conceptual Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the meansSE facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "recorded in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   756   C0034869:Record [Intellectual Product]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "BB/W diabetic animals after 5min intracellular dialysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003062:Animals [Animal]

Phrase: "with GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "GTP+PTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]

Phrase: "and"

Phrase: "GDPS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.285: With GTP dialysis, percent facilitation of the test pulse current amplitude was significantly smaller (*P<0.05) in DRGs from diabetic rats compared with controls. 

Phrase: "With GTP dialysis,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]

Phrase: "percent facilitation of the test pulse current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "significantly smaller"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547044:Smaller [Qualitative Concept]
   861   C0700321:Smaller [Quantitative Concept]

Phrase: "("

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "in DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011928:DRGs [Intellectual Product]
   966 E C1414151:DRG [Gene or Genome]

Phrase: "from diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0241863:DIABETIC [Finding]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.286: Percent facilitation of currents in analogue or PTX-treated neurons were compared against the corresponding GTP-treated group for statistical significance (i.e., diabetic GTPS vs. diabetic GTP). 

Phrase: "Percent facilitation of currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "in analogue"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0243071:Analog [Chemical Viewed Structurally]
   893 E C0679213:analogies [Idea or Concept]

Phrase: "or"

Phrase: "PTX-treated neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "compared against the corresponding GTP-treated group"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   748   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0332293:treated [Therapeutic or Preventive Procedure]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1522326:Treated [Functional Concept]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   748   C1707455:Compared [Activity]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "for statistical significance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:Statistical Significance [Quantitative Concept]
           Significance
  1000   C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistical [Occupation or Discipline]
   861   C0750502:Significance [Idea or Concept]
   789 E C1546944:Significant [Qualitative Concept]

Phrase: "(i.e., diabetic GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "vs. diabetic GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.287: Dialysis with GTPS significantly increased percent facilitation in both control (n=6) and diabetic (n=5) neurons compared with the corresponding GTP-dialyzed neurons (control; n=18; diabetic; n=17). 

Phrase: "Dialysis with GTPS significantly increased percent facilitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0011945:Dialysis [Natural Phenomenon or Process]
   748   C0011946:dialysis [Therapeutic or Preventive Procedure]
   748   C0917873:dialysis [Therapeutic or Preventive Procedure]
   748   C1059964:Dialysis [Eukaryote]

Phrase: "in both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(n=6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "compared with the corresponding GTP-dialyzed neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0027882:Neurons [Cell]
   748   C1707455:Compared [Activity]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "; n=18"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "; n=17"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.288: Compared to GTP-dialyzed neurons, PTX dialysis decreased facilitation (control, n=5; diabetic, n=5). 

Phrase: "Compared to GTP-dialyzed neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0027882:Neurons [Cell]
   760   C1707455:Compared [Activity]

Phrase: "PTX dialysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0011945:Dialysis [Natural Phenomenon or Process]
   827   C0011946:dialysis [Therapeutic or Preventive Procedure]
   827   C0917873:dialysis [Therapeutic or Preventive Procedure]
   827   C1059964:Dialysis [Eukaryote]
   734   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "(control,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "; diabetic, n=5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0241863:DIABETIC [Finding]

Phrase: ")."
Processing 00000000.tx.289: The decrease was significant in control DRGs but not in diabetic DRGs. 

Phrase: "The decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "significant in control DRGs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "but"

Phrase: "not in diabetic DRGs."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0011928:DRGs [Intellectual Product]
   770   C0241863:DIABETIC [Finding]
   770   C1518422:Not [Functional Concept]
   737 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.290: Dialysis with GDPS abolished facilitation in both control (n=4) and diabetic (n=5) neurons (*P<0.05,**P<0.01,***P<0.005). 

Phrase: "Dialysis with GDPS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011945:Dialysis [Natural Phenomenon or Process]
   790   C0011946:dialysis [Therapeutic or Preventive Procedure]
   790   C0917873:dialysis [Therapeutic or Preventive Procedure]
   790   C1059964:Dialysis [Eukaryote]

Phrase: "abolished"

Phrase: "facilitation in both control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "(n=4"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "*P<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*P<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.005"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.291: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.292: 6. 

Phrase: "6."
Processing 00000000.tx.293: Voltage dependence of facilitation in BB/W diabetic and nondiabetic control DRGs. 

Phrase: "Voltage dependence of facilitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011546:Dependence [Mental Process]
   770   C0439857:Dependence [Mental or Behavioral Dysfunction]
   770   C0598352:Voltage [Quantitative Concept]
   770   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "in BB/W"

Phrase: "diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "nondiabetic control DRGs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0011928:DRGs [Intellectual Product]
   793 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.294: A: representative tracing of the voltage-dependent facilitation protocol with the depolarizing voltages shown above the corresponding facilitated calcium current tracing. 

Phrase: "A"

Phrase: ":"

Phrase: "representative tracing of the voltage-dependent facilitation protocol"

Phrase: "with the depolarizing voltages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598352:Voltage [Quantitative Concept]

Phrase: "shown above the corresponding facilitated calcium current tracing."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C0521116:Current [Temporal Concept]
   744   C1705970:Current [Natural Phenomenon or Process]
   744   C2936886:Calcium [Pharmacologic Substance]
   711   C1547282:Show [Intellectual Product]
Processing 00000000.tx.295: Prepulse voltages were increased from 20 to +90 mV, resulting in a step-wise fashion (facilitation) in the test pulse current amplitude. 

Phrase: "Prepulse voltages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0598352:Voltage [Quantitative Concept]

Phrase: "were"

Phrase: "increased from 20 to +90 mV,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205217:Increased [Quantitative Concept]
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]

Phrase: "resulting in a step-wise fashion"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   790   C0332294:Resulting in [Functional Concept]
   753   C0678226:resulting [Functional Concept]
   753   C1261552:Step [Conceptual Entity]
   753   C1427738:WISE [Gene or Genome]
   753   C1704379:Step [Functional Concept]
   753   C1705117:Step [Quantitative Concept]
   753   C2825408:Step [Manufactured Object]
   719 E C1274040:Result [Functional Concept]
   719 E C1546471:Result [Idea or Concept]
   719 E C2825142:Result [Finding]

Phrase: "(facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: ")"

Phrase: "in the test pulse current amplitude."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.296: For clarity, only current tracings from 0to +90 are shown. 

Phrase: "For clarity,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0486588:Clarity [Clinical Attribute]
  1000   C3272888:Clarity [Laboratory Procedure]
   928 E C2963144:Clear [Qualitative Concept]

Phrase: "only current tracings from 0to +90"

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.297: B: the voltage dependence of facilitation was calculated for test pulse amplitudes normalized to maximum amplitude (F/Fmax) and plotted as a function of the prepulse voltage for 11control (C) and 11diabetic (D) neurons dialyzed with 100M GTP, 6control and 6diabetic DRGs dialyzed with 250M GTPS, and 4control and 4diabetic DRGs dialyzed with 250M GDPS. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "the voltage dependence of facilitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011546:Dependence [Mental Process]
   760   C0439857:Dependence [Mental or Behavioral Dysfunction]
   760   C0598352:Voltage [Quantitative Concept]
   760   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "was"

Phrase: "calculated for test pulse amplitudes"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0022885:Test [Laboratory Procedure]
   760   C0039593:Test [Functional Concept]
   760   C0232117:PULSE [Clinical Attribute]
   760   C0391850:Pulse [Physiologic Function]
   760   C0392366:test [Intellectual Product]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C1947910:Pulse [Phenomenon or Process]
   726   C2346753:Amplitude [Spatial Concept]

Phrase: "normalized to maximum amplitude"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0806909:Maximum [Quantitative Concept]
   770   C1552615:maximum [Quantitative Concept]
   770   C1882115:Normalized [Research Activity]
   770   C2346753:Amplitude [Spatial Concept]
   770   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "(F/Fmax)"

Phrase: "and"

Phrase: "plotted as a function of the prepulse voltage"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0598352:Voltage [Quantitative Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "for 11control"

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "11diabetic"

Phrase: "(D) neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "dialyzed with 100M GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "6control"

Phrase: "and"

Phrase: "6diabetic DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "dialyzed with 250M GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "4control"

Phrase: "and"

Phrase: "4diabetic DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "dialyzed with 250M GDPS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.298: At 50% F/Fmax, diabetes was associated with a significant (P<0.05) positive shift (V0.5=22.23.5) in the voltage dependence of facilitation (mV) compared with control recordings (V0.5=13.73.4). 

Phrase: "At 50% F/Fmax,"

Phrase: "diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "associated with a significant"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "positive shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333051:Shift [Functional Concept]
   861   C2347509:Shift [Phenomenon or Process]

Phrase: "(V0.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441906:V0 [Finding]
   861   C3540692:V0 [Quantitative Concept]

Phrase: "=22.23.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "in the voltage dependence"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C0598352:Voltage [Quantitative Concept]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]

Phrase: "of facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "(mV)"

Phrase: "compared with control recordings"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "(V0.5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441906:V0 [Finding]
   861   C3540692:V0 [Quantitative Concept]

Phrase: "=13.73.4"

Phrase: ")."
Processing 00000000.tx.299: Intracellular dialysis with GTPS produced a rightward shift (C+GTPS=35.22.4; D+GTPS=40.94.1), while GDPS dialysis (C+GDPS=8.03.1; D+GDPS=7.93.5) was associated with a leftward shift in the voltage dependence of facilitation. 

Phrase: "Intracellular dialysis with GTPS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0011945:Dialysis [Natural Phenomenon or Process]
   770   C0011946:dialysis [Therapeutic or Preventive Procedure]
   770   C0917873:dialysis [Therapeutic or Preventive Procedure]
   770   C1059964:Dialysis [Eukaryote]

Phrase: "produced"

Phrase: "a rightward shift"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333051:Shift [Functional Concept]
   861   C2347509:Shift [Phenomenon or Process]

Phrase: "(C+GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "=35.22.4"

Phrase: ";"

Phrase: "D+"

Phrase: "GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "=40.94.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "GDPS dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0011945:Dialysis [Natural Phenomenon or Process]
   861   C0011946:dialysis [Therapeutic or Preventive Procedure]
   861   C0917873:dialysis [Therapeutic or Preventive Procedure]
   861   C1059964:Dialysis [Eukaryote]

Phrase: "(C+GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "=8.03.1"

Phrase: ";"

Phrase: "D+"

Phrase: "GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "=7.93.5"

Phrase: ")"

Phrase: "was"

Phrase: "associated with a leftward shift"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0333051:Shift [Functional Concept]
   760   C2347509:Shift [Phenomenon or Process]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the voltage dependence"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C0598352:Voltage [Quantitative Concept]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]

Phrase: "of facilitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.300: Compared with facilitation in the presence of GTP alone, intracellular dialysis with medium containing GTP and PTX (50ng/ml; n=5) decreased facilitation to 163% (control) and 114% (diabetic; Fig. 5). 

Phrase: "Compared with facilitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0234112:Facilitation [Organ or Tissue Function]
   790   C1707455:Compared [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of GTP alone, intracellular dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0011945:Dialysis [Natural Phenomenon or Process]
   812   C0011946:dialysis [Therapeutic or Preventive Procedure]
   812   C0917873:dialysis [Therapeutic or Preventive Procedure]
   812   C1059964:Dialysis [Eukaryote]

Phrase: "with medium containing GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "(50ng/ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439526:/mL [Quantitative Concept]

Phrase: "; n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "decreased facilitation to 163%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "114%"

Phrase: "(diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "; Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.301: This decrease was significant in control DRGs but not in DRGs from BB/W diabetic animals. 

Phrase: "This decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "significant in control DRGs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0237881:significant [Quantitative Concept]
   770   C0750502:Significant [Idea or Concept]
   770   C1546944:Significant [Qualitative Concept]

Phrase: "but"

Phrase: "not in DRGs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0011928:DRGs [Intellectual Product]
   790   C1518422:Not [Functional Concept]
   756 E C1414151:DRG [Gene or Genome]

Phrase: "from BB/W diabetic animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]
Processing 00000000.tx.302: We believe that intracellular dialysis with this concentration of PTX was effective in inhibiting Gi/o-type G proteins, as 1M Dyn A or DAGO had no effect on calcium currents in PTX-dialyzed DRGs. 

Phrase: "We"

Phrase: "believe"

Phrase: "that intracellular dialysis with this concentration of PTX"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0011945:Dialysis [Natural Phenomenon or Process]
   742   C0011946:dialysis [Therapeutic or Preventive Procedure]
   742   C0917873:dialysis [Therapeutic or Preventive Procedure]
   742   C1059964:Dialysis [Eukaryote]

Phrase: "was"

Phrase: "effective in inhibiting Gi/o-type G proteins,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280519:effective [Qualitative Concept]
   744   C1704419:Effective [Qualitative Concept]

Phrase: "as"

Phrase: "1M Dyn A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600130:dyn [Quantitative Concept]

Phrase: "or"

Phrase: "DAGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "had"

Phrase: "no effect on calcium currents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "in PTX-dialyzed DRGs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0011928:DRGs [Intellectual Product]
   779 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.303: Dialysis of PTX concentrations >50 ng/ml appeared to be toxic as reliable recordings could not be performed in neurons exposed to 75or 100ng/ml of PTX. 

Phrase: "Dialysis of PTX concentrations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011945:Dialysis [Natural Phenomenon or Process]
   760   C0011946:dialysis [Therapeutic or Preventive Procedure]
   760   C0917873:dialysis [Therapeutic or Preventive Procedure]
   760   C1059964:Dialysis [Eukaryote]

Phrase: ">50 ng/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "toxic as reliable recordings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0600688:toxic [Injury or Poisoning]
   770   C1407029:Toxic [Qualitative Concept]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "performed in neurons"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "exposed to 75or 100ng/ml of PTX."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   770   C0332157:Exposed to [Clinical Attribute]
           Exposed
   744   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   744   C0043167:Pertussis [Disease or Syndrome]
   744   C0439526:/mL [Quantitative Concept]
Processing 00000000.tx.304: The effect of DAGO treatment on facilitation amplitude provided additional evidence that diabetic inhibitory G-protein pathways appeared to be relatively impaired. 

Phrase: "The effect of DAGO treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1518681:Treatment Effect [Finding]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on facilitation amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that diabetic inhibitory G-protein pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1704259:Pathways [Molecular Function]
   804   C1705987:Pathways [Conceptual Entity]
   717   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415142:INHIBITORY G PROTEIN [Gene or Genome]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "relatively"

Phrase: "impaired."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]
Processing 00000000.tx.305: We observed that opiate treatment (which presumably activates inhibitory G proteins) was significantly more effective in increasing the amplitude of facilitated currents in control animals (78%), compared with DRGs from STZ-induced diabetic animals (34%; Fig. 7). 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that opiate treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "("

Phrase: "which presumably"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "inhibitory G proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   966   C1415142:INHIBITORY G PROTEIN [Gene or Genome]
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]
   827   C3463820:Inhibitory [Activity]

Phrase: ")"

Phrase: "was"

Phrase: "significantly more effective in increasing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "the amplitude of facilitated currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "in control animals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   966   C1511501:Control Animal [Animal]
   861   C0003062:Animals [Animal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "(78%"

Phrase: ")"

Phrase: ","

Phrase: "compared with DRGs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0011928:DRGs [Intellectual Product]
   790   C1707455:Compared [Activity]
   756 E C1414151:DRG [Gene or Genome]

Phrase: "from STZ-induced diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]

Phrase: "(34%"

Phrase: "; Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.306: View larger version (19K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(19K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.307: 7. 

Phrase: "7."
Processing 00000000.tx.308: Compared to untreated neurons, DRGs from control (n=5) and STZ-induced diabetic (n=5) animals treated with 1M DAGO demonstrated significantly increased percent facilitation of test pulse currents within 1min of application. 

Phrase: "Compared to untreated neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C0332155:untreated [Finding]
   770   C1707455:Compared [Activity]

Phrase: "DRGs from control"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0011928:DRGs [Intellectual Product]
   756 E C1414151:DRG [Gene or Genome]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "STZ-induced diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0241863:DIABETIC [Finding]

Phrase: "(n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "treated with 1M DAGO"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0470296:1M [Quantitative Concept]
   770   C0525773:DAGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "demonstrated"

Phrase: "significantly increased percent facilitation of test pulse currents within 1min of application."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0521116:currents [Temporal Concept]
   703 E C1705970:Current [Natural Phenomenon or Process]
Processing 00000000.tx.309: Representative recordings of the effect of DAGO on test currents in a control and STZ-induced diabetic DRG are shown on the right. 

Phrase: "Representative recordings of the effect of DAGO"

Phrase: "on test currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "in a control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "STZ-induced diabetic DRG"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   861   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   861   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   827   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   827   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   799   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   799   C0040452:Root [Body Part, Organ, or Organ Component]
   799   C0205095:Dorsal [Spatial Concept]
   799   C0242726:Root [Plant]
   799   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   799   C1318154:Root [Body Part, Organ, or Organ Component]
   799   C1705917:Root [Idea or Concept]

Phrase: "are"

Phrase: "shown on the right."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205090:Right [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.310: *P<0.05; 

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.311: **P<0.01; 

Phrase: "*"

Phrase: "*P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ";"
Processing 00000000.tx.312: ***P<0.001. 

Phrase: "*"

Phrase: "*"

Phrase: "*P<0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.313: GTPase activity was diminished in diabetes Compared with nontreated neurons, DAGO treatment resulted in a significant increase in percent facilitation in both STZ-induced diabetic (365%) and control (7411%) animals. 

Phrase: "GTPase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149036:GTPase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "diminished in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205216:Diminished [Quantitative Concept]

Phrase: "Compared with nontreated neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C1707455:Compared [Activity]

Phrase: "DAGO treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in a significant increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0237881:significant [Quantitative Concept]
   760   C0442805:Increase [Functional Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in percent facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "in both STZ-induced diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0241863:DIABETIC [Finding]

Phrase: "(365%"

Phrase: ")"

Phrase: "and"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(7411%"

Phrase: ")"

Phrase: "animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]
Processing 00000000.tx.314: The magnitude of the effect of opiate treatment on facilitation of calcium currents was significantly less in DRGs from diabetic animals compared with controls. 

Phrase: "The magnitude of the effect of opiate treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449286:magnitude [Quantitative Concept]
   744   C1704240:Magnitude [Quantitative Concept]

Phrase: "on facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "of calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "significantly less in DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0011928:DRGs [Intellectual Product]
   737 E C1414151:DRG [Gene or Genome]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "compared with controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.315: We had previously observed that opiate treatment of diabetic DRGs resulted in significantly less opiate-mediated inhibition of calcium current amplitude (Hall et al. 1996). 

Phrase: "We"

Phrase: "had"

Phrase: "previously"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that opiate treatment of diabetic DRGs"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in significantly less opiate-mediated inhibition of calcium current amplitude"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   738   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0006726:Calcium [Inorganic Chemical]
   738   C0021467:Inhibition [Mental Process]
   738   C0021469:Inhibition [Molecular Function]
   738   C0086597:mediated [Social Behavior]
   738   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   738   C0376196:Opiate [Hazardous or Poisonous Substance,Pharmacologic Substance]
   738   C0521116:Current [Temporal Concept]
   738   C1628982:% inhibition [Quantitative Concept]
   738   C1705970:Current [Natural Phenomenon or Process]
   738   C2346753:Amplitude [Spatial Concept]
   738   C2936886:Calcium [Pharmacologic Substance]
   738   C3463820:Inhibition [Activity]
   704   C1274040:Result [Functional Concept]
   704   C1546471:Result [Idea or Concept]
   704   C2825142:Result [Finding]

Phrase: "(Hall et al. 1996"

Phrase: ")."
Processing 00000000.tx.316: These results suggested that the opiate receptor pathway coupled to calcium channels was significantly impaired in diabetes compared with nondiabetic controls. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the opiate receptor pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]
   734   C0034801:Opiate Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "coupled to calcium channels"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C1948027:Coupled [Functional Concept]
   770   C2936886:Calcium [Pharmacologic Substance]
   737 E C0010222:couple [Family Group]
   737   C0439799:Channel [Spatial Concept]
   737   C1706095:Channel [Conceptual Entity]

Phrase: "was"

Phrase: "significantly"

Phrase: "impaired in diabetes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]

Phrase: "compared with nondiabetic controls."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.317: Using a direct method to assess GTPase activity (Traynor and Nahorski 1995), we observed a significant decrease in the GTPase activity in diabetes as measured by binding of theopiate agonist DAMGO to membranes from diabetic and control rats. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a direct method to"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1704536:Direct Method [Therapeutic or Preventive Procedure]
   827   C0025663:Method [Intellectual Product]
   827   C0439851:Direct [Qualitative Concept]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]
   827   C1947931:Direct [Qualitative Concept]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "GTPase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149036:GTPase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "(Traynor"

Phrase: "and"

Phrase: "Nahorski 1995"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a significant decrease in the GTPase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "as"

Phrase: "measured by binding of theopiate agonist DAMGO"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0243122:binding [Functional Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C0525773:DAMGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   748   C2987634:Agonist [Pharmacologic Substance]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "to membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "from diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0241863:DIABETIC [Finding]

Phrase: "and"

Phrase: "control rats."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0034693:rats [Mammal]
   861   C0034721:Rats [Mammal]
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.318: The binding affinity of GTP[35S] in the presence of DAMGO was significantly (P<0.01) shifted to the right in DRGs from diabetic animals (Fig. 8), confirming that opiate stimulation resulted in diminished GTPase activity in diabetic neurons. 

Phrase: "The binding affinity of GTP[35S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "]"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DAMGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525773:DAMGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "was"

Phrase: "significantly"

Phrase: "(P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "shifted to the right"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0427514:right shifted [Finding]
   770   C0205090:Right [Spatial Concept]
   770   C0333051:shifted [Functional Concept]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "in DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0011928:DRGs [Intellectual Product]
   966 E C1414151:DRG [Gene or Genome]

Phrase: "from diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that opiate stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "resulted in diminished GTPase activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1149036:GTPase activity [Molecular Function]
   760   C0018296:GTPase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Activity [Functional Concept]
   760   C0205216:Diminished [Quantitative Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in diabetic neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.319: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.320: 8. 

Phrase: "8."
Processing 00000000.tx.321: GTPase activity was measured using binding of GTP[35S] in the presence of DAMGO as described in METHODS. 

Phrase: "GTPase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1149036:GTPase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "binding of GTP[35S"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1149035:GTP Binding [Molecular Function]
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "]"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DAMGO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0525773:DAMGO [Amino Acid, Peptide, or Protein,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in METHODS."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0025663:Methods [Intellectual Product]
   790   C0025664:methods [Intellectual Product]
   790   C0449851:Methods [Functional Concept]
   790   C1552738:described [Idea or Concept]
   756 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.322: Neurons from STZ-induced diabetic animals exhibited significantly lower DAMGO-stimulated binding compared with nondiabetic controls with a significant (P<0.01) leftward shift in the binding affinity.  

Phrase: "Neurons from STZ-induced diabetic animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "significantly lower DAMGO-stimulated binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "compared with nondiabetic controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1707455:Compared [Activity]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]

Phrase: "with a significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "(P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "leftward shift in the binding affinity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0333051:Shift [Functional Concept]
   753   C2347509:Shift [Phenomenon or Process]
Processing 00000000.tx.323: DISCUSSION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES This study documents enhanced calcium current amplitude and diminished facilitation in two models of diabetes, the spontaneous BB/W- and STZ-induced diabetic rat. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "documents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301746:Documents [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]
  1000   C1548385:documents [Intellectual Product]

Phrase: "enhanced calcium current amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2346753:Amplitude [Spatial Concept]

Phrase: "and"

Phrase: "diminished facilitation in two models of diabetes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "the spontaneous BB/W-"

Phrase: "and"

Phrase: "STZ-induced diabetic rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C0241863:DIABETIC [Finding]
Processing 00000000.tx.324: Voltage-dependent, transient facilitation of calcium currents has been documented in a variety of neuronal and nonneuronal cells (Dolphin 1996; Ikeda 1991). 

Phrase: "Voltage-dependent, transient facilitation of calcium currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "has"

Phrase: "been"

Phrase: "documented in a variety of neuronal"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0521390:Neuronal [Immunologic Factor]
   753   C1301725:Documented [Health Care Activity]
   753   C1609436:documented [Idea or Concept]
   753   C1883525:Variety [Conceptual Entity]
   753   C2346866:Variety [Conceptual Entity]
   719 E C1301746:document [Intellectual Product]
   719 E C1547673:Document [Intellectual Product]

Phrase: "and"

Phrase: "nonneuronal cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0027836:Non-neuronal cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Dolphin 1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013005:Dolphin [Mammal]

Phrase: "; Ikeda 1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: ")."
Processing 00000000.tx.325: Facilitation may have physiologic significance in neuronal circuits in which simultaneous depolarizing inputs may transiently elevate membrane potential to large positive values (Cens et al. 1998). 

Phrase: "Facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "may"

Phrase: "have"

Phrase: "physiologic significance in neuronal circuits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237881:Significance [Quantitative Concept]
   760   C0750502:Significance [Idea or Concept]

Phrase: "in which simultaneous depolarizing inputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708517:Input [Conceptual Entity]

Phrase: "may"

Phrase: "transiently"

Phrase: "elevate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:elevate [Qualitative Concept]

Phrase: "membrane potential to large positive values"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0025251:Membrane Potential [Cell Function]
   753   C0025255:Membrane [Tissue]
   753   C0596901:Membrane [Cell Component]
   753   C1706182:Membrane [Manufactured Object]
   753   C3245505:Potential [Qualitative Concept]

Phrase: "(Cens et al. 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0338283:CEN [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.326: The mechanism is thought to involve transient voltage-dependent dissociation of inhibitory G-protein subunits from the proposed effector site on the calcium channel (I-II intra-cytoplasmic loop) (De Waard et al. 1997; Garcia et al. 1998). 

Phrase: "The mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "transient voltage-dependent dissociation of inhibitory G-protein subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0086168:Dissociation [Mental or Behavioral Dysfunction]

Phrase: "from the proposed effector site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "on the calcium channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(I-II intra-cytoplasmic loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0419518:Loop [Medical Device]
   804   C0445022:Loop [Spatial Concept]

Phrase: ")"

Phrase: "(De Waard et al. 1997"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011198:DE [Geographic Area]
   804   C0017480:DE [Geographic Area]
   804   C3541240:DE [Idea or Concept]

Phrase: "; Garcia et al. 1998"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442999:Garcia [Intellectual Product]
   812   C1621797:Garcia [Plant]

Phrase: ")."
Processing 00000000.tx.327: The amplitude of facilitation decays rapidly with increasing inter-pulse intervals. 

Phrase: "The amplitude of facilitation decays rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2346753:Amplitude [Spatial Concept]

Phrase: "with increasing inter-pulse intervals."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C1272706:intervals [Temporal Concept]
   779 E C1552654:Interval [Idea or Concept]
   779 E C1552713:Interval [Intellectual Product]
Processing 00000000.tx.328: This suggests that facilitation represents a tightly coupled, membrane-delimited phenomenon (De Waard et al. 1997) comparable to that observed in kinetic studies of opiate receptor-G-protein coupling (Wilding et al. 1995). 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a tightly"

Phrase: "coupled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1948027:Coupled [Functional Concept]
   966 E C0010222:couple [Family Group]

Phrase: ","

Phrase: "membrane-delimited phenomenon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "(De Waard et al. 1997"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011198:DE [Geographic Area]
   804   C0017480:DE [Geographic Area]
   804   C3541240:DE [Idea or Concept]

Phrase: ")"

Phrase: "comparable to that"

Phrase: "observed in kinetic studies of opiate receptor-G-protein coupling"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   760   C0034801:Opiate Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   757 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   757   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   757   C0597359:receptor coupling [Molecular Function]
   739   C0022702:kinetic [Natural Phenomenon or Process]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0376196:Opiate [Hazardous or Poisonous Substance,Pharmacologic Substance]
   739   C0439267:g% [Quantitative Concept]
   739   C0947630:studies [Laboratory Procedure]
   739   C1441672:Observed [Functional Concept]
   739   C1948027:Coupling [Functional Concept]
   706 E C0557651:Study [Manufactured Object]
   706 E C2603343:Study [Research Activity]

Phrase: "(Wilding et al. 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0445392:wilding [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.329: Diabetes was associated with a significant decrease in voltage-dependent facilitation of calcium currents compared with age-matched control neurons. 

Phrase: "Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "was"

Phrase: "associated with a significant decrease"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0237881:significant [Quantitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in voltage-dependent facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "of calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "compared with age-matched control neurons."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   753   C0001779:Age [Organism Attribute]
   753   C0027882:Neurons [Cell]
   753   C0150103:matched [Research Activity]
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1707455:Compared [Activity]
   753   C1708943:Matched [Qualitative Concept]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.330: Facilitation was decreased by intracellular dialysis with PTX and abolished by dialysis with GDPS. 

Phrase: "Facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "decreased by intracellular dialysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0011945:Dialysis [Natural Phenomenon or Process]
   770   C0011946:dialysis [Therapeutic or Preventive Procedure]
   770   C0175996:intracellular [Cell Component]
   770   C0178719:Intracellular [Spatial Concept]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0917873:dialysis [Therapeutic or Preventive Procedure]
   770   C1059964:Dialysis [Eukaryote]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "with PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "and"

Phrase: "abolished by dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011945:Dialysis [Natural Phenomenon or Process]
   790   C0011946:dialysis [Therapeutic or Preventive Procedure]
   790   C0917873:dialysis [Therapeutic or Preventive Procedure]
   790   C1059964:Dialysis [Eukaryote]

Phrase: "with GDPS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.331: The elevated calcium currents and the diminished facilitation observed in diabetes were restored to control levels by intracellular dialysis with GTPS, suggesting that the impairment in G-protein-mediated inhibition observed in diabetes was reversible. 

Phrase: "The elevated calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0521116:currents [Temporal Concept]
   793 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "the diminished facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "observed in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1441672:Observed [Functional Concept]

Phrase: "were"

Phrase: "restored"

Phrase: "to control levels by intracellular dialysis"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   753   C0243148:control [Qualitative Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "with GTPS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the impairment in G-protein-mediated inhibition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0684336:Impairment [Pathologic Function]

Phrase: "observed in diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C1441672:Observed [Functional Concept]

Phrase: "was"

Phrase: "reversible."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]
Processing 00000000.tx.332: The voltage dependence of facilitation was shifted to the right in diabetes compared with controls, suggesting a relative impairment in elicitation of the response. 

Phrase: "The voltage dependence of facilitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0011546:Dependence [Mental Process]
   760   C0439857:Dependence [Mental or Behavioral Dysfunction]
   760   C0598352:Voltage [Quantitative Concept]
   760   C2698668:DEPENDENCE [Regulation or Law]

Phrase: "was"

Phrase: "shifted to the right"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   819   C0427514:right shifted [Finding]
   770   C0205090:Right [Spatial Concept]
   770   C0333051:shifted [Functional Concept]
   737 E C2347509:Shift [Phenomenon or Process]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "compared with controls,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1707455:Compared [Activity]
   756   C0243148:control [Qualitative Concept]
   756   C1550141:Control [Substance]
   756   C1882979:Control [Conceptual Entity]
   756   C2587213:Control [Functional Concept]
   756   C3274648:Control [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a relative impairment in elicitation of the response."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684336:Impairment [Pathologic Function]
Processing 00000000.tx.333: This effect may be analogous to voltage shifts in calcium currents observed in the presence of inhibitory ligands that have been interpreted as G-protein-mediated shifts of the calcium channel to a more "reluctant" state (Bean 1989). 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "analogous to voltage"

Phrase: "shifts in calcium currents"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C0333051:Shift [Functional Concept]
   770   C0521116:currents [Temporal Concept]
   770   C2347509:Shift [Phenomenon or Process]
   770   C2936886:Calcium [Pharmacologic Substance]
   737 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "observed in the presence of inhibitory ligands"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0023688:Ligands [Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1441672:Observed [Functional Concept]
   748   C3463820:Inhibitory [Activity]

Phrase: "that"

Phrase: "have"

Phrase: "been"

Phrase: "interpreted as G-protein-mediated shifts of the calcium channel"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   760   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   757 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   757   C0805431:Calcium/Protein [Quantitative Concept]
   739   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0006726:Calcium [Inorganic Chemical]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0086597:mediated [Social Behavior]
   739   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   739   C0333051:shifts [Functional Concept]
   739   C0439267:g% [Quantitative Concept]
   739   C0439799:Channel [Spatial Concept]
   739   C1285553:interpreted [Functional Concept]
   739   C1706095:Channel [Conceptual Entity]
   739   C2936886:Calcium [Pharmacologic Substance]
   706 E C2347509:Shift [Phenomenon or Process]

Phrase: "to a more ""reluctant"" state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1301808:State [Geographic Area]
   827   C1442792:State [Functional Concept]
   827   C3148680:State [Geographic Area]

Phrase: "(Bean 1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0004896:Bean [Food]

Phrase: ")."
Processing 00000000.tx.334: Modulation of G-protein activity by dialysis with GTPS and GDPS resulted in shifts in voltage dependence of facilitation that appeared to correspond with more (left shift) or less (right shift) inhibition, respectively. 

Phrase: "Modulation of G-protein activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443264:Modulation [Spatial Concept]

Phrase: "by dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0011945:Dialysis [Natural Phenomenon or Process]
  1000   C0011946:dialysis [Therapeutic or Preventive Procedure]
  1000   C0917873:dialysis [Therapeutic or Preventive Procedure]
  1000   C1059964:Dialysis [Eukaryote]

Phrase: "with GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "GDPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "resulted in shifts"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0333051:shifts [Functional Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756 E C2347509:Shift [Phenomenon or Process]
   756   C2825142:Result [Finding]

Phrase: "in voltage dependence"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   861   C0011546:Dependence [Mental Process]
   861   C0439857:Dependence [Mental or Behavioral Dysfunction]
   861   C0598352:Voltage [Quantitative Concept]
   861   C2698668:DEPENDENCE [Regulation or Law]
   789 E C0851827:Dependent [Qualitative Concept]
   789 E C1701901:Dependent [Qualitative Concept]
   789 E C3244310:dependent [Functional Concept]
   761 E C1546937:Dependency [Idea or Concept]

Phrase: "of facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "that"

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correspond with more"

Phrase: "(left shift"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0240173:Left shift [Finding]
   861   C0333051:Shift [Functional Concept]
   861   C2347509:Shift [Phenomenon or Process]

Phrase: ")"

Phrase: "or"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "(right shift"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0427514:Right shift [Finding]
   861   C0333051:Shift [Functional Concept]
   861   C2347509:Shift [Phenomenon or Process]

Phrase: ")"

Phrase: "inhibition,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "respectively."
Processing 00000000.tx.335: In the presence of GTPase modulators, IDCa and facilitation amplitudes were similar in diabetic and control neurons. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of GTPase modulators,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709060:Modulator [Manufactured Object]

Phrase: "IDCa"

Phrase: "and"

Phrase: "facilitation amplitudes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346753:Amplitude [Spatial Concept]

Phrase: "were"

Phrase: "similar in diabetic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "control neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.336: Expression of PTX-sensitive G-protein subunits (Gi1/2, Gi3, and Go) was not affected by diabetes, suggesting that impaired function of coupled G proteins, rather than decreased expression, underlies the increased calcium currents in diabetes (Hall et al. 1995b). 

Phrase: "Expression of PTX-sensitive G-protein subunits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Gi1/2,"

Phrase: "Gi3,"

Phrase: "and"

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: ")"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by diabetes,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that impaired function of coupled G proteins,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   774   C0815043:function proteins [Amino Acid, Peptide, or Protein]
   757 E C1527118:Protein Function [Molecular Function]
   748   C0031843:function [Physiologic Function]
   748   C0542341:Function [Functional Concept]
   748   C0700205:FUNCTION [Classification]
   748   C1705273:Function [Intellectual Product]

Phrase: "rather than"

Phrase: "decreased expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "underlies"

Phrase: "the increased calcium currents in diabetes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0521116:currents [Temporal Concept]
   719 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.337: This was confirmed using a direct assay of GTPase activity, which demonstrated a significant impairment in opiate-mediated GTP[35S] uptake, but notreceptor expression, in diabetic DRGs. 

Phrase: "This"

Phrase: "was"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a direct assay of GTPase activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1441554:Direct assay [Laboratory Procedure]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "which"

Phrase: "demonstrated"

Phrase: "a significant impairment in opiate-mediated GTP[35S"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0684336:Impairment [Pathologic Function]

Phrase: "] uptake,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243144:Uptake [Physiologic Function]
  1000   C0347980:% uptake [Quantitative Concept]

Phrase: "but"

Phrase: "notreceptor expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in diabetic DRGs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]
Processing 00000000.tx.338: We believe the present study provides functional evidence of impairment in G-protein-coupled calcium current modulation in two models of diabetic neuropathy and indicates a potential mechanism for the impairment in calcium current facilitation observed when nondiabetic DRGs are exposed to diabetic serum (Ristic et al. 1998). 

Phrase: "We"

Phrase: "believe"

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "functional evidence of impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in G-protein-coupled calcium current modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0443264:Modulation [Spatial Concept]

Phrase: "in two models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Models [Intellectual Product]

Phrase: "of diabetic neuropathy"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011882:Diabetic neuropathy [Disease or Syndrome]
   861   C0241863:DIABETIC [Finding]
   861   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "and"

Phrase: "indicates"

Phrase: "a potential mechanism for the impairment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "in calcium current facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "nondiabetic DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "are"

Phrase: "exposed to diabetic serum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0332157:Exposed to [Clinical Attribute]
           Exposed
   770   C0229671:Serum [Body Substance]
   770   C0241863:DIABETIC [Finding]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "(Ristic et al. 1998"

Phrase: ")."
Processing 00000000.tx.339: The facilitation response evoked by large amplitude depolarizations in rat DRGs appears, in part, to involve reversal of calcium-dependent inactivation of calcium currents. 

Phrase: "The facilitation response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871261:Response [Organism Attribute]
   861   C1704632:Response [Finding]
   861   C1706817:Response [Intellectual Product]
   861   C2911692:Response [Mental Process]

Phrase: "evoked by large amplitude depolarizations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0549177:Large [Quantitative Concept]
   760   C1444748:Evoked [Qualitative Concept]
   760   C2346753:Amplitude [Spatial Concept]

Phrase: "in rat DRGs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0011928:DRGs [Intellectual Product]
   827 E C1414151:DRG [Gene or Genome]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: ","

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "reversal of calcium-dependent inactivation of calcium currents."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443290:Reversal [Functional Concept]
Processing 00000000.tx.340: Under conditions promoting Ca2+-dependent inactivation (Fig. 4A), the test current was often smaller than the preceding prepulse current despite the identical amplitude of the voltage steps. 

Phrase: "Under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "promoting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promoting [Activity]

Phrase: "Ca2+-dependent inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "the test current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0521116:Current [Temporal Concept]
   861   C1705970:Current [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "often smaller than the preceding prepulse current"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0547044:Smaller [Qualitative Concept]
   748   C0700321:Smaller [Quantitative Concept]

Phrase: "despite the identical amplitude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2346753:Amplitude [Spatial Concept]

Phrase: "of the voltage steps."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C1261552:steps [Conceptual Entity]
   827 E C1704379:Step [Functional Concept]
   827 E C1705117:Step [Quantitative Concept]
   827 E C2825408:Step [Manufactured Object]
Processing 00000000.tx.341: This diminution was not observed if test currents were elicited under conditions designed to minimize Ca2+-dependent inactivation: i.e., the 0/90 facilitation protocol (Fig. 4C) or recording in Ba2+-containing solutions. 

Phrase: "This diminution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332511:Diminution [Qualitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "if"

Phrase: "test currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "elicited under conditions"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0449265:elicited [Qualitative Concept]
   756   C0012634:condition [Disease or Syndrome]
   756   C0348080:Condition [Qualitative Concept]
   756   C1705253:Condition [Conceptual Entity]
   706 E C0009647:Conditioned [Mental Process]
   706 E C1701901:Conditional [Qualitative Concept]
   706 E C1963686:Conditional [Functional Concept]

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "minimize"

Phrase: "Ca2+-dependent inactivation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0544461:Inactivation [Cell or Molecular Dysfunction]

Phrase: ":"

Phrase: "i.e.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "the 0/90 facilitation protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]

Phrase: "(Fig. 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "recording in Ba2+-containing solutions."
Processing 00000000.tx.342: Because increased calcium influx would be expected to result in increased inhibition by this mechanism (i.e., increased facilitation), calcium-dependent inhibition of currents does not explain the observation that facilitation is decreased in diabetes. 

Phrase: "Because"

Phrase: "increased calcium influx"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0553702:increased calcium [Finding]

Phrase: "would"

Phrase: "be"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "result in increased inhibition"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C2825142:Result [Finding]
   770   C3463820:Inhibition [Activity]

Phrase: "by this mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "(i.e., increased facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0234112:Facilitation [Organ or Tissue Function]

Phrase: ")"

Phrase: ","

Phrase: "calcium-dependent inhibition of currents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "explain"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "is"

Phrase: "decreased in diabetes."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.343: Facilitation in skeletal muscle from streptozotocin-induced diabetic rats has been attributed to increased numbers of calcium channels (Ogawa et al. 1995). 

Phrase: "Facilitation in skeletal muscle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "from streptozotocin-induced diabetic rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to increased numbers of calcium channels"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0553702:increased calcium [Finding]
   748   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0006726:Calcium [Inorganic Chemical]
   748   C0205217:Increased [Quantitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C0449788:Number [Quantitative Concept]
   748   C2936886:Calcium [Pharmacologic Substance]
   714   C0439799:Channel [Spatial Concept]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1706095:Channel [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "(Ogawa et al. 1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0443037:Ogawa [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.344: The almost-complete reversal of the effects of diabetes on calcium currents in the presence of analogues that modulate G-protein activity argues against an absolute increase in the number of calcium channels in diabetes. 

Phrase: "The almost-complete reversal of the effects of diabetes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0443290:Reversal [Functional Concept]

Phrase: "on calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of analogues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0243071:Analogue [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "G-protein activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1537044:protein activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "argues against an absolute increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205344:Absolute [Qualitative Concept]
   760   C0442805:Increase [Functional Concept]

Phrase: "in the number"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237753:*Number [Quantitative Concept]
  1000   C0449788:Number [Quantitative Concept]

Phrase: "of calcium channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.345: Decreased opiate receptor expression could also account for impaired opiate-mediated inhibition of calcium channels in diabetes (Hall et al. 1996). 

Phrase: "Decreased opiate receptor expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597360:receptor expression [Genetic Function]
   812   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "could"

Phrase: "also"

Phrase: "account for impaired opiate-mediated inhibition of calcium channels"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   767   C1516145:Calcium Channel Inhibition [Cell Function]
   764   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   742   C0006726:Calcium [Inorganic Chemical]
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0086597:mediated [Social Behavior]
   742   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   742   C0221099:Impaired [Functional Concept]
   742   C0376196:Opiate [Hazardous or Poisonous Substance,Pharmacologic Substance]
   742   C0684336:Impaired [Pathologic Function]
   742   C1551359:account [Idea or Concept]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C2741673:Account # [Clinical Attribute]
   742   C2936886:Calcium [Pharmacologic Substance]
   742   C2981730:Account [Classification]
   742   C3463820:Inhibition [Activity]
   708   C0439799:Channel [Spatial Concept]
   708   C1706095:Channel [Conceptual Entity]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Hall et al. 1996"

Phrase: ")."
Processing 00000000.tx.346: However, our preliminary data in the STZ-induced diabetic model indicate thatopiate receptor expression on DRGs is increased, not decreased, in diabetes (unpublished observations). 

Phrase: "However,"

Phrase: "our preliminary data in the STZ-induced diabetic model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1511726:Data [Idea or Concept]
   742   C3245479:data [Medical Device]

Phrase: "indicate"

Phrase: "thatopiate receptor expression on DRGs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0597360:receptor expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: ","

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: ","

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(unpublished observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0302523:observations [Research Activity]
   861   C0700325:observations [Health Care Activity]
   861   C3244290:observations [Functional Concept]
   827 E C1964257:Observation [Diagnostic Procedure]
   777 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: ")."
Processing 00000000.tx.347: Expression studies in Xenopus oocytes demonstrate that voltage-dependent facilitation is independent of inhibitory receptor expression and function (De Waard et al. 1997). 

Phrase: "Expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "studies in Xenopus oocytes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   816   C0597694:Xenopus oocyte [Cell]
   770   C0029045:Oocytes [Cell]
   770   C0043342:Xenopus [Amphibian]
   770   C0043343:Xenopus [Amphibian]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C1504663:Xenopus [Amphibian]
   770   C2603343:Study [Research Activity]

Phrase: "demonstrate"

Phrase: "that voltage-dependent facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "is independent of inhibitory receptor expression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0332291:Independent of [Functional Concept]
   790   C0597360:receptor expression [Genetic Function]
   753   C0085862:Independent [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1299583:Independent [Finding]
   753   C3463820:Inhibitory [Activity]

Phrase: "and"

Phrase: "function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "(De Waard et al. 1997"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0011198:DE [Geographic Area]
   804   C0017480:DE [Geographic Area]
   804   C3541240:DE [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.348: Our results suggest that both PTX-sensitive and -insensitive G proteins may be involved in calcium current inhibition. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "both PTX-sensitive"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0043167:Pertussis [Disease or Syndrome]
   827   C0332324:Sensitive [Functional Concept]
   827   C1550474:sensitive [Idea or Concept]

Phrase: "and -"

Phrase: "insensitive G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in calcium current inhibition."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0521116:Current [Temporal Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C1705970:Current [Natural Phenomenon or Process]
   760   C2936886:Calcium [Pharmacologic Substance]
   760   C3463820:Inhibition [Activity]
Processing 00000000.tx.349: Facilitation was decreased by dialysis with PTX and abolished by dialysis with GDPS. 

Phrase: "Facilitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "was"

Phrase: "decreased by dialysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0011945:Dialysis [Natural Phenomenon or Process]
   790   C0011946:dialysis [Therapeutic or Preventive Procedure]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   790   C0917873:dialysis [Therapeutic or Preventive Procedure]
   790   C1059964:Dialysis [Eukaryote]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "with PTX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020731:Pertussis Toxin [Amino Acid, Peptide, or Protein,Enzyme,Hazardous or Poisonous Substance]
   861   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   861   C0043167:Pertussis [Disease or Syndrome]

Phrase: "and"

Phrase: "abolished by dialysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011945:Dialysis [Natural Phenomenon or Process]
   790   C0011946:dialysis [Therapeutic or Preventive Procedure]
   790   C0917873:dialysis [Therapeutic or Preventive Procedure]
   790   C1059964:Dialysis [Eukaryote]

Phrase: "with GDPS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018340:GDP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.350: Based on previous reports, Go is a likely candidate for the PTX-sensitive component (Moises et al. 1994; Wiley et al. 1997). 

Phrase: "Based on previous reports,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0205156:Previous [Temporal Concept]
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   770   C1527178:Based [Functional Concept]
   770   C1552607:previous [Temporal Concept]
   770   C1705938:Based [Idea or Concept]
   737 E C0002055:base [Inorganic Chemical]
   737 E C0178499:Base [Chemical Viewed Functionally]
   737 E C1880279:Base [Biomedical or Dental Material]
   737 E C3273238:Report [Intellectual Product]

Phrase: "Go"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "is"

Phrase: "a likely candidate for the PTX-sensitive component"

Phrase: "(Moises et al. 1994"

Phrase: "; Wiley et al. 1997"

Phrase: ")."
Processing 00000000.tx.351: The PTX-insensitive G-protein species mediating tonic inhibition of neuronal calcium channels remains to be characterized. 

Phrase: "The PTX-insensitive G-protein species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1705920:Species [Conceptual Entity]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "tonic inhibition of neuronal calcium channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C1516145:Calcium Channel Inhibition [Cell Function]
   783   C0234074:Neuronal inhibition [Organ or Tissue Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "characterized."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880022:Characterized [Activity]
Processing 00000000.tx.352: The mechanism of facilitation has been proposed to involve a voltage-dependent, transient uncoupling of the G-protein subunit complex from a binding site on the calcium channel (Reuveny et al. 1994; Stanley and Mirotznik 1997). 

Phrase: "The mechanism of facilitation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "involve"

Phrase: "a voltage-dependent, transient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040704:Transient [Population Group]
   827   C0205374:Transient [Temporal Concept]

Phrase: "uncoupling of the G-protein subunit complex"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   800   C1335530:Protein Complex Subunit [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0599220:Protein Subunit [Amino Acid, Peptide, or Protein]
   774 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   774   C1180347:Protein complex [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C1523872:protein complex [Cell Component]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0439267:g% [Quantitative Concept]
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]
   748   C1711351:Subunit [Quantitative Concept]

Phrase: "from a binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005456:Binding Site [Receptor]
  1000   C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Site [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "on the calcium channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(Reuveny et al. 1994"

Phrase: "; Stanley"

Phrase: "and"

Phrase: "Mirotznik 1997"

Phrase: ")."
Processing 00000000.tx.353: The binding site may be close to, or identical with, the location of calcium channel subunit-binding site on the I-II intracytoplasmic loop of the 1 calcium channel subunit (Cens et al. 1998). 

Phrase: "The binding site"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0005456:Binding Site [Receptor]
  1000   C0682969:Binding Site [Amino Acid Sequence]
   861   C0205145:Site [Spatial Concept]
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]
   861   C1515974:Site [Body Location or Region]
   861   C2825164:Site [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "close to,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0587267:Close [Functional Concept]

Phrase: "or"

Phrase: "identical with,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0205280:Identical [Qualitative Concept]

Phrase: "the location of calcium channel subunit-binding site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0450429:Location [Spatial Concept]
   744   C1515974:Location [Body Location or Region]

Phrase: "on the I-II intracytoplasmic loop"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]

Phrase: "of the 1 calcium channel subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1711351:Subunit [Quantitative Concept]

Phrase: "(Cens et al. 1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0338283:CEN [Therapeutic or Preventive Procedure]

Phrase: ")."
Processing 00000000.tx.354: Alterations in the binding characteristics of the subunits involved, whether on the calcium channel or G protein, could explain the changes in calcium current amplitude and facilitation. 

Phrase: "Alterations in the binding characteristics of the subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1515926:Alteration [Idea or Concept]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "whether on the calcium channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0439799:Channel [Spatial Concept]
   760   C1706095:Channel [Conceptual Entity]
   760   C2936886:Calcium [Pharmacologic Substance]

Phrase: "or"

Phrase: "G protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "could"

Phrase: "explain"

Phrase: "the changes in calcium current amplitude"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0025320:The change [Physiologic Function]
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "facilitation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.355: Interest has centered on phosphorylation, particularly by protein kinase C (PKC), as a potential mechanism for modulation of G-protein-calcium channel function. 

Phrase: "Interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0543488:Interest [Mental Process]

Phrase: "has"

Phrase: "centered on phosphorylation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C0205099:centered [Spatial Concept]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "particularly by protein kinase C (PKC),"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   862   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C1259877:kinase c protein [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   797   C1168438:Protein C [Laboratory Procedure]
   797   C1418943:PROTEIN C [Gene or Genome]
   797   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as"

Phrase: "a potential mechanism for modulation of G-protein-calcium channel function."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0441712:Mechanism [Functional Concept]
   738   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.356: Calcium currents are increased by treatment with PKC (Hall et al. 1995a; Sculptoreanu et al. 1995), although it is not clear whether such effects are due to phosphorylation of consensus sites on the channel or on the G protein. 

Phrase: "Calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "increased by treatment"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "with PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Hall et al. 1995a"

Phrase: "; Sculptoreanu et al. 1995"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "whether"

Phrase: "such effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "are due to phosphorylation of consensus sites"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0678226:Due to [Functional Concept]
           due
   757   C1519063:Phosphorylation Site [Amino Acid Sequence]
   757   C2945843:Site of [Qualitative Concept]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C0205145:Sites [Spatial Concept]
   748   C0376298:Consensus [Social Behavior]
   748   C1158886:Phosphorylation [Molecular Function]
   748   C1551058:Are [Quantitative Concept]
   748   C3146286:Due [Idea or Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "on the channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "or on the G protein."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   797 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.357: A recent report indicates that PKC can modulate calcium channels by phosphorylation of two separate sites on the I-II domain of the channel subunit (Hamid et al. 1999). 

Phrase: "A recent report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0684224:Report [Intellectual Product]
   861   C0700287:Report [Health Care Activity]
   861   C3273238:Report [Intellectual Product]

Phrase: "indicates"

Phrase: "that PKC"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "calcium channels by phosphorylation of two separate sites"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0006726:Calcium [Inorganic Chemical]
   744   C2936886:Calcium [Pharmacologic Substance]
   711   C0439799:Channel [Spatial Concept]
   711   C1706095:Channel [Conceptual Entity]

Phrase: "on the I-II domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of the channel subunit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1711351:Subunit [Quantitative Concept]

Phrase: "(Hamid et al. 1999"

Phrase: ")."
Processing 00000000.tx.358: Mutation of one site abolished the ability of PKC to increase calcium currents but had no effect on G-protein-mediated inhibition, whereas mutation of a separate site on the channel prevented G-protein-mediated inhibition of calcium currents. 

Phrase: "Mutation of one site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0026882:Mutation [Genetic Function]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "abolished"

Phrase: "the ability of PKC to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0085732:Ability [Organism Attribute]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521116:currents [Temporal Concept]
   827 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "but"

Phrase: "had"

Phrase: "no effect on G-protein-mediated inhibition,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "whereas"

Phrase: "mutation of a separate site"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0026882:Mutation [Genetic Function]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on the channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "G-protein-mediated inhibition of calcium currents."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]
Processing 00000000.tx.359: Our results indicate that increased calcium current density in diabetic neuropathy is associated with a relative decrease in the ability of G proteins to inhibit channels. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that increased calcium current density in diabetic neuropathy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0029053:Increased density [Finding]
   744   C0178587:density [Quantitative Concept]

Phrase: "is"

Phrase: "associated with a relative decrease"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the ability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085732:Ability [Organism Attribute]
   928 E C1299581:Able [Finding]

Phrase: "of G proteins to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439799:Channel [Spatial Concept]
   966   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.360: This effect appears to be reversible. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "reversible."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]
Processing 00000000.tx.361: G-protein-mediated modulation of channels could be decreased in diabetes by PKC-mediated phosphorylation of the G-protein-associated site on the calcium channel (Hamid et al. 1999) or the G proteins themselves (Katada et al. 1985). 

Phrase: "G-protein-mediated modulation of channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "could"

Phrase: "be"

Phrase: "decreased in diabetes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "by PKC-mediated phosphorylation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   804   C0031715:Phosphorylation [Molecular Function]
   717   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "of the G-protein-associated site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "on the calcium channel"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C0439799:Channel [Spatial Concept]
   861   C1706095:Channel [Conceptual Entity]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(Hamid et al. 1999"

Phrase: ")"

Phrase: "or"

Phrase: "the G proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439267:g% [Quantitative Concept]

Phrase: "themselves"

Phrase: "(Katada et al. 1985"

Phrase: ")."
Processing 00000000.tx.362: Increased phosphorylation of the PTX-sensitive Gi2 subunit has been reported in hepatocytes of STZ-induced diabetic rats (Morris et al. 1996); 

Phrase: "Increased phosphorylation of the PTX-sensitive Gi2 subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1158886:Phosphorylation [Molecular Function]

Phrase: "has"

Phrase: "been"

Phrase: "reported in hepatocytes of STZ-induced diabetic rats"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   744   C0034693:rats [Mammal]
   744   C0034721:Rats [Mammal]
   744   C0038432:Streptozotocin [Antibiotic,Carbohydrate]
   744   C0205263:Induced [Functional Concept]
   744   C0227525:Hepatocytes [Cell]
   744   C0241863:DIABETIC [Finding]
   744   C0684224:Reported [Intellectual Product]
   744   C0700287:Reported [Health Care Activity]
   744   C3496591:Reported [Clinical Attribute]
   711 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
   711 E C3273238:Report [Intellectual Product]

Phrase: "(Morris et al. 1996"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.363: however, it remains to be seen whether the Go-subtype coupled to opiate receptors in DRG neurons is similarly affected. 

Phrase: "however,"

Phrase: "it"

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "whether"

Phrase: "the"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "subtype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449560:Subtype [Classification]

Phrase: "coupled to opiate receptors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0034801:Receptors, Opiate [Amino Acid, Peptide, or Protein,Receptor]
   770   C0376196:Opiate [Hazardous or Poisonous Substance,Pharmacologic Substance]
   770   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   770   C1948027:Coupled [Functional Concept]
   737 E C0010222:couple [Family Group]

Phrase: "in DRG neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "is"

Phrase: "similarly"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.364: We favor the interpretation that the enhancement in calcium influx in diabetes (Hall et al. 1995b,1996; Levy et al. 1994) is pathophysiologic rather than compensatory. 

Phrase: "We"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the interpretation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0459471:Interpretation [Intellectual Product]
  1000   C3173575:Interpretation [Clinical Attribute]

Phrase: "that"

Phrase: "the enhancement in calcium influx"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   760   C2349975:Enhancement [Activity]

Phrase: "in diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]

Phrase: "(Hall et al. 1995b,"

Phrase: "1996"

Phrase: "; Levy et al. 1994"

Phrase: ")"

Phrase: "is"

Phrase: "pathophysiologic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C0031847:pathophysiology [Functional Concept]
   928   C0277785:Pathophysiology [Qualitative Concept]

Phrase: "rather than"

Phrase: "compensatory."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231186:Compensatory [Functional Concept]
Processing 00000000.tx.365: The calcium "set point" hypothesis (Orrenius and Nicotera 1994) suggests that modest changes in cytosolic calcium ([Ca2+]i) over prolonged periods may be injurious. 

Phrase: "The calcium ""set point"" hypothesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1512571:Hypothesis [Idea or Concept]
   756   C0429672:Calcium set point [Finding]

Phrase: "(Orrenius"

Phrase: "and"

Phrase: "Nicotera 1994"

Phrase: ")"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that modest changes in cytosolic calcium ([Ca2+]i)"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "over prolonged periods"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0425945:Prolonged periods [Finding]
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   777 E C0332182:Periodic [Temporal Concept]
   777 E C1706381:PERIODIC [Intellectual Product]
   755 E C0031084:Periodicities [Temporal Concept]

Phrase: "may"

Phrase: "be"

Phrase: "injurious."
Processing 00000000.tx.366: Our previous studies demonstrated that the magnitude of enhancement increased with diabetic duration and was correlated with increasing impairment in nerve conduction velocity (Hall et al. 1995b). 

Phrase: "Our previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the magnitude of enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449286:magnitude [Quantitative Concept]
   770   C1704240:Magnitude [Quantitative Concept]

Phrase: "increased with diabetic duration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205217:Increased [Quantitative Concept]
   770   C0241863:DIABETIC [Finding]
   770   C0442805:Increased [Functional Concept]
   770   C0449238:Duration [Temporal Concept]
   770   C2926735:Duration [Pharmacologic Substance]

Phrase: "and"

Phrase: "was"

Phrase: "correlated with increasing impairment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442808:Increasing [Functional Concept]
   770   C0684336:Impairment [Pathologic Function]
   770   C1707520:Correlated [Qualitative Concept]

Phrase: "in nerve conduction velocity"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
  1000   C0429381:Nerve conduction velocity [Finding]
  1000   C2982003:Nerve Conduction Velocity [Diagnostic Procedure]
   901   C0027788:Nerve Conduction [Organ or Tissue Function]
   901   C0234084:Conduction velocity [Organ or Tissue Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0232217:Conduction [Organ or Tissue Function]
   827   C0439830:Velocity [Quantitative Concept]
   827   C0457405:Conduction [Natural Phenomenon or Process]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1547053:*Velocity [Quantitative Concept]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "(Hall et al. 1995b"

Phrase: ")."
Processing 00000000.tx.367: Treatment of new onset BB/W diabetic animals with long-term administration of an aldose reductase inhibitor was associated with normalization of nerve conduction velocity and neuronal calcium influx despite persistent hyperglycemia. 

Phrase: "Treatment of new onset BB/W diabetic animals"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: "with long-term administration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001554:Administration [Occupational Activity]
   827   C1533734:Administration [Therapeutic or Preventive Procedure]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "of an aldose reductase inhibitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2348243:Aldose Reductase Inhibitor [Pharmacologic Substance]
   901   C0002003:Aldose Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1412322:ALDOSE REDUCTASE [Gene or Genome]
   827   C0030016:Reductase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0682934:Aldose [Carbohydrate]
   827   C1999216:Inhibitor [Qualitative Concept]

Phrase: "was"

Phrase: "associated with normalization of nerve conduction velocity"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   814   C0429381:Nerve conduction velocity [Finding]
   814   C2982003:Nerve Conduction Velocity [Diagnostic Procedure]
   778   C0027788:Nerve Conduction [Organ or Tissue Function]
   778   C0234084:Conduction velocity [Organ or Tissue Function]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0027740:Nerve [Tissue]
   748   C0027757:NERVE [Tissue]
   748   C0232217:Conduction [Organ or Tissue Function]
   748   C0439830:Velocity [Quantitative Concept]
   748   C0457405:Conduction [Natural Phenomenon or Process]
   748   C1280541:Nerve [Body Part, Organ, or Organ Component]
   748   C1547053:*Velocity [Quantitative Concept]
   748   C1882115:Normalization [Research Activity]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "neuronal calcium influx despite persistent hyperglycemia."
Processing 00000000.tx.368: Exposure to diabetic serum is associated with elevated calcium influx and increased programmed, apoptotic cell death (Prittinger et al. 1998; Srinivasan et al. 1998), both of which can be prevented by short-term treatment with calcium channel antagonists (Srinivasan et al. 1998). 

Phrase: "Exposure to diabetic serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "is"

Phrase: "associated with elevated calcium influx"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0006726:Calcium [Inorganic Chemical]
   760   C0205250:Elevated [Qualitative Concept]
   760   C2936886:Calcium [Pharmacologic Substance]
   760   C3163633:Elevated [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "programmed, apoptotic cell death"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0162638:Programmed Cell Death [Cell Function]
           apoptotic cell death
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "(Prittinger et al. 1998"

Phrase: "; Srinivasan et al. 1998"

Phrase: ")"

Phrase: ","

Phrase: "both of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0238767:Both [Spatial Concept]
   790   C1706086:Both [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "prevented by short-term treatment"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   806   C0443303:Short-term [Temporal Concept]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1282927:short [Qualitative Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C1705313:Term [Idea or Concept]
   760   C1806781:Short [Quantitative Concept]
   760   C2350002:Short [Quantitative Concept]
   760   C2826302:TERM [Intellectual Product]
   760   C3538994:TREATMENT [Research Activity]
   726   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "with calcium channel antagonists"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C2757014:Calcium Channel Antagonists [Molecular Function]
   901   C0006685:Calcium Channel [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   896   C0006684:calcium antagonist [Pharmacologic Substance]
   827   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0006726:Calcium [Inorganic Chemical]
   827   C0243076:antagonists [Chemical Viewed Functionally]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
   827   C2936886:Calcium [Pharmacologic Substance]
   793 E C0231491:Antagonist [Organ or Tissue Function]
   721 E C0680242:antagonism [Social Behavior]

Phrase: "(Srinivasan et al. 1998"

Phrase: ")."
Processing 00000000.tx.369: In addition, treatment with diabetic serum increased calcium current density and decreased facilitation in nondiabetic neurons in a manner similar to that reported in this study (Ristic et al. 1998). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "treatment with diabetic serum"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "calcium current density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0178587:density [Quantitative Concept]
   755 E C0439794:Dense [Qualitative Concept]

Phrase: "and"

Phrase: "decreased facilitation in nondiabetic neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "in a manner"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "reported in this study"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   802   C1317750:Study report [Intellectual Product]
   802   C1831145:Study report [Clinical Attribute]
   770   C0557651:Study [Manufactured Object]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C2603343:Study [Research Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(Ristic et al. 1998"

Phrase: ")."
Processing 00000000.tx.370: This suggests that autoimmune factors in serum may be the underlying cause of abnormal calcium signaling in diabetes. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that autoimmune factors in serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   824   C0104699:autoimmune serum factor [Amino Acid, Peptide, or Protein]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "the underlying cause of abnormal calcium signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.371: In summary, the results of this study suggest that the function of the inhibitory G-protein-calcium channel complex is impaired in diabetes, providing one explanation for the abnormal calcium signaling described previously (Biessels and Gispen 1996; Hall et al. 1995b, 1996; Levy et al. 1994). 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the results of this study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0683954:results study [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the function of the inhibitory G-protein-calcium channel complex"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   777   C1153433:Calcium channel, function [Molecular Function]
   757   C0815043:function protein [Amino Acid, Peptide, or Protein]
   757   C1527118:Protein Function [Molecular Function]
   739   C0031843:function [Physiologic Function]
   739   C0542341:Function [Functional Concept]
   739   C0700205:FUNCTION [Classification]
   739   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "impaired in diabetes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0011847:Diabetes [Disease or Syndrome]
   790   C0011849:Diabetes [Disease or Syndrome]
   790   C0221099:Impaired [Functional Concept]
   790   C0684336:Impaired [Pathologic Function]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "one explanation for the abnormal calcium signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(Biessels"

Phrase: "and"

Phrase: "Gispen 1996"

Phrase: "; Hall et al. 1995b,"

Phrase: "1996"

Phrase: "; Levy et al. 1994"

Phrase: ")."
Processing 00000000.tx.372: Altered G-protein function in diabetes was not due to a relative decrease in expression of PTX-sensitive inhibitory G proteins (Gi/o), and the functional changes were reversible, as maximal (or near-maximal) activation of G proteins by GTPS resulted in equivalent enhancement of inhibitory G-protein function in neurons from both control and diabetic animals. 

Phrase: "Altered G-protein function in diabetes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0815043:protein function [Amino Acid, Peptide, or Protein]
   790   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "was"

Phrase: "not due to a relative decrease"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0678226:Due to [Functional Concept]
           due
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]
   753   C1518422:Not [Functional Concept]
   753   C1547039:*Relative [Quantitative Concept]
   753   C3146286:Due [Idea or Concept]

Phrase: "in expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "of PTX-sensitive inhibitory G proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0086376:G-Proteins [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1415142:INHIBITORY G PROTEIN [Gene or Genome]
   799   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0439267:g% [Quantitative Concept]
   799   C3463820:Inhibitory [Activity]

Phrase: "(Gi/o"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the functional changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0205245:Functional [Functional Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "reversible,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205343:Reversible [Functional Concept]
   928 E C0449261:Reversibility [Temporal Concept]

Phrase: "as"

Phrase: "maximal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205289:Maximal [Qualitative Concept]
  1000   C0806909:Maximal [Quantitative Concept]
   928 E C1552615:maximum [Quantitative Concept]
   928 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: "("

Phrase: "or"

Phrase: "near-maximal"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205289:Maximal [Qualitative Concept]
   861   C0806909:Maximal [Quantitative Concept]
   789 E C1552615:maximum [Quantitative Concept]
   789 E C2826546:MAXIMUM [Quantitative Concept]

Phrase: ")"

Phrase: "activation of G proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0599177:protein activation [Genetic Function]
   770   C1879547:Activation [Activity]

Phrase: "by GTPS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "resulted in equivalent enhancement of inhibitory G-protein function"
Meta Candidates (Total=20; Excluded=1; Pruned=0; Remaining=19)
   790   C0086706:inhibitory G-protein [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1415142:INHIBITORY G PROTEIN [Gene or Genome]
   764   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0815043:protein function [Amino Acid, Peptide, or Protein]
   764   C1527118:Protein Function [Molecular Function]
   762 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   742   C0031843:function [Physiologic Function]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0439185:equivalent [Quantitative Concept]
   742   C0439267:g% [Quantitative Concept]
   742   C0542341:Function [Functional Concept]
   742   C0700205:FUNCTION [Classification]
   742   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   742   C1705273:Function [Intellectual Product]
   742   C2349975:Enhancement [Activity]
   742   C3463820:Inhibitory [Activity]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "from both control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "diabetic animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.373: This study indicates that a significant impairment in GTPase function is the likely explanation for the decreased efficacy of opiate-mediated inhibition in diabetes.  

Phrase: "This study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "indicates"

Phrase: "that"

Phrase: "a significant impairment in GTPase function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "is"

Phrase: "the likely explanation for the decreased efficacy of opiate-mediated inhibition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0681841:Explanation [Intellectual Product]

Phrase: "in diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011847:Diabetes [Disease or Syndrome]
  1000   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.374: ACKNOWLEDGMENTS We thank B.

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.375: Dzwonek, H.Sheng, A.Merry, and H.Ristic for expert technical assistance. 

Phrase: "Dzwonek,"

Phrase: "H.Sheng,"

Phrase: "A.Merry,"

Phrase: "and"

Phrase: "H.Ristic for expert technical assistance."
Processing 00000000.tx.376: These studies were supported by a Michigan Peptide Research Center Pilot Feasibility Award and Juvenile Diabetes International Research Award 195036to K.E.Hall, a Veterans Affairs Merit Award, University of Michigan Diabetes Research and Training Center Pilot Feasibility Award to J.W.Wiley, and National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-45820-01 (J.W.Wiley) and DK-43884 (A.A.F. Sima).  

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "supported by a Michigan Peptide Research Center Pilot Feasibility Award"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   760   C0683939:research center [Manufactured Object,Organization]
   757   C0035176:research supported [Quantitative Concept]
   739   C0004446:Award [Manufactured Object]
   739   C0025939:Michigan [Geographic Area]
   739   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   739   C0035168:research [Research Activity]
   739   C0205099:Center [Spatial Concept]
   739   C0242481:Research [Research Activity]
   739   C0473169:Pilot [Professional or Occupational Group]
   739   C1414316:PILOT [Gene or Genome]
   739   C1521721:Supported [Conceptual Entity]
   706 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "Juvenile Diabetes International Research Award 195036to K.E.Hall,"

Phrase: "a Veterans Affairs Merit Award,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0004446:Award [Manufactured Object]

Phrase: "University of Michigan Diabetes Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]

Phrase: "and"

Phrase: "Training Center Pilot Feasibility Award to J.W.Wiley,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0004446:Award [Manufactured Object]

Phrase: "and"

Phrase: "National Institute of Diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021622:institute [Organization]
   770   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases Grants DK-45820-01"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   827   C0022658:Kidney Diseases [Disease or Syndrome]
   799   C0011318:DK [Geographic Area]
   799   C0012634:Diseases [Disease or Syndrome]
   799   C0018173:Grants [Quantitative Concept]
   799   C0022646:Kidney [Body Part, Organ, or Organ Component]
   799   C0227665:kidney [Body Part, Organ, or Organ Component]
   799   C1278978:Kidney [Body Part, Organ, or Organ Component]
   799   C1514845:KIDNEY [Tissue]
   766 E C1548284:Grant [Idea or Concept]
   727 E C1836721:MALS [Finding]
   727 E C3538764:MALS [Gene or Genome]
   727 E C3540595:MAL [Gene or Genome]
   706 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "(J.W.Wiley"

Phrase: ")"

Phrase: "and"

Phrase: "DK-43884"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "(A.A.F. Sima"

Phrase: ")."
Processing 00000000.tx.377: FOOTNOTES Address for reprint requests: K.E.Hall, VA Medical Center, GRECC 11G, D-318, Ann Arbor, MI 48105(E-mail: kehall{at}umich.edu ). 

Phrase: "FOOTNOTES Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "K.E.Hall,"

Phrase: "VA Medical Center,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0565990:Medical center [Health Care Related Organization,Manufactured Object]
   901   C1552471:Medical Center [Health Care Related Organization,Manufactured Object]
   827   C0205099:Center [Spatial Concept]
   827   C0205476:Medical [Functional Concept]

Phrase: "GRECC 11G,"

Phrase: "D-"

Phrase: "318,"

Phrase: "Ann Arbor,"

Phrase: "MI 48105"

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "kehall{at}umich.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.378: Received 6 November 2000; 

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "6 November 2000"

Phrase: ";"
Processing 00000000.tx.379: accepted in final form 2 May 2001.  

Phrase: "accepted in final form 2 May 2001."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205088:Final [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.380: REFERENCES TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION REFERENCES Bean BP. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557061:Discussion [Therapeutic or Preventive Procedure]
   799   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Bean BP."
Processing 00000000.tx.381: Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. 

Phrase: "Neurotransmitter inhibition of neuronal calcium currents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0234074:Neuronal inhibition [Organ or Tissue Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "by changes in channel voltage dependence."
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   804   C0011546:Dependence [Mental Process]
   804   C0439857:Dependence [Mental or Behavioral Dysfunction]
   804   C0598352:Voltage [Quantitative Concept]
   804   C2698668:DEPENDENCE [Regulation or Law]
   733 E C0851827:Dependent [Qualitative Concept]
   733 E C1701901:Dependent [Qualitative Concept]
   733 E C3244310:dependent [Functional Concept]
   704 E C1546937:Dependency [Idea or Concept]
Processing 00000000.tx.382: Nature 340: 153-156, 1989[ISI][Medline]. 

Phrase: "Nature 340"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "153-156,"

Phrase: "1989"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.383: Biessels G, and Gispen WH. 

Phrase: "Biessels G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Gispen WH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349143:Wh [Quantitative Concept]
Processing 00000000.tx.384: The calcium hypothesis of brain aging and neurodegenerative disorders: significance in diabetic neuropathy. 

Phrase: "The calcium hypothesis of brain aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1512571:Hypothesis [Idea or Concept]

Phrase: "and"

Phrase: "neurodegenerative disorders"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
  1000   C1522560:Neurodegenerative Disorders [Functional Concept]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: ":"

Phrase: "significance in diabetic neuropathy."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237881:Significance [Quantitative Concept]
   770   C0750502:Significance [Idea or Concept]
Processing 00000000.tx.385: Life Sci 59: 379-387, 1996[ISI][Medline]. 

Phrase: "Life Sci 59"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0376558:Life [Idea or Concept]
   827   C3642273:SCI [Professional or Occupational Group]
   743 E C0595998:lives [Finding]

Phrase: ":"

Phrase: "379-387,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.386: Cens T, Restituito S, Vallentin A, and Charnet P. 

Phrase: "Cens T,"

Phrase: "Restituito S,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "Vallentin A,"

Phrase: "and"

Phrase: "Charnet P."
Processing 00000000.tx.387: Promotion and inhibition of L-type Ca2+ channel facilitation by distinct domains of the subunit. 

Phrase: "Promotion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promotion [Activity]

Phrase: "and"

Phrase: "inhibition of L-type Ca2+ channel facilitation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by distinct domains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1880389:Domain [Functional Concept]
   827   C1883221:Domain [Conceptual Entity]
   827   C3541951:Domain [Intellectual Product]

Phrase: "of the subunit."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.388: J Biol Chem 273: 18308-18315, 1998[Abstract/Free FullText]. 

Phrase: "J Biol Chem 273"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "18308-18315,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.389: De Waard M, Liu H, Walker D, Scott VES, Gurnett CA, and Campbell KP. 

Phrase: "De Waard M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Liu H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Walker D,"

Phrase: "Scott VES,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042584:VES [Disease or Syndrome]

Phrase: "Gurnett CA,"

Phrase: "and"

Phrase: "Campbell KP."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022772:KP [Geographic Area]
   861   C1881334:kp [Quantitative Concept]
Processing 00000000.tx.390: Direct binding of G-protein complex to voltage-dependent calcium channels. 

Phrase: "Direct binding of G-protein complex"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   820   C1819317:protein complex binding [Molecular Function]
   783   C0033618:Protein Binding [Molecular Function]
   783   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to voltage-dependent calcium channels."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0006685:Voltage-Dependent Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Calcium Channels
   812   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006726:Calcium [Inorganic Chemical]
   812   C0598352:Voltage [Quantitative Concept]
   812   C0851827:Dependent [Qualitative Concept]
   812   C1701901:Dependent [Qualitative Concept]
   812   C2936886:Calcium [Pharmacologic Substance]
   812   C3244310:dependent [Functional Concept]
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.391: Nature 385: 446-450, 1997[ISI][Medline]. 

Phrase: "Nature 385"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "446-450,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.392: Dolphin AC. 

Phrase: "Dolphin AC."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]
Processing 00000000.tx.393: Facilitation of Ca2+ current in excitable cells. 

Phrase: "Facilitation of Ca2+ current"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "in excitable cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.394: Trends Neurosci 19: 35-43, 1996[ISI][Medline]. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci 19"

Phrase: ":"

Phrase: "35-43,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.395: Doupnik CA, and Pun RYK. 

Phrase: "Doupnik CA,"

Phrase: "and"

Phrase: "Pun RYK."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0215512:RYK [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1335655:RYK [Gene or Genome]
Processing 00000000.tx.396: G-protein activation mediates prepulse facilitation of Ca2+ channel currents in bovine chromaffin cells. 

Phrase: "G-protein activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599177:protein activation [Genetic Function]
   827   C1879547:Activation [Activity]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "prepulse facilitation of Ca2+ channel currents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "in bovine chromaffin cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0376604:Chromaffin Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.397: J Membr Biol 140: 47-56, 1994[ISI][Medline]. 

Phrase: "J Membr Biol 140"

Phrase: ":"

Phrase: "47-56,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.398: Garcia DE, Li B, Garcia-Ferreiro RE, Hernandez-Ochoa EO, Yan K, Gautam N, Catterall WA, Mackie K, and Hille B. 

Phrase: "Garcia DE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011198:DE [Geographic Area]
   861   C0017480:DE [Geographic Area]
   861   C3541240:DE [Idea or Concept]

Phrase: "Li B,"

Phrase: "Garcia-Ferreiro RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2986904:RE [Idea or Concept]

Phrase: "Hernandez-Ochoa EO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:EO [Functional Concept]

Phrase: "Yan K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Gautam N,"

Phrase: "Catterall WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043038:WA [Geographic Area]

Phrase: "Mackie K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Hille B."
Processing 00000000.tx.399: G-protein beta-subunit specificity in the fast membrane-delimited inhibition of Ca2+ channels. 

Phrase: "G-protein beta-subunit specificity in the fast membrane-delimited inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0037791:Specificity [Quantitative Concept]
   738   C1511884:Specificity [Quantitative Concept]

Phrase: "of Ca2+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.400: J Neurosci 18: 9163-9170, 1998[Abstract/Free FullText]. 

Phrase: "J Neurosci 18"

Phrase: ":"

Phrase: "9163-9170,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.401: Greene DA, Sima AA, Stevens MJ, Feldman EL, and Lattimer SA. 

Phrase: "Greene DA,"

Phrase: "Sima AA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1235746:Aa [Plant]
   861   C1882141:aa [Qualitative Concept]

Phrase: "Stevens MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Feldman EL,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416870:EL [Gene or Genome]
   861   C1823249:EL [Gene or Genome]

Phrase: "and"

Phrase: "Lattimer SA."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]
Processing 00000000.tx.402: Complications: neuropathy, pathogenetic considerations. 

Phrase: "Complications"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0009566:Complications [Pathologic Function]
  1000   C1171258:complications [Pathologic Function]
   966 E C2362589:Complication [Idea or Concept]
   916 E C0231242:Complicated [Functional Concept]

Phrase: ":"

Phrase: "neuropathy,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "pathogenetic considerations."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0518609:considerations [Finding]
Processing 00000000.tx.403: Diabetes Care 15: 1902-1925, 1992[Abstract]. 

Phrase: "Diabetes Care 15"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C1947933:Care [Activity]

Phrase: ":"

Phrase: "1902-1925,"

Phrase: "1992"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.404: Hall KE, Browning MD, Dudek EM, and Macdonald RL. 

Phrase: "Hall KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Browning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "MD,"

Phrase: "Dudek EM,"

Phrase: "and"

Phrase: "Macdonald RL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]
Processing 00000000.tx.405: Enhancement of high threshold calcium currents in rat primary afferent neurons by constitutively active protein kinase C. 

Phrase: "Enhancement of high threshold calcium currents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "in rat primary afferent neurons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   906   C2325162:Primary afferent neuron [Cell]
   861   C0027883:Neurons, Afferent [Cell]
   861   C0682680:primary afferent [Cell Component]
   812   C0027882:Neurons [Cell]
   812   C0205115:Afferent [Spatial Concept]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "by constitutively active protein kinase C."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   853   C1168438:Protein C [Laboratory Procedure]
   853   C1418943:PROTEIN C [Gene or Genome]
   853   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.406: J Neurosci 15: 6069-6076, 1995a[Abstract]. 

Phrase: "J Neurosci 15"

Phrase: ":"

Phrase: "6069-6076,"

Phrase: "1995a"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.407: Hall KE, Sima AAF, and Wiley J. 

Phrase: "Hall KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "Wiley J."
Processing 00000000.tx.408: Voltage-dependent calcium currents are enhanced in rat dorsal root ganglion neurones from the Bio/Bred Worchester diabetic rat. 

Phrase: "Voltage-dependent calcium currents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "are"

Phrase: "enhanced in rat dorsal root ganglion neurones"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   814   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   814   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   778   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   778   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   748   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   748   C0034693:Rat, NOS [Mammal]
   748   C0034721:Rat [Mammal]
   748   C0040452:Root [Body Part, Organ, or Organ Component]
   748   C0205095:Dorsal [Spatial Concept]
   748   C0242726:Root [Plant]
   748   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   748   C1318154:Root [Body Part, Organ, or Organ Component]
   748   C1705917:Root [Idea or Concept]
   748   C2349975:Enhanced [Activity]
   714   C0027882:Neurone [Cell]

Phrase: "from the Bio/Bred Worchester diabetic rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0034693:Rat, NOS [Mammal]
   804   C0034721:Rat [Mammal]
   804   C0241863:DIABETIC [Finding]
Processing 00000000.tx.409: J Physiol (Lond) 486: 313-322, 1995b[Abstract]. 

Phrase: "J Physiol"

Phrase: "(Lond) 486"

Phrase: ":"

Phrase: "313-322,"

Phrase: "1995b"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.410: Hall KE, Sima AAF, and Wiley JW. 

Phrase: "Hall KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "Wiley JW."
Processing 00000000.tx.411: Opiate-mediated inhibition of calcium signaling is decreased in DRG neurons from the diabetic BB/W rat. 

Phrase: "Opiate-mediated inhibition of calcium signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   895   C2259037:inhibition of calcium-mediated signaling [Organism Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "is"

Phrase: "decreased in DRG neurons"
Meta Candidates (Total=17; Excluded=1; Pruned=0; Remaining=16)
   833   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
           Dorsal Root
   833   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   790   C0205955:Dorsal root [Body Part, Organ, or Organ Component]
   790   C1186181:root ganglion [Body Part, Organ, or Organ Component]
   753   C0017067:Ganglion [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0040452:Root [Body Part, Organ, or Organ Component]
   753   C0205095:Dorsal [Spatial Concept]
   753   C0205216:Decreased [Quantitative Concept]
   753   C0242726:Root [Plant]
   753   C0392756:Decreased [Qualitative Concept]
   753   C0442797:decreased [Qualitative Concept]
   753   C1258666:Ganglion, NOS [Acquired Abnormality,Disease or Syndrome]
   753   C1318154:Root [Body Part, Organ, or Organ Component]
   753   C1705917:Root [Idea or Concept]
   719 E C0547047:Decrease [Quantitative Concept]

Phrase: "from the diabetic BB/W rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
Processing 00000000.tx.412: J Clin Invest 97: 1165-1172, 1996[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ":"

Phrase: "1165-1172,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.413: Hamid J, Nelson D, Spaetgens R, Dubel SJ, Snutch TP, and Zamponi GW. 

Phrase: "Hamid J,"

Phrase: "Nelson D,"

Phrase: "Spaetgens R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Dubel SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Snutch TP,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0232117:PULSE [Clinical Attribute]
   827   C0391850:Pulse [Physiologic Function]
   827   C1947910:Pulse [Phenomenon or Process]
   743 E C0034107:Pulses [Health Care Activity]

Phrase: "and"

Phrase: "Zamponi GW."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018387:GW [Geographic Area]
Processing 00000000.tx.414: Identification of an integration center for cross-talk between protein kinase C and G protein modulation of N-type calcium channels. 

Phrase: "Identification of an integration center"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "for cross-talk"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0010357:Crosstalk [Molecular Function]
  1000   C2986468:Cross-talk [Cell Function]
   861   C0037817:Talk [Organism Function]
   861   C0234856:talk [Daily or Recreational Activity]
   861   C0600118:talk [Finding]
   861   C2828360:Cross [Conceptual Entity]

Phrase: "between protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "G protein modulation of N-type calcium channels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443264:Modulation [Spatial Concept]
Processing 00000000.tx.415: J Biol Chem 274: 6195-6202, 1999[Abstract/Free FullText]. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "6195-6202,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.416: Ikeda SR. 

Phrase: "Ikeda SR."
Processing 00000000.tx.417: Double-pulse calcium channel current facilitation in adult rat sympathetic neurons. 

Phrase: "Double-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "pulse calcium channel current facilitation in adult rat sympathetic neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0234112:Facilitation [Organ or Tissue Function]
Processing 00000000.tx.418: J Physiol (Lond) 439: 181-214, 1991[Abstract]. 

Phrase: "J Physiol"

Phrase: "(Lond) 439"

Phrase: ":"

Phrase: "181-214,"

Phrase: "1991"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.419: Katada T, Gilman AG, Watanabe Y, Bauer S, and Jakobs KH. 

Phrase: "Katada T,"

Phrase: "Gilman AG,"

Phrase: "Watanabe Y,"

Phrase: "Bauer S,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "Jakobs KH."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006797:KH [Geographic Area]
Processing 00000000.tx.420: Protein kinase C phosphorylates the inhibitory guanine-nucleotide-binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase. 

Phrase: "Protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "phosphorylates"

Phrase: "the inhibitory guanine-nucleotide-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0018328:guanine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0018321:Guanine [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "regulatory component"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449432:Component [Manufactured Object]
   861   C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750541:apparently [Idea or Concept]

Phrase: "suppresses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:suppress [Functional Concept]

Phrase: "its function in hormonal inhibition of adenylate cyclase."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0021469:Inhibition, function [Molecular Function]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]
Processing 00000000.tx.421: Eur J Biochem 151: 431-437, 1985[Abstract]. 

Phrase: "Eur J Biochem 151"

Phrase: ":"

Phrase: "431-437,"

Phrase: "1985"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.422: Kostyuk E, Svichar N, Shishkin V, and Kostyuk P. 

Phrase: "Kostyuk E,"

Phrase: "Svichar N,"

Phrase: "Shishkin V,"

Phrase: "and"

Phrase: "Kostyuk P."
Processing 00000000.tx.423: Role of mitochondrial dysfunction in calcium signalling alterations in dorsal root ganglion neurons of mice with experimentally-induced diabetes. 

Phrase: "Role of mitochondrial dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in calcium signalling alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1515926:Alteration [Idea or Concept]
   734   C0600431:calcium signalling [Cell Function]

Phrase: "in dorsal root ganglion neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0027882:Neurons [Cell]
   756   C0017070:Dorsal Root Ganglion [Body Part, Organ, or Organ Component]
   756   C1761610:Dorsal root ganglion [Body Part, Organ, or Organ Component]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "of mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mice [Mammal]
  1000   C0025929:mice [Mammal]
  1000   C0026809:Mice [Mammal]

Phrase: "with experimentally-induced diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.424: Neuroscience 90: 535-541, 1999[ISI][Medline]. 

Phrase: "Neuroscience 90"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "535-541,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.425: Levy J, Gavin JR III, and Sowers JR. 

Phrase: "Levy J,"

Phrase: "Gavin JR III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "Sowers JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.426: Diabetes mellitus: a disease of abnormal cellular calcium metabolism. 

Phrase: "Diabetes mellitus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011849:Diabetes Mellitus [Disease or Syndrome]
           Diabetes
   861   C0011847:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "a disease of abnormal cellular calcium metabolism."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.427: Am J Med 96: 260-273, 1994[ISI][Medline]. 

Phrase: "Am"

Phrase: "J Med 96"

Phrase: ":"

Phrase: "260-273,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.428: Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. 

Phrase: "Lowry OH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "Rosebrough NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Farr AL,"

Phrase: "and"

Phrase: "Randall RJ."
Processing 00000000.tx.429: Protein measurement with the Folin phenol reagent. 

Phrase: "Protein measurement with the Folin phenol reagent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0202202:Protein measurement [Laboratory Procedure]
   774   C0202446:Phenol measurement [Laboratory Procedure]
   748   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.430: J Biol Chem 193: 265-275, 1951[Free FullText]. 

Phrase: "J Biol Chem 193"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "265-275,"

Phrase: "1951"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.431: Mendenhall W. 

Phrase: "Mendenhall W."
Processing 00000000.tx.432: Introduction to Probability and Statistics (4th ed.)., North Scltuate, MA: Duxbury, 1975, p. 

Phrase: "Introduction to Probability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1293116:Introduction [Health Care Activity]
   790   C1875307:INTRODUCTION [Manufactured Object]

Phrase: "and"

Phrase: "Statistics"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]

Phrase: "(4th ed.).,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538926:ED [Idea or Concept]

Phrase: "North Scltuate,"

Phrase: "MA"

Phrase: ":"

Phrase: "Duxbury,"

Phrase: "1975,"

Phrase: "p."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.433: 214-217. 

Phrase: "214-217."
Processing 00000000.tx.434: Moises HC, Rusin KI, and Macdonald RL. 

Phrase: "Moises HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Rusin KI,"

Phrase: "and"

Phrase: "Macdonald RL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]
Processing 00000000.tx.435: Mu-opioid receptor-mediated reduction of neuronal calcium current occurs via a Go-type GTP binding protein. 

Phrase: "Mu-opioid receptor-mediated reduction of neuronal calcium current"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0301630:Reduction [Natural Phenomenon or Process]
   742   C0392756:Reduction [Qualitative Concept]
   742   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "occurs via a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "type GTP binding protein."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0086376:GTP-Binding Protein [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1427594:GTP-binding protein [Gene or Genome]
   861   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1149035:GTP Binding [Molecular Function]
   812   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]
Processing 00000000.tx.436: J Neurosci 14: 3842-3851, 1994[Abstract]. 

Phrase: "J Neurosci 14"

Phrase: ":"

Phrase: "3842-3851,"

Phrase: "1994"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.437: Morris NJ, Bushfield M, Lavan BE, and Houslay MD. 

Phrase: "Morris NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Bushfield M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lavan"

Phrase: "BE"

Phrase: ","

Phrase: "and"

Phrase: "Houslay MD."
Processing 00000000.tx.438: Streptozotocin-induced diabetes elicits the phosphorylation of hepatocyte Gi2 at the protein kinase C but not at the protein kinase A-controlled site. 

Phrase: "Streptozotocin-induced diabetes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0038433:Streptozotocin Diabetes [Experimental Model of Disease]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]

Phrase: "elicits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicit [Qualitative Concept]

Phrase: "the phosphorylation of hepatocyte Gi2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "at the protein kinase C"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0033634:Protein Kinase C [Amino Acid, Peptide, or Protein,Enzyme]
   913   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   913   C1168438:Protein C [Laboratory Procedure]
   913   C1418943:PROTEIN C [Gene or Genome]
   913   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "not at the protein kinase A-controlled site."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205145:Site [Spatial Concept]
   744   C1515974:Site [Body Location or Region]
   744   C1518422:Not [Functional Concept]
   744   C2587213:Controlled [Functional Concept]
   744   C2825164:Site [Spatial Concept]
Processing 00000000.tx.439: Biochem J 315: 417-420, 1996[ISI][Medline]. 

Phrase: "Biochem J 315"

Phrase: ":"

Phrase: "417-420,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.440: Mumby SM, and Gilman AG. 

Phrase: "Mumby SM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036154:SM [Geographic Area]

Phrase: "and"

Phrase: "Gilman AG."
Processing 00000000.tx.441: Synthetic peptide antisera with determined specificity for G protein alpha or beta subunits. 

Phrase: "Synthetic peptide antisera with determined specificity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for G protein alpha"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1420511:G-ALPHA [Gene or Genome]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "beta subunits."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C1264631:Beta subunit [Qualitative Concept]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]
   827   C1711351:Subunit [Quantitative Concept]
Processing 00000000.tx.442: Methods Enzymol 195: 215-233, 1991[ISI][Medline]. 

Phrase: "Methods Enzymol 195"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "215-233,"

Phrase: "1991"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.443: Munson P, and Rodbard D. 

Phrase: "Munson P,"

Phrase: "and"

Phrase: "Rodbard D."
Processing 00000000.tx.444: LIGAND: a versatile computerized approach for characterization of ligand binding systems. 

Phrase: "LIGAND"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: ":"

Phrase: "a versatile computerized approach for characterization of ligand binding systems."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.445: Anal Biochem 107: 220-239, 1980[ISI][Medline]. 

Phrase: "Anal Biochem 107"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003461:Anal [Body Part, Organ, or Organ Component]
   827   C2939124:Anal [Spatial Concept]

Phrase: ":"

Phrase: "220-239,"

Phrase: "1980"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.446: Ogawa T, Kashiwagi A, Kikkawa R, and Shigeta Y. 

Phrase: "Ogawa T,"

Phrase: "Kashiwagi A,"

Phrase: "Kikkawa R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Shigeta Y."
Processing 00000000.tx.447: Increase of voltage-sensitive calcium channels and calcium accumulation in skeletal muscles of streptozotocin-induced diabetic rats. 

Phrase: "Increase of voltage-sensitive calcium channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "calcium accumulation in skeletal muscles of streptozotocin-induced diabetic rats."
Processing 00000000.tx.448: Metabolism 44: 1455-1461, 1995[ISI][Medline]. 

Phrase: "Metabolism 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: ":"

Phrase: "1455-1461,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.449: Orrenius S, and Nicotera P. 

Phrase: "Orrenius S,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "and"

Phrase: "Nicotera P."
Processing 00000000.tx.450: The calcium ion and cell death. 

Phrase: "The calcium ion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0596235:Calcium ion [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0022023:Ion [Element, Ion, or Isotope]
   861   C1700702:ION [Functional Concept]

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.451: J Neural Trans (Suppl) 43: 1-11, 1994. 

Phrase: "J Neural Trans"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2826298:TRANS [Idea or Concept]

Phrase: "(Suppl) 43"

Phrase: ":"

Phrase: "1-11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1994."
Processing 00000000.tx.452: Ozaki K, Miura K, Tsuchitani M, and Narama I. 

Phrase: "Ozaki K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Miura K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tsuchitani M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Narama I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.453: Peripheral neuropathy in the spontaneously diabetic WBN/Kob rat. 

Phrase: "Peripheral neuropathy in the spontaneously diabetic WBN/Kob rat."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   784   C0740447:Diabetic peripheral neuropathy [Disease or Syndrome]
   764   C0031117:Peripheral Neuropathy [Disease or Syndrome]
   762   C0011882:Diabetic neuropathy [Disease or Syndrome]
   742   C0205100:Peripheral [Spatial Concept]
   742   C0442874:Neuropathy [Disease or Syndrome]
Processing 00000000.tx.454: Acta Neuropathol 92: 603-607, 1996[ISI][Medline]. 

Phrase: "Acta Neuropathol 92"

Phrase: ":"

Phrase: "603-607,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.455: Pittenger GL, Liu D, and Vinik AI. 

Phrase: "Pittenger GL,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0018229:GL [Geographic Area]
   861   C1423073:GL [Gene or Genome]
   861   C1427674:GL [Gene or Genome]

Phrase: "Liu D,"

Phrase: "and"

Phrase: "Vinik AI."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003353:AI [Geographic Area]
   861   C0003504:ai [Disease or Syndrome]
Processing 00000000.tx.456: The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated. 

Phrase: "The apoptotic death of neuroblastoma cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   803   C0162638:apoptotic cell death [Cell Function]
   783   C0007587:cells death [Cell Function]
   753   C0011065:Death [Organism Function]
   753   C1306577:Death, NOS [Finding]

Phrase: "caused by serum"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0229671:Serum [Body Substance]
   790   C1546774:Serum [Intellectual Product]
   790   C1550100:Serum [Body Substance]
   756   C0015127:cause [Functional Concept]
   756   C1524003:Cause [Conceptual Entity]

Phrase: "from patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with insulin-dependent diabetes"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0011854:Insulin Dependent Diabetes [Disease or Syndrome]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0851827:Dependent [Qualitative Concept]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   827   C1701901:Dependent [Qualitative Concept]
   827   C3244310:dependent [Functional Concept]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "may"

Phrase: "be"

Phrase: "Fas-"

Phrase: "mediated."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.457: J Neuroimmunol 76: 153-160, 1997[ISI][Medline]. 

Phrase: "J Neuroimmunol 76"

Phrase: ":"

Phrase: "153-160,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.458: Remmers AE, Clark MJ, Liu XY, and Medzihradsky F. 

Phrase: "Remmers AE,"

Phrase: "Clark MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Liu XY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710693:XY [Organism Attribute]

Phrase: "and"

Phrase: "Medzihradsky F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.459: Delta opioid receptor down-regulation is independent of functional G protein yet is dependent on agonist efficacy. 

Phrase: "Delta opioid receptor down-regulation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   884   C0949469:Receptor Down-Regulation [Molecular Function]
   840   C0013081:Down-Regulation [Cell Function,Molecular Function]
   804   C0851285:Regulation [Governmental or Regulatory Activity]
   804   C1327622:Regulation [Biologic Function]
   748   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   748   C2626739:Lanugo [Eukaryote]
   717   C0140057:delta Opioid Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is independent of functional G protein yet"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0332291:Independent of [Functional Concept]
   774 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0085862:Independent [Idea or Concept]
   748   C0205245:Functional [Functional Concept]
   748   C0439267:g% [Quantitative Concept]
   748   C0542341:Functional [Functional Concept]
   748   C1299583:Independent [Finding]
   748   C2700217:Functional [Conceptual Entity]

Phrase: "is"

Phrase: "dependent on agonist efficacy."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]
Processing 00000000.tx.460: J Pharmacol Exp Ther 287: 625-632, 1998[Abstract/Free FullText]. 

Phrase: "J Pharmacol Exp Ther 287"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "625-632,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.461: Reuveny E, Slesinger PA, Inglese J, Morales JM, Iniguez-Lluhi JA, Lefkowitz RJ, Bourne HR, Jan YN, and Jan LY. 

Phrase: "Reuveny E,"

Phrase: "Slesinger PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Inglese J,"

Phrase: "Morales JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Iniguez-Lluhi JA,"

Phrase: "Lefkowitz RJ,"

Phrase: "Bourne HR,"

Phrase: "Jan YN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2826183:YN [Conceptual Entity]

Phrase: "and"

Phrase: "Jan LY."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023634:LY [Geographic Area]
Processing 00000000.tx.462: Activation of the cloned muscarinic potassium channel by G protein subunits. 

Phrase: "Activation of the cloned muscarinic potassium channel"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1879547:Activation [Activity]

Phrase: "by G protein subunits."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599220:Protein Subunits [Amino Acid, Peptide, or Protein]
   793   C1711351:Subunit [Quantitative Concept]
   734   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.463: Nature 370: 143-146, 1994[ISI][Medline]. 

Phrase: "Nature 370"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "143-146,"

Phrase: "1994"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.464: Ristic H, Hall KE, Sima AAF, and Wiley JW. 

Phrase: "Ristic H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hall KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "Sima AAF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "and"

Phrase: "Wiley JW."
Processing 00000000.tx.465: Serum from diabetic BB/W rats enhances calcium influx in primary sensory neurons: evidence supporting impaired regulation of the inhibitory G protein-calcium channel complex. 

Phrase: "Serum from diabetic BB/W rats"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0229671:Serum [Body Substance]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "calcium influx in primary sensory neurons"

Phrase: ":"

Phrase: "evidence supporting impaired regulation of the inhibitory G protein-calcium channel complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0851285:Regulation [Governmental or Regulatory Activity]
   736   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.466: J Neurophysiol 80: 1236-1244, 1998[Abstract/Free FullText]. 

Phrase: "J Neurophysiol 80"

Phrase: ":"

Phrase: "1236-1244,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.467: Sculptoreanu A, Figourov A, and De Groat WC. 

Phrase: "Sculptoreanu"

Phrase: "A,"

Phrase: "Figourov A,"

Phrase: "and"

Phrase: "De Groat WC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013123:WC [Organism Function]
   827   C2825512:WC [Quantitative Concept]
Processing 00000000.tx.468: Voltage-dependent potentiation of neuronal L-type calcium channels due to state-dependent phosphorylation. 

Phrase: "Voltage-dependent potentiation of neuronal L-type calcium channels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "due to state-dependent phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0031715:Phosphorylation [Molecular Function]
   827   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.469: Am J Physiol Cell Physiol 269: C725-C732, 1995[Abstract]. 

Phrase: "Am"

Phrase: "J Physiol Cell Physiol 269"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "C725-C732,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.470: Srinivasan S, Hosoda K, Dharia D, Ristic H, Hall KE, and Wiley JW. 

Phrase: "Srinivasan S,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "Hosoda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Dharia D,"

Phrase: "Ristic H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hall KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "and"

Phrase: "Wiley JW."
Processing 00000000.tx.471: Impaired neuronal calcium signaling in streptozotocin (STZ)-induced diabetes: comparison with the spontaneous BB/W rat model (Abstract). 

Phrase: "Impaired neuronal calcium signaling in streptozotocin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600431:Calcium Signaling [Cell Function]
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "(STZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: ")-"

Phrase: "induced diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "comparison with the spontaneous BB/W rat model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1707455:Comparison [Activity]

Phrase: "(Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.472: Gastroenterology 112: A1190, 1997[ISI]. 

Phrase: "Gastroenterology 112"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017163:Gastroenterology [Biomedical Occupation or Discipline]

Phrase: ":"

Phrase: "A1190,"

Phrase: "1997"

Phrase: "[ISI"

Phrase: "]."
Processing 00000000.tx.473: Srinivasan S, Stevens M, Sheng H, Hall KE, and Wiley JW. 

Phrase: "Srinivasan S,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1442989:Standard [Qualitative Concept]
   861   C2828392:Standard [Intellectual Product]

Phrase: "Stevens M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Sheng H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hall KE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022558:KE [Geographic Area]

Phrase: "and"

Phrase: "Wiley JW."
Processing 00000000.tx.474: Serum from Type 2diabetics with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells. 

Phrase: "Serum from Type 2diabetics"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0229671:Serum [Body Substance]
   770   C1546774:Serum [Intellectual Product]
   770   C1550100:Serum [Body Substance]

Phrase: "with neuropathy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442874:Neuropathy [Disease or Syndrome]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "complement-independent, calcium-dependent apoptosis in cultured neuronal cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   773   C1660771:neuronal cell apoptosis [Cell Function]
           neuron apoptosis
   742   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.475: J Clin Invest 102: 1454-1462, 1998[Abstract/Free FullText]. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "102"

Phrase: ":"

Phrase: "1454-1462,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.476: Stanley EF, and Mirotznik RR. 

Phrase: "Stanley EF,"

Phrase: "and"

Phrase: "Mirotznik RR."
Processing 00000000.tx.477: Cleavage of sytaxin prevents G-protein regulation of presynaptic calcium channels. 

Phrase: "Cleavage of sytaxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "G-protein regulation of presynaptic calcium channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]
Processing 00000000.tx.478: Nature 385: 340-343, 1997[ISI][Medline]. 

Phrase: "Nature 385"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "340-343,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.479: Szekeres PG, and Traynor JR. 

Phrase: "Szekeres PG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]

Phrase: "and"

Phrase: "Traynor JR."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.480: Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects. 

Phrase: "Delta opioid modulation of the binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443264:Modulation [Spatial Concept]

Phrase: "of guanosine-5'-O-(3-"

Phrase: "[35S"

Phrase: "]thio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412102:THIO [Gene or Genome]

Phrase: ")"

Phrase: "triphosphate to NG108-15 cell membranes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0146894:triphosphate [Inorganic Chemical]

Phrase: ":"

Phrase: "characterization of agonist"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "inverse agonist effects."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.481: J Pharmacol Exp Ther 283: 1276-1284, 1997[Abstract/Free FullText]. 

Phrase: "J Pharmacol Exp Ther 283"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "1276-1284,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.482: Traynor JR, and Nahorski SR. 

Phrase: "Traynor JR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708595:Jr [Idea or Concept]
   861   C3280986:JR [Disease or Syndrome]

Phrase: "and"

Phrase: "Nahorski SR."
Processing 00000000.tx.483: Modulation by -opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. 

Phrase: "Modulation by -opioid agonists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0443264:Modulation [Spatial Concept]

Phrase: "of guanosine-5'-O-(3-"

Phrase: "[35S"

Phrase: "]thio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412102:THIO [Gene or Genome]

Phrase: ")"

Phrase: "triphosphate binding to membranes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "from human neuroblastoma SH-SY5Y cells."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   897   C0427861:Human cells [Laboratory or Test Result]
   858   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.484: Mol Pharmacol 47: 848-854, 1995[Abstract]. 

Phrase: "Mol Pharmacol 47"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   827   C0027960:Mole [Neoplastic Process]
   827   C0324740:Mole [Mammal]
   827   C0439189:Mole [Quantitative Concept]
   827   C1456781:mole [Neoplastic Process]
   827   C1824986:mol [Gene or Genome]
   743 E C0026367:Molar [Body Part, Organ, or Organ Component]
   727 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "848-854,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.485: Voitenko NV, Kostyuk EP, Kruglikov IA, and Kostyuk PG. 

Phrase: "Voitenko NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "Kostyuk EP,"

Phrase: "Kruglikov IA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "and"

Phrase: "Kostyuk PG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]
Processing 00000000.tx.486: Changes in calcium signalling in dorsal horn neurons in rats with streptozotocin-induced diabetes. 

Phrase: "Changes in calcium signalling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in dorsal horn neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0752062:Neurons, Dorsal Horn [Body Part, Organ, or Organ Component]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
   734   C0228575:dorsal horn [Body Part, Organ, or Organ Component]

Phrase: "in rats"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034693:rats [Mammal]
  1000   C0034721:Rats [Mammal]

Phrase: "with streptozotocin-induced diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0038433:Streptozotocin Diabetes [Experimental Model of Disease]
   827   C0011847:Diabetes [Disease or Syndrome]
   827   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.487: Neuroscience 94: 887-890, 1999[ISI][Medline]. 

Phrase: "Neuroscience 94"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "887-890,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.488: Voitenko NV, Kruglikov IA, Kostyuk EP, and Kostyuk PG. 

Phrase: "Voitenko NV,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027951:NV [Geographic Area]
   861   C3540591:NV [Idea or Concept]

Phrase: "Kruglikov IA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1947960:Ia [Mammal]

Phrase: "Kostyuk EP,"

Phrase: "and"

Phrase: "Kostyuk PG."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1266240:PG [Laboratory Procedure]
Processing 00000000.tx.489: Effect of streptozotocin-induced diabetes on the activity of calcium channels in rat dorsal horn neurons. 

Phrase: "Effect of streptozotocin-induced diabetes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on the activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "of calcium channels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0006685:Calcium Channels [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]

Phrase: "in rat dorsal horn neurons."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0752062:Neurons, Dorsal Horn [Body Part, Organ, or Organ Component]
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.490: Neuroscience 95: 519-524, 2000[ISI][Medline]. 

Phrase: "Neuroscience 95"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "519-524,"

Phrase: "2000"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.491: Wilding TJ, Womack MD, and McCleskey EW. 

Phrase: "Wilding TJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039247:TJ [Geographic Area]

Phrase: "Womack MD,"

Phrase: "and"

Phrase: "McCleskey EW."
Processing 00000000.tx.492: Fast, local signal transduction between the mu opioid receptor and Ca2+ channels. 

Phrase: "Fast,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015663:Fast [Finding]
  1000   C0456962:Fast [Qualitative Concept]

Phrase: "local signal transduction between the mu opioid receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037083:Signal Transduction [Cell Function]
   744   C1160185:transduction [Organism Function]
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "Ca2+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439799:Channel [Spatial Concept]
   827   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.493: J Neurosci 15: 4124-4132, 1995[Abstract]. 

Phrase: "J Neurosci 15"

Phrase: ":"

Phrase: "4124-4132,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.494: Wiley JW, Moises HC, Gross RA, and Macdonald RL. 

Phrase: "Wiley JW,"

Phrase: "Moises HC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020268:HC [Hormone,Pharmacologic Substance,Steroid]
   861   C1413512:Hc [Gene or Genome]

Phrase: "Gross RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "and"

Phrase: "Macdonald RL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1419337:RL [Gene or Genome]
   861   C3539667:RL [Gene or Genome]
Processing 00000000.tx.495: Dynorphin A-mediated reduction in multiple calcium currents involves a Go-subtype G protein in rat primary afferent neurons. 

Phrase: "Dynorphin A-mediated reduction in multiple calcium currents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0301630:Reduction [Natural Phenomenon or Process]
   744   C0392756:Reduction [Qualitative Concept]
   744   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "involves"

Phrase: "a"

Phrase: "Go-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1822658:GO [Gene or Genome]

Phrase: "subtype G protein in rat primary afferent neurons."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   767 E C0060916:protein g [Amino Acid, Peptide, or Protein]
   767   C1335665:Rat Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.496: J Neurophysiol 77: 1338-1348, 1997[Abstract/Free FullText]. 

Phrase: "J Neurophysiol 77"

Phrase: ":"

Phrase: "1338-1348,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.497: 0022-3077/01 $5.00 Copyright  2001 The American Physiological Society

Phrase: "0022-3077/01 $5.00 Copyright  2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0009993:Copyright [Intellectual Product]
   795   C1552856:copyright [Idea or Concept]

Phrase: "The American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

